PRKX
Normalized values from positional scanning peptide array
Phospho-serine (pS) is a duplicate of phospho-tyrosine (pT) in PSPA
Position-wise Probabilities
Log-Odds: Probabilities / STY Background
Sites with acceptor types representing >8% and count ≥10 are included
S Sites Probabilities
Log-Odds: S Sites / S Background
Sites with acceptor types representing >8% and count ≥10 are included
Motif clusters with count ≥ 10 are shown
Download
| substrate_uniprot | site | source | substrate_genes | site_seq |
|---|---|---|---|---|
| O00562 | S664 | Sugiyama | PITPNM1 DRES9 NIR2 PITPNM | SQNSLQAAPATTSSWEPRRAstAFCPPAASSEAPDGPSSTA |
| O14579 | S99 | Sugiyama | COPE | PELQAVRMFADyLAHEsRRDsIVAELDREMsRSVDVTNTTF |
| O14618 | S267 | Sugiyama | CCS | DGLTIWEERGRPIAGKGRKEsAQPPAHL_____________ |
| O14974 | S695 | Sugiyama | PPP1R12A MBS MYPT1 | DEEsEsQRKARSRQARQsRRstQGVtLtDLQEAEKtIGRSR |
| O14974 | S910 | Sugiyama | PPP1R12A MBS MYPT1 | yETssTsAGDRyDsLLGRsGsysYLEERKPYSSRLEKDDST |
| O14980 | S1055 | Sugiyama | XPO1 CRM1 | LEEREIALRQADEEKHKRQMsVPGIFNPHEIPEEMCD____ |
| O15143 | S328 | Sugiyama | ARPC1B ARC41 | KAssEGGtAAGAGLDsLHKNsVsQIsVLsGGKAKCSQFCTT |
| O43318 | S439 | Sugiyama | MAP3K7 TAK1 | GNILDVPEIVISGNGQPRRRsIQDLtVtGTEPGQVssRsss |
| O43541 | S435 | GPS6|EPSD|PSP | SMAD6 MADH6 | PTLDAPGGRALVVRKVPPGYsIKVFDFERSGLQHAPEPDAA |
| O43615 | S180 | Sugiyama | TIMM44 MIMT44 TIM44 | AESVSKGGEKLGRTAAFRALsQGVEsVKKEIDDsVLGQtGP |
| O43847 | S94 | Sugiyama | NRDC NRD1 | ENSRVARLGADEsEEEGRRGsLsNAGDPEIVKsPsDPKQYR |
| O43930 | S81 | Sugiyama | PRKY | GRVHLVKEKTAKHFFALKVMsIPDVIRRKQEQHVHNEKSVL |
| O60293 | S42 | Sugiyama | ZFC3H1 CCDC131 KIAA0546 PSRC2 | LEDGEIsDDDNNSQIRSRsssSsSGGGLLPYPRRRPPHSAR |
| O60343 | S588 | Sugiyama | TBC1D4 AS160 KIAA0603 | tssLENIFSRGANRMRGRLGsVDsFERsNsLASEKDYsPGD |
| O60814 | S37 | Sugiyama | H2BC12 H2BFT HIRIP1 HIST1H2BK | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| O60841 | S182 | Sugiyama | EIF5B IF2 KIAA0741 | DGsEEDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKK |
| O60841 | S186 | Sugiyama | EIF5B IF2 KIAA0741 | EDEDNsKKIKERsRINssGEsGDEsDEFLQsRKGQKKNQKN |
| O75348 | S68 | Sugiyama | ATP6V1G1 ATP6G ATP6G1 ATP6J | RLQREKEFKAKEAAALGsRGsCstEVEKETQEKMTILQtyF |
| O75390 | S97 | Sugiyama | CS | GLVyEtsVLDPDEGIRFRGFsIPECQKLLPKAKGGEEPLPE |
| O75665 | S899 | Sugiyama | OFD1 CXorf5 | EEKIREQQVKERRQREERRQsNLQEVLERERRELEKLyQER |
| O94915 | S1957 | Sugiyama | FRYL AF4P12 KIAA0826 | ARsNsLRLsLIGDRRGDRRRsNtLDIMDGRINHsssLARtR |
| O95218 | S181 | Sugiyama | ZRANB2 ZIS ZNF265 | DEDLsKyKLDEDEDEDDADLsKyNLDAsEEEDsNKKKSNRR |
| O95613 | S1814 | Sugiyama | PCNT KIAA0402 PCNT2 | AALEAKEALSRLLADQERRHsQALEALQQRLQGAEEAAELQ |
| P00491 | S176 | Sugiyama | PNP NP | GDRFPAMsDAyDRtMRQRALstWKQMGEQRELQEGTYVMVA |
| P01023 | S273 | Sugiyama | A2M CPAMD5 FWP007 | LYTYGKPVPGHVTVSICRKYsDAsDCHGEDSQAFCEKFSGQ |
| P01023 | S276 | Sugiyama | A2M CPAMD5 FWP007 | YGKPVPGHVTVSICRKYsDAsDCHGEDSQAFCEKFSGQLNS |
| P04075 | S39 | Sugiyama | ALDOA ALDA | IAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRRFy |
| P04075 | S46 | Sugiyama | ALDOA ALDA | PGKGILAADEstGsIAKRLQsIGtENtEENRRFyRQLLLtA |
| P04075 | T37 | Sugiyama | ALDOA ALDA | sDIAHRIVAPGKGILAADEstGsIAKRLQsIGtENtEENRR |
| P04406 | S241 | Sugiyama | GAPDH GAPD CDABP0047 OK/SW-cl.12 | IPELNGKLtGMAFRVPtANVsVVDLtCRLEKPAKyDDIKKV |
| P04792 | S82 | Sugiyama | HSPB1 HSP27 HSP28 | AIEsPAVAAPAYsRALsRQLssGVsEIRHtADRWRVsLDVN |
| P05362 | S43 | Sugiyama | ICAM1 | GPGNAQTSVSPSKVILPRGGsVLVTCstsCDQPKLLGIETP |
| P05386 | S104 | Sugiyama | RPLP1 RRP1 | tAAAPAEEKKVEAKKEEsEEsDDDMGFGLFD__________ |
| P05387 | S105 | Sugiyama | RPLP2 D11S2243E RPP2 | GsAPAAAEEKKDEKKEEsEEsDDDMGFGLFD__________ |
| P05455 | S94 | Sugiyama | SSB | KSKAELMEIsEDKTKIRRsPsKPLPEVTDEyKNDVKNRsVY |
| P07195 | S162 | Sugiyama | LDHB | DILTYVTWKLSGLPKHRVIGsGCNLDsARFRyLMAEKLGIH |
| P07900 | S623 | Sugiyama | HSP90AA1 HSP90A HSPC1 HSPCA | tyGWTANMERIMKAQALRDNstMGyMAAKKHLEINPDHsII |
| P08238 | S452 | Sugiyama | HSP90AB1 HSP90B HSPC2 HSPC3 HSPCB | AFSKNLKLGIHEDstNRRRLsELLRyHtsQsGDEMtsLsEy |
| P09972 | S45 | Sugiyama | ALDOC ALDC | APGKGILAADEsVGsMAKRLsQIGVENtEENRRLYRQVLFs |
| P0C0L4 | S1567 | Sugiyama | C4A CO4 CPAMD2 | GLVQPASATLYDYYNPERRCsVFYGAPSKSRLLATLCSAEV |
| P0C0L5 | S1567 | Sugiyama | C4B CO4 CPAMD3; C4B_2 | GLVQPASATLYDYYNPERRCsVFYGAPSKSRLLATLCSAEV |
| P0DPH7 | S48 | Sugiyama | TUBA3C TUBA2 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P10412 | S36 | Sugiyama | H1-4 H1F4 HIST1H1E | EKtPVKKKARKsAGAAKRKAsGPPVsELItKAVAASKERsG |
| P11142 | S40 | Sugiyama | HSPA8 HSC70 HSP73 HSPA10 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P11586 | S490 | Sugiyama | MTHFD1 MTHFC MTHFD | QTDKALFNRLVPSVNGVRRFsDIQIRRLKRLGIEKTDPTTL |
| P13639 | S23 | Sugiyama | EEF2 EF2 | NFtVDQIRAIMDKKANIRNMsVIAHVDHGKStLtDsLVCKA |
| P13861 | S99 | Sugiyama | PRKAR2A PKR2 PRKAR2 | EsEEDEDLEVPVPsRFNRRVsVCAEtyNPDEEEEDTDPRVI |
| P14314 | S126 | Sugiyama | PRKCSH G19P1 | yNsGVICENtCKEKGRKEREsLQQMAEVtREGFRLKKILIE |
| P15880 | S190 | Sugiyama | RPS2 RPS4 | WGNKIGKPHTVPCKVTGRCGsVLVRLIPAPRGtGIVsAPVP |
| P16333 | S85 | Sugiyama | NCK1 NCK | ASIVKNLKDTLGIGKVKRKPsVPDsAsPADDsFVDPGERLy |
| P16402 | S37 | Sugiyama | H1-3 H1F3 HIST1H1D | KtPVKKKAKKAGATAGKRKAsGPPVsELItKAVAASKERsG |
| P16403 | S36 | Sugiyama | H1-2 H1F2 HIST1H1C | EKAPVKKKAAKKAGGtPRKAsGPPVsELItKAVAASKERsG |
| P17066 | S42 | Sugiyama | HSPA6 HSP70B' | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P17812 | S573 | Sugiyama | CTPS1 CTPS | HYLQKGCRLsPRDtysDRsGsssPDsEItELKFPsINHD__ |
| P18615 | S131 | Sugiyama | NELFE RD RDBP | QRsIsADDDLQEsSRRPQRKsLyEsFVsssDRLRELGPDGE |
| P18621 | S5 | Sugiyama | RPL17 | ________________MVRysLDPENPtKsCKSRGSNLRVH |
| P19174 | S1233 | Sugiyama | PLCG1 PLC1 | PAKENGDLsPFsGtsLRERGsDASGQLFHGRAREGsFEsRy |
| P19338 | S460 | Sugiyama | NCL | ADAEKTFEEKQGtEIDGRsIsLyytGEKGQNQDYRGGKNST |
| P22090 | S204 | Sugiyama | RPS4Y1 RPS4Y PRO2646 | IGGANLGRVGVITNRERHPGsFDVVHVKDANGNSFATRLSN |
| P25205 | S447 | Sugiyama | MCM3 | EQGRVTIAKAGIHARLNARCsVLAAANPVyGRyDQyKTPME |
| P26373 | S77 | Sugiyama | RPL13 BBC1 OK/SW-cl.46 | PIVRCPTVRYHTKVRAGRGFsLEELRVAGIHKKVARTIGIs |
| P27448 | S42 | Sugiyama | MARK3 CTAK1 EMK2 | GDGRQEVTSRTSRSGARCRNsIAsCADEQPHIGNyRLLKTI |
| P27708 | S1859 | Sugiyama | CAD | RGIPGLPDGRFHLPPRIHRAsDPGLPAEEPKEKSSRKVAEP |
| P29401 | S190 | Sugiyama | TKT | ASIYKLDNLVAILDINRLGQsDPAPLQHQMDIyQKRCEAFG |
| P29401 | S305 | Sugiyama | TKT | LAtPPQEDAPsVDIANIRMPsLPsyKVGDKIATRKAYGQAL |
| P29401 | S473 | Sugiyama | TKT | AtEKAVELAANTKGICFIRTsRPENAIIyNNNEDFQVGQAK |
| P29692 | S60 | Sugiyama | EEF1D EF1D | ENGAsVILRDIARARENIQKsLAGssGPGAssGtsGDHGEL |
| P30086 | S52 | Sugiyama | PEBP1 PBP PEBP | AAVDELGKVLtPtQVKNRPtsIsWDGLDsGKLytLVLtDPD |
| P30533 | S242 | Sugiyama | LRPAP1 A2MRAP | TELKEKLRsINQGLDRLRRVsHQGystEAEFEEPRVIDLWD |
| P32119 | S112 | Sugiyama | PRDX2 NKEFB TDPX1 | KEGGLGPLNIPLLADVTRRLsEDyGVLKTDEGIAYRGLFII |
| P34931 | S42 | Sugiyama | HSPA1L | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P34932 | S76 | Sugiyama | HSPA4 APG2 HSPH2 | VISNAKNTVQGFKRFHGRAFsDPFVEAEKSNLAYDIVQLPT |
| P37802 | S163 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | LFsGDPNWFPKKSKENPRNFsDNQLQEGKNVIGLQMGtNRG |
| P37802 | S185 | Sugiyama | TAGLN2 KIAA0120 CDABP0035 | NQLQEGKNVIGLQMGtNRGAsQAGMtGyGMPRQIL______ |
| P38646 | S89 | Sugiyama | HSPA9 GRP75 HSPA9B mt-HSP70 | VMEGKQAKVLENAEGARttPsVVAFtADGERLVGMPAKRQA |
| P39023 | S13 | Sugiyama | RPL3 OK/SW-cl.32 | ________MSHRKFSAPRHGsLGFLPRKRSSRHRGKVKSFP |
| P40818 | S718 | Sugiyama | USP8 KIAA0055 UBPY | AKPQIPAERDREPSKLKRsyssPDItQAIQEEEKRKPTVtP |
| P41091 | S107 | Sugiyama | EIF2S3 EIF2G | KIYKLDDPSCPRPECyRSCGsstPDEFPtDIPGtKGNFKLV |
| P43487 | S60 | Sugiyama | RANBP1 | TLEEDEEELFKMRAKLFRFAsENDLPEWKERGTGDVKLLKH |
| P46013 | S648 | Sugiyama | MKI67 | RVSISRsQHDILQMICSKRRsGAsEANLIVAKSWADVVKLG |
| P46776 | S68 | Sugiyama | RPL27A | yHPGyFGKVGMKHYHLKRNQsFCPtVNLDKLWtLVsEQtRV |
| P46779 | S115 | Sugiyama | RPL28 | HMIRKNKYRPDLRMAAIRRAsAILRSQKPVMVKRKRTRPTK |
| P46937 | S109 | Sugiyama | YAP1 YAP65 | RKLPDsFFKPPEPKsHsRQAstDAGtAGALtPQHVRAHssP |
| P47712 | S727 | Sugiyama | PLA2G4A CPLA2 PLA2G4 | VIKEAMVESIEyRRQNPsRCsVsLsNVEARRFFNKEFLSKP |
| P48741 | S42 | Sugiyama | HSPA7 HSP70B | VFQQGRVEILANDQGNRTtPsyVAFtDtERLVGDAAKsQAA |
| P49207 | S12 | Sugiyama | RPL34 | _________MVQRLTYRRRLsYNtASNKTRLSRTPGNRIVy |
| P49419 | S84 | Sugiyama | ALDH7A1 ATQ1 | EVIttyCPANNEPIARVRQAsVADyEEtVKKAREAWKIWAD |
| P49588 | S237 | Sugiyama | AARS1 AARS | LVFIQYNREADGILKPLPKKsIDtGMGLERLVsVLQNKMSN |
| P49736 | S229 | Sugiyama | MCM2 BM28 CCNL1 CDCL1 KIAA0030 | sHGHNVFKERIsDMCKENREsLVVNyEDLAAREHVLAYFLP |
| P51116 | S601 | Sugiyama | FXR2 FMR1L2 | RPQRRNRSRRRRNRGNRtDGsIsGDRQPVtVADyIsRAEsQ |
| P51817 | S81 | Sugiyama | PRKX PKX1 | GRVHLVKEKTAKHFFALKVMsIPDVIRLKQEQHVHNEKSVL |
| P52298 | S13 | Sugiyama | NCBP2 CBP20 PIG55 | ________MSGGLLKALRsDsyVELSQYRDQHFRGDNEEQE |
| P52732 | S36 | Sugiyama | KIF11 EG5 KNSL1 TRIP5 | GKNIQVVVRCRPFNLAERKAsAHsIVECDPVRKEVSVRTGG |
| P53396 | S455 | Sugiyama | ACLY | ANFLLNAsGststPAPsRtAsFsEsRADEVAPAKKAKPAMP |
| P54105 | S102 | Sugiyama | CLNS1A CLCI ICLN | VNAKFEEEsKEPVADEEEEDsDDDVEPITEFRFVPSDKSAL |
| P54652 | S41 | Sugiyama | HSPA2 | VFQHGKVEIIANDQGNRttPsyVAFtDtERLIGDAAKNQVA |
| P57053 | S37 | Sugiyama | H2BC12L H2BFS H2BS1 | KAVTKAQKKDGRKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P58876 | S37 | Sugiyama | H2BC5 H2BFB HIRIP2 HIST1H2BD | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| P60174 | S21 | Sugiyama | TPI1 TPI | MAPSRKFFVGGNWKMNGRKQsLGELIGtLNAAKVPADtEVV |
| P60174 | S212 | Sugiyama | TPI1 TPI | WLKsNVsDAVAQstRIIyGGsVtGAtCKELASQPDVDGFLV |
| P60709 | S199 | Sugiyama | ACTB | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P60709 | S52 | Sugiyama | ACTB | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P60709 | Y53 | Sugiyama | ACTB | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P61313 | S100 | Sugiyama | RPL15 EC45 TCBAP0781 | tyGKPVHHGVNQLKFARsLQsVAEERAGRHCGALRVLNsyW |
| P61353 | S86 | Sugiyama | RPL27 | SKIKSFVKVyNyNHLMPtRysVDIPLDKtVVNKDVFRDPAL |
| P61978 | S75 | Sugiyama | HNRNPK HNRPK | GAVIGKGGKNIKALRtDyNAsVsVPDssGPERILsISADIE |
| P62249 | S9 | Sugiyama | RPS16 | ____________MPsKGPLQsVQVFGRKKTATAVAHCKRGN |
| P62277 | S12 | Sugiyama | RPS13 | _________MGRMHAPGKGLsQsALPyRRsVPtWLKLTsDD |
| P62701 | S204 | Sugiyama | RPS4X CCG2 RPS4 SCAR | tGGANLGRIGVITNRERHPGsFDVVHVKDANGNSFATRLsN |
| P62736 | S54 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P62736 | Y55 | Sugiyama | ACTA2 ACTSA ACTVS GIG46 | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P62807 | S37 | Sugiyama | H2BC4 H2BFL HIST1H2BC; H2BC6 H2BFH HIST1H2BE; H2BC7 H2BFG HIST1H2BF; H2BC8 H2BFA HIST1H2BG; H2BC10 H2BFK HIST1H2BI | KAVTKAQKKDGKKRKRsRKEsysVyVyKVLKQVHPDTGIss |
| P62906 | S64 | Sugiyama | RPL10A NEDD6 | QKDKRFsGTVRLKSTPRPKFsVCVLGDQQHCDEAKAVDIPH |
| P62917 | S130 | Sugiyama | RPL8 | GTIVCCLEEKPGDRGKLARAsGNyAtVIsHNPEtKKtRVKL |
| P62917 | S14 | Sugiyama | RPL8 | _______MGRVIRGQRKGAGsVFRAHVKHRKGAARLRAVDF |
| P63146 | S142 | Sugiyama | UBE2B RAD6B UBCH1 | ANSQAAQLYQENKREYEKRVsAIVEQsWNDS__________ |
| P63261 | S199 | Sugiyama | ACTG1 ACTG | DLAGRDLTDyLMKILtERGysFtttAEREIVRDIKEKLCyV |
| P63261 | S52 | Sugiyama | ACTG1 ACTG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIE |
| P63261 | Y53 | Sugiyama | ACTG1 ACTG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKYPIEH |
| P63267 | S53 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P63267 | Y54 | Sugiyama | ACTG2 ACTA3 ACTL3 ACTSG | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68032 | S54 | Sugiyama | ACTC1 ACTC | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68032 | Y55 | Sugiyama | ACTC1 ACTC | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68133 | S54 | Sugiyama | ACTA1 ACTA | PsIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIE |
| P68133 | Y55 | Sugiyama | ACTA1 ACTA | sIVGRPRHQGVMVGMGQKDsyVGDEAQsKRGILTLKyPIEH |
| P68363 | S48 | Sugiyama | TUBA1B | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| P78345 | S253 | Sugiyama | RPP38 | DtsFEDLsKPKRKLADGRQAsVtLQPLKIKKLIPNPNKIRK |
| P83731 | S86 | Sugiyama | RPL24 | EIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKAQRE |
| P83731 | T83 | Sugiyama | RPL24 | QsEEIQKKRTRRAVKFQRAItGAsLADIMAKRNQKPEVRKA |
| P84098 | S12 | Sugiyama | RPL19 | _________MSMLRLQKRLAssVLRCGKKKVWLDPNEtNEI |
| P98161 | S4166 | GPS6|SIGNOR|EPSD|PSP | PKD1 | VKEFRHKVRFEGMEPLPSRSsRGsKVSPDVPPPSAGSDASH |
| Q00610 | S146 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | AVYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLL |
| Q00610 | S147 | Sugiyama | CLTC CLH17 CLTCL2 KIAA0034 | VYHWSMEGESQPVKMFDRHssLAGCQIINYRTDAKQKWLLL |
| Q02543 | S123 | Sugiyama | RPL18A | AGAVtQCyRDMGARHRARAHsIQIMKVEEIAASKCRRPAVK |
| Q04917 | S145 | Sugiyama | YWHAH YWHA1 | KMKGDYYRYLAEVASGEKKNsVVEAsEAAyKEAFEISKEQM |
| Q07021 | S210 | Sugiyama | C1QBP GC1QBP HABP1 SF2P32 | EDEVGQEDEAEsDIFsIREVsFQstGESEWKDTNYTLNTDS |
| Q07666 | S20 | Sugiyama | KHDRBS1 SAM68 | _MQRRDDPAARMsRssGRsGsMDPsGAHPsVRQtPsRQPPL |
| Q08211 | S449 | Sugiyama | DHX9 DDX9 LKP NDH2 | FIQNDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSC |
| Q08211 | S452 | Sugiyama | DHX9 DDX9 LKP NDH2 | NDRAAECNIVVTQPRRIsAVsVAERVAFERGEEPGKSCGYS |
| Q09028 | S146 | Sugiyama | RBBP4 RBAP48 | EVNRARYMPQNPCIIATKtPssDVLVFDyTKHPsKPDPsGE |
| Q09161 | S22 | Sugiyama | NCBP1 CBP80 NCBP | SRRRHsDENDGGQPHKRRKtsDANEtEDHLEsLICKVGEKS |
| Q12789 | S1868 | Sugiyama | GTF3C1 | EGQAPPsHsPRGTKRRAsWAsENGEtDAEGTQMtPAKRPAL |
| Q12982 | S114 | Sugiyama | BNIP2 NIP2 | EFEWEDDLPKPKTTEVIRKGsItEyTAAEEKEDGRRWRMFR |
| Q13247 | S301 | Sugiyama | SRSF6 SFRS6 SRP55 | PKENGKGDIKsKSRsRsQsRsNsPLPVPPsKARsVsPPPKR |
| Q13501 | S24 | Sugiyama | SQSTM1 ORCA OSIL | LTVKAYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPC |
| Q13501 | S28 | Sugiyama | SQSTM1 ORCA OSIL | AYLLGKEDAAREIRRFsFCCsPEPEAEAEAAAGPGPCERLL |
| Q14152 | S584 | Sugiyama | EIF3A EIF3S10 KIAA0139 | EHQRILARRQtIEERKERLEsLNIQREKEELEQREAELQKV |
| Q14157 | S852 | Sugiyama | UBAP2L KIAA0144 NICE4 | LDyysIPFPtPttPLtGRDGsLAsNPysGDLtKFGRGDASS |
| Q14671 | S709 | Sugiyama | PUM1 KIAA0099 PUMH1 | LGGFGTAVANSNTGSGSRRDsLtGSsDLYKRTSSSLTPIGH |
| Q14738 | S573 | Sugiyama | PPP2R5D | TEAVQMLKDIKKEKVLLRRKsELPQDVyTIKALEAHKRAEE |
| Q15080 | S67 | Sugiyama | NCF4 SH3PXD4 | TKGGSKYLIYRRYRQFHALQsKLEERFGPDSKSSALACTLP |
| Q15149 | S4386 | Sugiyama | PLEC PLEC1 | ItEFADMLsGNAGGFRsRsssVGssssyPIsPAVsRtQLAs |
| Q15785 | S93 | Sugiyama | TOMM34 URCC3 | DCTSALALVPFSIKPLLRRAsAyEALEKYPMAYVDYKTVLQ |
| Q16576 | S145 | Sugiyama | RBBP7 RBAP46 | EVNRARYMPQNPHIIATKtPssDVLVFDyTKHPAKPDPsGE |
| Q32MZ4 | S120 | Sugiyama | LRRFIP1 GCF2 TRIP | MPGLSAAtLAsLGGtssRRGsGDtsISIDTEASIREIKELN |
| Q32MZ4 | S124 | Sugiyama | LRRFIP1 GCF2 TRIP | SAAtLAsLGGtssRRGsGDtsISIDTEASIREIKELNELKD |
| Q3KQU3 | S112 | Sugiyama | MAP7D1 KIAA1187 PARCC1 RPRC1 PP2464 | KsRGPtPPAMGPRDARPPRRssQPsPtAVPAsDsPPtKQEV |
| Q5QNW6 | S37 | Sugiyama | H2BC18 HIST2H2BF | KAVTKVQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q5T0N5 | S488 | Sugiyama | FNBP1L C1orf39 TOCA1 | NEAWLSEVEGKTGGRGDRRHssDINHLVtQGREsPEGsytD |
| Q5T1M5 | S1162 | Sugiyama | FKBP15 KIAA0674 | EAGstVAGAALRPsHHsQRssLsGDEEDELFKGATLKALRP |
| Q5T2R2 | S355 | Sugiyama | PDSS1 DPS1 TPRT | PVLFACQQFPEMNAMIMRRFsLPGDVDRARQYVLQSDGVQQ |
| Q6PEY2 | S48 | Sugiyama | TUBA3E | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q6ZN18 | S206 | Sugiyama | AEBP2 | DEGYGTGGGGSSATSGGRRGsLEMssDGEPLSRMDSEDSIS |
| Q71U36 | S48 | Sugiyama | TUBA1A TUBA3 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q7Z417 | S655 | Sugiyama | NUFIP2 KIAA1321 PIG1 | LGsAKEQRYQRGLERNDsWGsFDLRAAIVYHTKEMEsIWNL |
| Q7Z4V5 | S370 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | KERRRERADRGEAERGsGGssGDELREDDEPVKKRGRKGRG |
| Q7Z4V5 | S454 | Sugiyama | HDGFL2 HDGF2 HDGFRP2 HRP2 UNQ785/PRO1604 | VRPEEKQQAKPVKVERTRKRsEGFsMDRKVEKKKEPSVEEK |
| Q7Z5L9 | S455 | Sugiyama | IRF2BP2 | AGGSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVG |
| Q7Z5L9 | S457 | Sugiyama | IRF2BP2 | GSHASKDANQVHSTTRRNsNsPPsPssMNQRRLGPREVGGQ |
| Q86W56 | Y832 | Sugiyama | PARG | DDWQRRCTEIVAIDALHFRRyLDQFVPEKMRRELNKAYCGF |
| Q8IWX8 | S904 | Sugiyama | CHERP DAN26 SCAF6 | KGVGVALDDPyENyRRNKsysFIARMKARDECK________ |
| Q8IZ21 | S590 | Sugiyama | PHACTR4 PRO2963 | SKEEWNEIRHQIGNTLIRRLsQRPtPEELEQRNILQPKNEA |
| Q8NBJ7 | S256 | Sugiyama | SUMF2 PSEC0171 UNQ1968/PRO4500 | EWTASPYQAAEQDMRVLRGAsWIDtADGsANHRARVttRMG |
| Q8TEW0 | S720 | Sugiyama | PARD3 PAR3 PAR3A | ELPIETALDDRERRIsHsLysGIEGLDEsPsRNAALsRIMG |
| Q92597 | S330 | Sugiyama | NDRG1 CAP43 DRG1 RTP | QGMGYMPsAsMtRLMRsRtAsGssVtsLDGtRsRsHtSEGT |
| Q92766 | S1167 | Sugiyama | RREB1 FINB | AGTSKKRGRKRGMRSRPRANsGGVDLDssGEFASIEKMLAT |
| Q93079 | S37 | Sugiyama | H2BC9 H2BFJ HIST1H2BH | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q96EP0 | S466 | Sugiyama | RNF31 ZIBRA | RPYAssLEKGPPKPGPPRRLsAPLPSsCGDPEKQRQDKMRE |
| Q96G46 | S236 | Sugiyama | DUS3L | QQLRKREVRFERAEQALRRFsQGPtPAAAVPEGTAAEGAPR |
| Q96PK6 | S618 | Sugiyama | RBM14 SIP | MSKRYGSDRRLAELsDYRRLsEsQLsFRRsPtKSSLDYRRL |
| Q99584 | S32 | Sugiyama | S100A13 | SIETVVTTFFTFARQEGRKDsLsVNEFKELVTQQLPHLLKD |
| Q99877 | S37 | Sugiyama | H2BC15 H2BFD HIST1H2BN | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99879 | S37 | Sugiyama | H2BC14 H2BFE HIST1H2BM | KAINKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q99880 | S37 | Sugiyama | H2BC13 H2BFC HIST1H2BL | KAVTKAQKKDGKKRKRSRKEsysVyVyKVLKQVHPDTGIss |
| Q9BQE3 | S48 | Sugiyama | TUBA1C TUBA6 | HGIQPDGQMPSDKtIGGGDDsFNtFFsEtGAGKHVPRAVFV |
| Q9BRA2 | S41 | Sugiyama | TXNDC17 TXNL5 | QHNGKTIFAyFTGSKDAGGKsWCPDCVQAEPVVREGLKHIS |
| Q9BTC0 | S1456 | Sugiyama | DIDO1 C20orf158 DATF1 KIAA0333 | EAKVTVDDLPNRMCADVRRNsVERPAEPVAGAAtPsLVEQQ |
| Q9C0C2 | S429 | Sugiyama | TNKS1BP1 KIAA1741 TAB182 | EEEAKGDAHLRPtsLVQRRFsEGVLQsPsQDQEKLGGsLAA |
| Q9H0B6 | S428 | Sugiyama | KLC2 | NKPIWMHAEEREESKDKRRDsAPyGEyGsWYKACKVDsPtV |
| Q9H0D6 | S678 | Sugiyama | XRN2 | LRAALEEVyPDLTPEEtRRNsLGGDVLFVGKHHPLHDFILE |
| Q9H2G2 | S340 | Sugiyama | SLK KIAA0204 STK2 | EEDEEEEtENsLPIPAsKRAssDLsIAssEEDKLsQNACIL |
| Q9H788 | S315 | Sugiyama | SH2D4A PPP1R38 SH2A | LNSGAYPQKPLRNQGVVRtLsssAQEDIIRWFKEEQLPLRA |
| Q9H7D7 | S121 | Sugiyama | WDR26 CDW2 MIP2 PRO0852 | ASSSLATPELGSSLKKKKRLsQsDEDVIRLIGQHLNGLGLN |
| Q9H7E9 | T40 | Sugiyama | C8orf33 | PCAsRGARLPGPVsSARNPstVCLCPEQPTCSNADSRAHPL |
| Q9P0K1 | S834 | Sugiyama | ADAM22 MDC2 | RIPDTKHISDICENGRPRsNsWQGNLGGNKKKIRGKRFRPR |
| Q9P265 | S203 | Sugiyama | DIP2B KIAA1463 | stsssASSTLSHGEVKGtsGsLADVFANtRIENFSAPPDVT |
| Q9UBP6 | S27 | Sugiyama | METTL1 C12orf1 | NVAGAEAPPPQKRYYRQRAHsNPMADHTLRYPVKPEEMDWS |
| Q9UGV2 | S327 | Sugiyama | NDRG3 | KYFLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsV |
| Q9UGV2 | S331 | Sugiyama | NDRG3 | QGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQ |
| Q9UGV2 | S333 | Sugiyama | NDRG3 | MGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQsD |
| Q9UGV2 | T329 | Sugiyama | NDRG3 | FLQGMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVts |
| Q9UGV2 | T332 | Sugiyama | NDRG3 | GMGYIPSASMTRLARsRtHstsssLGsGEsPFsRsVtsNQs |
| Q9UHD1 | S200 | Sugiyama | CHORDC1 CHP1 | SGVPIFHEGMKYWSCCRRKtsDFNtFLAQEGCtKGKHMWTK |
| Q9UI15 | S185 | Sugiyama | TAGLN3 NP25 | EQLRQGQNVIGLQMGSNKGAsQAGMtGyGMPRQIM______ |
| Q9UKV8 | S387 | Sugiyama | AGO2 EIF2C2 | ATARSAPDRQEEISKLMRsAsFNTDPyVREFGIMVKDEMTD |
| Q9UNH7 | S316 | Sugiyama | SNX6 | LKYYLRESQAAKDLLYRRsRsLVDYENANKALDKARAKNKD |
| Q9UPQ0 | S201 | Sugiyama | LIMCH1 KIAA1102 | DCWDsERsDsLsPPRHGRDDsFDsLDsFGsRsRQtPsPDVV |
| Q9UPQ0 | S377 | Sugiyama | LIMCH1 KIAA1102 | LREEDDKWQDDLARWKSRRRsVsQDLIKKEEERKKMEKLLA |
| Q9UQ35 | S1539 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sEssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEs |
| Q9UQ35 | S1541 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ssVDQKtVARtPLGQRsRsGssQELDVKPsAsPQERsEsDs |
| Q9UQ35 | S2692 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | ERRSRSPRKPIDsLRDsRsLsysPVERRRPsPQPsPRDQQS |
| Q9UQ35 | S854 | Sugiyama | SRRM2 KIAA0324 SRL300 SRM300 HSPC075 | sHSsssPHPKVKsGtPPRQGsItsPQANEQsVtPQRRsCFE |
Site Promiscuity
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Chromatin modifying enzymes | R-HSA-3247509 | 2.836505e-07 | 6.547 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 7.594410e-07 | 6.120 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 6.562878e-06 | 5.183 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 7.261620e-06 | 5.139 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.088726e-05 | 4.680 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 2.632850e-05 | 4.580 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 2.483822e-05 | 4.605 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 4.212803e-05 | 4.375 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 6.647974e-05 | 4.177 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 9.854993e-05 | 4.006 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 1.047670e-04 | 3.980 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 1.143028e-04 | 3.942 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 1.451507e-04 | 3.838 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 1.701871e-04 | 3.769 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.441782e-04 | 3.612 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 2.647094e-04 | 3.577 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 2.835166e-04 | 3.547 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 3.330239e-04 | 3.478 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 4.552694e-04 | 3.342 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 5.501770e-04 | 3.259 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 7.463601e-04 | 3.127 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 7.734208e-04 | 3.112 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 8.127871e-04 | 3.090 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 8.245656e-04 | 3.084 | 1 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 8.132062e-04 | 3.090 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 8.845928e-04 | 3.053 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 1.012137e-03 | 2.995 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.031107e-03 | 2.987 | 0 | 0 |
| Kinesins | R-HSA-983189 | 1.039623e-03 | 2.983 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 1.088469e-03 | 2.963 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.150111e-03 | 2.939 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 1.138139e-03 | 2.944 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.174477e-03 | 2.930 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 1.406026e-03 | 2.852 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 1.447791e-03 | 2.839 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 1.532185e-03 | 2.815 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 1.607322e-03 | 2.794 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 2.163849e-03 | 2.665 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 2.254837e-03 | 2.647 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 2.284155e-03 | 2.641 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 2.314794e-03 | 2.635 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 2.708800e-03 | 2.567 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 2.622257e-03 | 2.581 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 2.622257e-03 | 2.581 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 2.690492e-03 | 2.570 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 3.030634e-03 | 2.518 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 3.087285e-03 | 2.510 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 4.228654e-03 | 2.374 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 5.342547e-03 | 2.272 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 5.190254e-03 | 2.285 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 5.190254e-03 | 2.285 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 5.190254e-03 | 2.285 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 5.190254e-03 | 2.285 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 5.341593e-03 | 2.272 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 5.321515e-03 | 2.274 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 4.871987e-03 | 2.312 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 5.939228e-03 | 2.226 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 6.363945e-03 | 2.196 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 6.216455e-03 | 2.206 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 6.510752e-03 | 2.186 | 1 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 7.220524e-03 | 2.141 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 7.220524e-03 | 2.141 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 7.220524e-03 | 2.141 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 7.220524e-03 | 2.141 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 7.220524e-03 | 2.141 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 6.926243e-03 | 2.160 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 7.617467e-03 | 2.118 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 8.211843e-03 | 2.086 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 8.211843e-03 | 2.086 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 9.073647e-03 | 2.042 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 9.534138e-03 | 2.021 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 9.630044e-03 | 2.016 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 1.034488e-02 | 1.985 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 1.037435e-02 | 1.984 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.042255e-02 | 1.982 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.042255e-02 | 1.982 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.135110e-02 | 1.945 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 1.233259e-02 | 1.909 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 1.241192e-02 | 1.906 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 1.401589e-02 | 1.853 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 1.401589e-02 | 1.853 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 1.566270e-02 | 1.805 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.566270e-02 | 1.805 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 1.539002e-02 | 1.813 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 1.491204e-02 | 1.826 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.654290e-02 | 1.781 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.654290e-02 | 1.781 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.654290e-02 | 1.781 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.654290e-02 | 1.781 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.741827e-02 | 1.759 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.710022e-02 | 1.767 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.885163e-02 | 1.725 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.885163e-02 | 1.725 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.885163e-02 | 1.725 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.885163e-02 | 1.725 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.885163e-02 | 1.725 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 1.878984e-02 | 1.726 | 0 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 1.809406e-02 | 1.742 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 1.854754e-02 | 1.732 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 1.878926e-02 | 1.726 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest | R-HSA-6804116 | 1.956798e-02 | 1.708 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.151093e-02 | 1.667 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 2.099399e-02 | 1.678 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 2.149773e-02 | 1.668 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 2.149773e-02 | 1.668 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 2.099399e-02 | 1.678 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of cell cycle factors | R-HSA-8866911 | 2.553695e-02 | 1.593 | 0 | 0 |
| RUNX2 regulates genes involved in differentiation of myeloid cells | R-HSA-8941333 | 2.553695e-02 | 1.593 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 2.409551e-02 | 1.618 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 2.409551e-02 | 1.618 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 2.409551e-02 | 1.618 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 2.535977e-02 | 1.596 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 2.409551e-02 | 1.618 | 0 | 0 |
| Transcriptional activation of cell cycle inhibitor p21 | R-HSA-69895 | 2.553695e-02 | 1.593 | 0 | 0 |
| Transcriptional activation of p53 responsive genes | R-HSA-69560 | 2.553695e-02 | 1.593 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.449646e-02 | 1.611 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 2.574214e-02 | 1.589 | 0 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 2.592735e-02 | 1.586 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 2.777504e-02 | 1.556 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 2.777504e-02 | 1.556 | 0 | 0 |
| M Phase | R-HSA-68886 | 2.832280e-02 | 1.548 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 2.916510e-02 | 1.535 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 3.040640e-02 | 1.517 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 2.909358e-02 | 1.536 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.166395e-02 | 1.499 | 1 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 3.122570e-02 | 1.505 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 2.908004e-02 | 1.536 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 3.352996e-02 | 1.475 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 3.379964e-02 | 1.471 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 3.488799e-02 | 1.457 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 3.524656e-02 | 1.453 | 0 | 0 |
| RUNX2 regulates chondrocyte maturation | R-HSA-8941284 | 3.761706e-02 | 1.425 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.554238e-02 | 1.449 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 3.826555e-02 | 1.417 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 3.826555e-02 | 1.417 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 3.879536e-02 | 1.411 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 3.879536e-02 | 1.411 | 1 | 0 |
| Semaphorin interactions | R-HSA-373755 | 3.826555e-02 | 1.417 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 4.165869e-02 | 1.380 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 4.893292e-02 | 1.310 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 4.893292e-02 | 1.310 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 4.596180e-02 | 1.338 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 4.596180e-02 | 1.338 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.815933e-02 | 1.317 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 4.713829e-02 | 1.327 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 4.841471e-02 | 1.315 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 4.425966e-02 | 1.354 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 4.738218e-02 | 1.324 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 4.738218e-02 | 1.324 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 4.890648e-02 | 1.311 | 0 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 4.841471e-02 | 1.315 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 4.898586e-02 | 1.310 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 5.211128e-02 | 1.283 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 5.211128e-02 | 1.283 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 5.211128e-02 | 1.283 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.212699e-02 | 1.283 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 5.269819e-02 | 1.278 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 5.415138e-02 | 1.266 | 1 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 5.428191e-02 | 1.265 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 5.428191e-02 | 1.265 | 1 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.435992e-02 | 1.265 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 5.435992e-02 | 1.265 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 5.468661e-02 | 1.262 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 5.468661e-02 | 1.262 | 0 | 0 |
| RUNX3 regulates RUNX1-mediated transcription | R-HSA-8951911 | 6.589246e-02 | 1.181 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 6.589246e-02 | 1.181 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 6.104815e-02 | 1.214 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 6.080163e-02 | 1.216 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 6.080163e-02 | 1.216 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 5.890592e-02 | 1.230 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 5.928278e-02 | 1.227 | 0 | 0 |
| Regulation of TP53 Expression | R-HSA-6804754 | 6.589246e-02 | 1.181 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 6.007805e-02 | 1.221 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 6.794147e-02 | 1.168 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 6.823004e-02 | 1.166 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 6.823004e-02 | 1.166 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in WNT signaling | R-HSA-8939256 | 6.889041e-02 | 1.162 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 7.009762e-02 | 1.154 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 7.069082e-02 | 1.151 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 7.125520e-02 | 1.147 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 7.317191e-02 | 1.136 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 7.334386e-02 | 1.135 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 7.518240e-02 | 1.124 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 7.645708e-02 | 1.117 | 0 | 0 |
| Regulation of gene expression in beta cells | R-HSA-210745 | 7.645708e-02 | 1.117 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 8.778134e-02 | 1.057 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 8.778134e-02 | 1.057 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 8.778134e-02 | 1.057 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 8.778134e-02 | 1.057 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 8.463641e-02 | 1.072 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 8.699179e-02 | 1.061 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 8.629375e-02 | 1.064 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 8.162528e-02 | 1.088 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 8.694320e-02 | 1.061 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 8.628265e-02 | 1.064 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 8.285945e-02 | 1.082 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 8.168196e-02 | 1.088 | 1 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 8.226409e-02 | 1.085 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 8.541025e-02 | 1.068 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 8.782395e-02 | 1.056 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 9.477593e-02 | 1.023 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 9.477593e-02 | 1.023 | 0 | 0 |
| Nephron development | R-HSA-9831926 | 9.477593e-02 | 1.023 | 0 | 0 |
| Drug resistance of PDGFR mutants | R-HSA-9674415 | 9.879373e-02 | 1.005 | 0 | 0 |
| PDGFR mutants bind TKIs | R-HSA-9674428 | 9.879373e-02 | 1.005 | 0 | 0 |
| Sorafenib-resistant PDGFR mutants | R-HSA-9674404 | 9.879373e-02 | 1.005 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 9.879373e-02 | 1.005 | 0 | 0 |
| Imatinib-resistant PDGFR mutants | R-HSA-9674396 | 9.879373e-02 | 1.005 | 0 | 0 |
| Defective translocation of RB1 mutants to the nucleus | R-HSA-9661070 | 9.879373e-02 | 1.005 | 0 | 0 |
| Sunitinib-resistant PDGFR mutants | R-HSA-9674401 | 9.879373e-02 | 1.005 | 0 | 0 |
| Regorafenib-resistant PDGFR mutants | R-HSA-9674403 | 9.879373e-02 | 1.005 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 9.633337e-02 | 1.016 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 1.085815e-01 | 0.964 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 1.085815e-01 | 0.964 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 1.085815e-01 | 0.964 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 1.085815e-01 | 0.964 | 0 | 0 |
| Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects | R-HSA-9659787 | 1.035677e-01 | 0.985 | 0 | 0 |
| Defective binding of RB1 mutants to E2F1,(E2F2, E2F3) | R-HSA-9661069 | 1.035677e-01 | 0.985 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 1.081959e-01 | 0.966 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 9.636414e-02 | 1.016 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 9.636414e-02 | 1.016 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 1.033459e-01 | 0.986 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 1.047037e-01 | 0.980 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 9.773372e-02 | 1.010 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 1.019281e-01 | 0.992 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 9.590619e-02 | 1.018 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 9.636414e-02 | 1.016 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 9.955749e-02 | 1.002 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.063954e-01 | 0.973 | 0 | 0 |
| Kidney development | R-HSA-9830369 | 9.762082e-02 | 1.010 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 1.061318e-01 | 0.974 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 1.115822e-01 | 0.952 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.154751e-01 | 0.938 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 1.164124e-01 | 0.934 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.169137e-01 | 0.932 | 0 | 0 |
| Defective DNA double strand break response due to BARD1 loss of function | R-HSA-9699150 | 1.878325e-01 | 0.726 | 0 | 0 |
| Impaired BRCA2 binding to SEM1 (DSS1) | R-HSA-9763198 | 1.878325e-01 | 0.726 | 0 | 0 |
| Defective DNA double strand break response due to BRCA1 loss of function | R-HSA-9663199 | 1.878325e-01 | 0.726 | 0 | 0 |
| Impaired BRCA2 translocation to the nucleus | R-HSA-9709275 | 1.878325e-01 | 0.726 | 0 | 0 |
| Regulation of gap junction activity | R-HSA-191650 | 1.298782e-01 | 0.886 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 1.298782e-01 | 0.886 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 1.298782e-01 | 0.886 | 0 | 0 |
| PI and PC transport between ER and Golgi membranes | R-HSA-1483196 | 2.680790e-01 | 0.572 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.680790e-01 | 0.572 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.680790e-01 | 0.572 | 0 | 0 |
| PTEN Loss of Function in Cancer | R-HSA-5674404 | 2.680790e-01 | 0.572 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.680790e-01 | 0.572 | 0 | 0 |
| Intestinal infectious diseases | R-HSA-8942233 | 2.680790e-01 | 0.572 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.680790e-01 | 0.572 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in interleukin signaling | R-HSA-8939247 | 1.656173e-01 | 0.781 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 1.656173e-01 | 0.781 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in BCR signaling | R-HSA-8939245 | 1.656173e-01 | 0.781 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.656173e-01 | 0.781 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 1.656173e-01 | 0.781 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 1.310702e-01 | 0.882 | 0 | 0 |
| Signaling by MAPK mutants | R-HSA-9652817 | 2.027905e-01 | 0.693 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 3.404010e-01 | 0.468 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 3.404010e-01 | 0.468 | 0 | 0 |
| Interaction between PHLDA1 and AURKA | R-HSA-8854521 | 3.404010e-01 | 0.468 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 3.404010e-01 | 0.468 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 3.404010e-01 | 0.468 | 0 | 0 |
| Potassium transport channels | R-HSA-1296067 | 3.404010e-01 | 0.468 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 3.404010e-01 | 0.468 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | R-HSA-5655799 | 3.404010e-01 | 0.468 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 3.404010e-01 | 0.468 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 3.404010e-01 | 0.468 | 0 | 0 |
| HHAT G278V doesn't palmitoylate Hh-Np | R-HSA-5658034 | 3.404010e-01 | 0.468 | 0 | 0 |
| Mitotic Metaphase/Anaphase Transition | R-HSA-68881 | 3.404010e-01 | 0.468 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 3.404010e-01 | 0.468 | 0 | 0 |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | R-HSA-5619049 | 3.404010e-01 | 0.468 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 3.404010e-01 | 0.468 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 3.404010e-01 | 0.468 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 3.404010e-01 | 0.468 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 3.404010e-01 | 0.468 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 3.404010e-01 | 0.468 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 3.404010e-01 | 0.468 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.550185e-01 | 0.810 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 1.204974e-01 | 0.919 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 1.801954e-01 | 0.744 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 1.385248e-01 | 0.858 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 1.224859e-01 | 0.912 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 1.224859e-01 | 0.912 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 1.224859e-01 | 0.912 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 1.224859e-01 | 0.912 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 1.224859e-01 | 0.912 | 0 | 0 |
| Differentiation of naive CD+ T cells to T helper 1 cells (Th1 cells) | R-HSA-9942503 | 1.575531e-01 | 0.803 | 0 | 0 |
| Differentiation of T cells | R-HSA-9945266 | 1.575531e-01 | 0.803 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 2.063743e-01 | 0.685 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 2.063743e-01 | 0.685 | 0 | 0 |
| RUNX1 regulates estrogen receptor mediated transcription | R-HSA-8931987 | 2.790228e-01 | 0.554 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.790228e-01 | 0.554 | 0 | 0 |
| Netrin mediated repulsion signals | R-HSA-418886 | 2.790228e-01 | 0.554 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 2.790228e-01 | 0.554 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to triglyceride lipolysis in adipose | R-HSA-9031528 | 2.790228e-01 | 0.554 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 2.790228e-01 | 0.554 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.790228e-01 | 0.554 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.790228e-01 | 0.554 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 2.790228e-01 | 0.554 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 4.055806e-01 | 0.392 | 0 | 0 |
| Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | R-HSA-9944997 | 4.055806e-01 | 0.392 | 0 | 0 |
| Loss of Function of KMT2D in Kabuki Syndrome | R-HSA-9944971 | 4.055806e-01 | 0.392 | 0 | 0 |
| Invadopodia formation | R-HSA-8941237 | 4.055806e-01 | 0.392 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.774799e-01 | 0.751 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 1.774799e-01 | 0.751 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 2.333364e-01 | 0.632 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 1.534911e-01 | 0.814 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 1.334008e-01 | 0.875 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 3.171349e-01 | 0.499 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 3.171349e-01 | 0.499 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.470549e-01 | 0.833 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.470549e-01 | 0.833 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 2.608744e-01 | 0.584 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 2.196018e-01 | 0.658 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 1.613117e-01 | 0.792 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 1.761355e-01 | 0.754 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 3.547578e-01 | 0.450 | 0 | 0 |
| TNFR1-mediated ceramide production | R-HSA-5626978 | 4.643228e-01 | 0.333 | 0 | 0 |
| AKT-mediated inactivation of FOXO1A | R-HSA-211163 | 4.643228e-01 | 0.333 | 0 | 0 |
| PLCG1 events in ERBB2 signaling | R-HSA-1251932 | 4.643228e-01 | 0.333 | 0 | 0 |
| Defective CP causes aceruloplasminemia (ACERULOP) | R-HSA-5619060 | 4.643228e-01 | 0.333 | 0 | 0 |
| Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes | R-HSA-69200 | 4.643228e-01 | 0.333 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 1.914875e-01 | 0.718 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 2.236397e-01 | 0.650 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 3.169160e-01 | 0.499 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 3.169160e-01 | 0.499 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 3.169160e-01 | 0.499 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 3.169160e-01 | 0.499 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 2.425100e-01 | 0.615 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 2.868397e-01 | 0.542 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 3.916162e-01 | 0.407 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 1.277203e-01 | 0.894 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 2.402964e-01 | 0.619 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 3.450760e-01 | 0.462 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 3.450760e-01 | 0.462 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 3.099146e-01 | 0.509 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 3.099146e-01 | 0.509 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.900006e-01 | 0.721 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 2.573374e-01 | 0.589 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 1.415070e-01 | 0.849 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 1.845709e-01 | 0.734 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 2.144361e-01 | 0.669 | 0 | 0 |
| Phase 2 - plateau phase | R-HSA-5576893 | 3.731260e-01 | 0.428 | 0 | 0 |
| RUNX2 regulates genes involved in cell migration | R-HSA-8941332 | 4.274940e-01 | 0.369 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 4.274940e-01 | 0.369 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 4.274940e-01 | 0.369 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 5.172631e-01 | 0.286 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 5.172631e-01 | 0.286 | 0 | 0 |
| NOSIP mediated eNOS trafficking | R-HSA-203754 | 5.172631e-01 | 0.286 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 5.172631e-01 | 0.286 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 5.172631e-01 | 0.286 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 5.172631e-01 | 0.286 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 5.172631e-01 | 0.286 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 2.675536e-01 | 0.573 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 2.923047e-01 | 0.534 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 3.213592e-01 | 0.493 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.213592e-01 | 0.493 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 3.101399e-01 | 0.508 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 4.009333e-01 | 0.397 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 3.415913e-01 | 0.466 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 3.415913e-01 | 0.466 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 2.666224e-01 | 0.574 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 2.666224e-01 | 0.574 | 0 | 0 |
| Inhibition of replication initiation of damaged DNA by RB1/E2F1 | R-HSA-113501 | 4.622252e-01 | 0.335 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 4.622252e-01 | 0.335 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.045591e-01 | 0.516 | 0 | 0 |
| Trafficking of GluR2-containing AMPA receptors | R-HSA-416993 | 4.283807e-01 | 0.368 | 0 | 0 |
| G beta:gamma signalling through PLC beta | R-HSA-418217 | 4.283807e-01 | 0.368 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 2.267507e-01 | 0.644 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 2.267507e-01 | 0.644 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 3.822517e-01 | 0.418 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 2.872401e-01 | 0.542 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 3.645140e-01 | 0.438 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 4.553656e-01 | 0.342 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 4.956860e-01 | 0.305 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 4.956860e-01 | 0.305 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 5.649742e-01 | 0.248 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 5.649742e-01 | 0.248 | 0 | 0 |
| PKB-mediated events | R-HSA-109703 | 5.649742e-01 | 0.248 | 0 | 0 |
| PDE3B signalling | R-HSA-165160 | 5.649742e-01 | 0.248 | 0 | 0 |
| PTK6 Regulates Cell Cycle | R-HSA-8849470 | 5.649742e-01 | 0.248 | 0 | 0 |
| Cam-PDE 1 activation | R-HSA-111957 | 5.649742e-01 | 0.248 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 5.649742e-01 | 0.248 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 5.649742e-01 | 0.248 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 5.649742e-01 | 0.248 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 2.923304e-01 | 0.534 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 4.010585e-01 | 0.397 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 4.010585e-01 | 0.397 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.010585e-01 | 0.397 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 4.488504e-01 | 0.348 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 4.488504e-01 | 0.348 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 4.429089e-01 | 0.354 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.122171e-01 | 0.385 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 4.490532e-01 | 0.348 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 4.655836e-01 | 0.332 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 6.079723e-01 | 0.216 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 6.079723e-01 | 0.216 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 6.079723e-01 | 0.216 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 6.079723e-01 | 0.216 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 4.982641e-01 | 0.303 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.087374e-01 | 0.294 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 4.792069e-01 | 0.319 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 5.571065e-01 | 0.254 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 3 Promoter | R-HSA-76071 | 5.571065e-01 | 0.254 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 5.275150e-01 | 0.278 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 5.877100e-01 | 0.231 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 5.877100e-01 | 0.231 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 5.877100e-01 | 0.231 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 5.767160e-01 | 0.239 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 5.929010e-01 | 0.227 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 6.154823e-01 | 0.211 | 0 | 0 |
| Defective HLCS causes multiple carboxylase deficiency | R-HSA-3371599 | 6.467227e-01 | 0.189 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 6.467227e-01 | 0.189 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 6.467227e-01 | 0.189 | 0 | 0 |
| Disinhibition of SNARE formation | R-HSA-114516 | 6.467227e-01 | 0.189 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 6.041081e-01 | 0.219 | 0 | 0 |
| Tight junction interactions | R-HSA-420029 | 6.254412e-01 | 0.204 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 6.777032e-01 | 0.169 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation | R-HSA-2892247 | 6.417949e-01 | 0.193 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 6.417949e-01 | 0.193 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 6.417949e-01 | 0.193 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 6.630160e-01 | 0.178 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.448832e-01 | 0.191 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.448832e-01 | 0.191 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 6.534241e-01 | 0.185 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 6.666650e-01 | 0.176 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.816449e-01 | 0.166 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 6.861664e-01 | 0.164 | 0 | 0 |
| RNA Polymerase III Transcription Termination | R-HSA-73980 | 6.901207e-01 | 0.161 | 0 | 0 |
| DNA methylation | R-HSA-5334118 | 7.046918e-01 | 0.152 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 7.046918e-01 | 0.152 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 3.138850e-01 | 0.503 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 1.652171e-01 | 0.782 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 5.020132e-01 | 0.299 | 0 | 0 |
| EPH-Ephrin signaling | R-HSA-2682334 | 1.184074e-01 | 0.927 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 2.923047e-01 | 0.534 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 1.470549e-01 | 0.833 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 2.236113e-01 | 0.651 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 3.822517e-01 | 0.418 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 4.260373e-01 | 0.371 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 1.914875e-01 | 0.718 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 3.720824e-01 | 0.429 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 3.213592e-01 | 0.493 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 5.327273e-01 | 0.273 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 4.817998e-01 | 0.317 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 4.911912e-01 | 0.309 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 6.861664e-01 | 0.164 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 1.310702e-01 | 0.882 | 0 | 0 |
| Transcriptional regulation of testis differentiation | R-HSA-9690406 | 1.774799e-01 | 0.751 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 3.158730e-01 | 0.500 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 3.237553e-01 | 0.490 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 1.197559e-01 | 0.922 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 5.400229e-01 | 0.268 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 1.277203e-01 | 0.894 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 4.817998e-01 | 0.317 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 2.972702e-01 | 0.527 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 6.649796e-01 | 0.177 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 2.608744e-01 | 0.584 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 1.902406e-01 | 0.721 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 2.168009e-01 | 0.664 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 2.597455e-01 | 0.585 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 5.302830e-01 | 0.275 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 5.929010e-01 | 0.227 | 0 | 0 |
| Regulation of commissural axon pathfinding by SLIT and ROBO | R-HSA-428542 | 1.310702e-01 | 0.882 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 2.790228e-01 | 0.554 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 1.981988e-01 | 0.703 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 1.397783e-01 | 0.855 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 2.236113e-01 | 0.651 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 1.445069e-01 | 0.840 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 3.331560e-01 | 0.477 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.462883e-01 | 0.461 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 4.874220e-01 | 0.312 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 5.585132e-01 | 0.253 | 0 | 0 |
| WNT5A-dependent internalization of FZD4 | R-HSA-5099900 | 6.154823e-01 | 0.211 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 3.548726e-01 | 0.450 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 5.559697e-01 | 0.255 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 5.922545e-01 | 0.227 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 4.260373e-01 | 0.371 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 5.374860e-01 | 0.270 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 1.373720e-01 | 0.862 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 5.936514e-01 | 0.226 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 1.298782e-01 | 0.886 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 1.298782e-01 | 0.886 | 0 | 0 |
| NTRK3 as a dependence receptor | R-HSA-9603505 | 2.680790e-01 | 0.572 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 2.027905e-01 | 0.693 | 0 | 0 |
| Role of second messengers in netrin-1 signaling | R-HSA-418890 | 2.333364e-01 | 0.632 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 3.547578e-01 | 0.450 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 3.547578e-01 | 0.450 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 3.012718e-01 | 0.521 | 0 | 0 |
| Phosphorylation and nuclear translocation of BMAL1 (ARNTL) and CLOCK | R-HSA-9931529 | 5.172631e-01 | 0.286 | 0 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 2.116326e-01 | 0.674 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.458944e-01 | 0.836 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 4.283807e-01 | 0.368 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 3.297528e-01 | 0.482 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 6.741726e-01 | 0.171 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of keratinocytes | R-HSA-8939242 | 6.816449e-01 | 0.166 | 0 | 0 |
| Nef mediated downregulation of MHC class I complex cell surface expression | R-HSA-164940 | 6.816449e-01 | 0.166 | 0 | 0 |
| S Phase | R-HSA-69242 | 6.533795e-01 | 0.185 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 2.451994e-01 | 0.610 | 0 | 0 |
| Interleukin-2 signaling | R-HSA-9020558 | 1.801954e-01 | 0.744 | 0 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.631242e-01 | 0.249 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 6.597485e-01 | 0.181 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 1.203823e-01 | 0.919 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 1.192098e-01 | 0.924 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 5.936514e-01 | 0.226 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 2.923304e-01 | 0.534 | 1 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 1.522496e-01 | 0.817 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 2.236397e-01 | 0.650 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 3.206427e-01 | 0.494 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 6.450409e-01 | 0.190 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 3.502448e-01 | 0.456 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 5.008876e-01 | 0.300 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 3.450760e-01 | 0.462 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 1.310702e-01 | 0.882 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 2.027905e-01 | 0.693 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 1.204974e-01 | 0.919 | 0 | 0 |
| Ca2+ activated K+ channels | R-HSA-1296052 | 2.790228e-01 | 0.554 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 1.774799e-01 | 0.751 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 1.774799e-01 | 0.751 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 3.171349e-01 | 0.499 | 0 | 0 |
| Neurotransmitter uptake and metabolism In glial cells | R-HSA-112313 | 3.171349e-01 | 0.499 | 0 | 0 |
| Astrocytic Glutamate-Glutamine Uptake And Metabolism | R-HSA-210455 | 3.171349e-01 | 0.499 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 2.608744e-01 | 0.584 | 1 | 1 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 2.236113e-01 | 0.651 | 0 | 0 |
| Killing mechanisms | R-HSA-9664420 | 3.450760e-01 | 0.462 | 0 | 0 |
| WNT5:FZD7-mediated leishmania damping | R-HSA-9673324 | 3.450760e-01 | 0.462 | 0 | 0 |
| Formation of the posterior neural plate | R-HSA-9832991 | 4.274940e-01 | 0.369 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression to control bile acid homeostasis | R-HSA-9623433 | 4.622252e-01 | 0.335 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 4.192978e-01 | 0.377 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 3.123434e-01 | 0.505 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 5.192496e-01 | 0.285 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 6.467227e-01 | 0.189 | 0 | 0 |
| Fanconi Anemia Pathway | R-HSA-6783310 | 6.448832e-01 | 0.191 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 6.682407e-01 | 0.175 | 0 | 0 |
| Formyl peptide receptors bind formyl peptides and many other ligands | R-HSA-444473 | 6.816449e-01 | 0.166 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 4.010585e-01 | 0.397 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 3.037392e-01 | 0.517 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.360799e-01 | 0.866 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 4.628404e-01 | 0.335 | 0 | 0 |
| G1 Phase | R-HSA-69236 | 4.555248e-01 | 0.341 | 0 | 0 |
| Cyclin D associated events in G1 | R-HSA-69231 | 4.555248e-01 | 0.341 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 6.447446e-01 | 0.191 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 1.500586e-01 | 0.824 | 0 | 0 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 4.911912e-01 | 0.309 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 2.896209e-01 | 0.538 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 1.701005e-01 | 0.769 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 2.153079e-01 | 0.667 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 1.548639e-01 | 0.810 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 2.048482e-01 | 0.689 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 4.025673e-01 | 0.395 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 4.324298e-01 | 0.364 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.779696e-01 | 0.750 | 0 | 0 |
| SARS-CoV-1-mediated effects on programmed cell death | R-HSA-9692913 | 1.298782e-01 | 0.886 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 2.027905e-01 | 0.693 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 2.027905e-01 | 0.693 | 0 | 0 |
| Leukotriene receptors | R-HSA-391906 | 2.407660e-01 | 0.618 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 2.333364e-01 | 0.632 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 2.333364e-01 | 0.632 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 2.333364e-01 | 0.632 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.887941e-01 | 0.539 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 3.547578e-01 | 0.450 | 0 | 0 |
| Defective RIPK1-mediated regulated necrosis | R-HSA-9693928 | 3.916162e-01 | 0.407 | 0 | 0 |
| p38MAPK events | R-HSA-171007 | 5.877100e-01 | 0.231 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.374650e-01 | 0.359 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 6.754938e-01 | 0.170 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 3.822517e-01 | 0.418 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 6.254412e-01 | 0.204 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 1.987208e-01 | 0.702 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 5.277220e-01 | 0.278 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 2.407660e-01 | 0.618 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 2.407660e-01 | 0.618 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 2.365533e-01 | 0.626 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 5.076079e-01 | 0.294 | 1 | 1 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.432069e-01 | 0.353 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.566360e-01 | 0.340 | 0 | 0 |
| Formation of the ureteric bud | R-HSA-9830674 | 5.807047e-01 | 0.236 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 5.773590e-01 | 0.239 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.338418e-01 | 0.873 | 1 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 2.073270e-01 | 0.683 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 6.379199e-01 | 0.195 | 0 | 0 |
| Microbial modulation of RIPK1-mediated regulated necrosis | R-HSA-9686347 | 2.790228e-01 | 0.554 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.777742e-01 | 0.238 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 6.154823e-01 | 0.211 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 1.794346e-01 | 0.746 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 3.221568e-01 | 0.492 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 6.197133e-01 | 0.208 | 1 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 5.384465e-01 | 0.269 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.255373e-01 | 0.371 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 5.459918e-01 | 0.263 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 6.955790e-01 | 0.158 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 5.327273e-01 | 0.273 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 1.919250e-01 | 0.717 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 4.553656e-01 | 0.342 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 2.687787e-01 | 0.571 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 4.429089e-01 | 0.354 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 3.667984e-01 | 0.436 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 4.431618e-01 | 0.353 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.142563e-01 | 0.289 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 6.064100e-01 | 0.217 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 3.822517e-01 | 0.418 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 6.825180e-01 | 0.166 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.073270e-01 | 0.683 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 4.328723e-01 | 0.364 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 3.404010e-01 | 0.468 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 3.404010e-01 | 0.468 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 4.055806e-01 | 0.392 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 4.055806e-01 | 0.392 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 4.055806e-01 | 0.392 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 2.887941e-01 | 0.539 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 3.547578e-01 | 0.450 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 3.916162e-01 | 0.407 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 3.916162e-01 | 0.407 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 2.215177e-01 | 0.655 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 3.099146e-01 | 0.509 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 3.331560e-01 | 0.477 | 0 | 0 |
| Trafficking of myristoylated proteins to the cilium | R-HSA-5624138 | 5.172631e-01 | 0.286 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 5.172631e-01 | 0.286 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 3.101399e-01 | 0.508 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 3.045591e-01 | 0.516 | 0 | 0 |
| PKA activation | R-HSA-163615 | 4.283807e-01 | 0.368 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 4.283807e-01 | 0.368 | 0 | 0 |
| Presynaptic function of Kainate receptors | R-HSA-500657 | 4.283807e-01 | 0.368 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 3.645140e-01 | 0.438 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 3.221568e-01 | 0.492 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 5.649742e-01 | 0.248 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 5.649742e-01 | 0.248 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 5.649742e-01 | 0.248 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 4.935330e-01 | 0.307 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 5.185181e-01 | 0.285 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 5.599100e-01 | 0.252 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 5.975521e-01 | 0.224 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 6.154823e-01 | 0.211 | 0 | 0 |
| Activated NTRK2 signals through CDK5 | R-HSA-9032845 | 6.467227e-01 | 0.189 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 6.171659e-01 | 0.210 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 6.171659e-01 | 0.210 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 6.859758e-01 | 0.164 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 6.448832e-01 | 0.191 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 6.944470e-01 | 0.158 | 0 | 0 |
| Modulation of host responses by IFN-stimulated genes | R-HSA-9909505 | 6.666650e-01 | 0.176 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 6.816449e-01 | 0.166 | 0 | 0 |
| Regulation by c-FLIP | R-HSA-3371378 | 6.816449e-01 | 0.166 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 6.816449e-01 | 0.166 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 6.876577e-01 | 0.163 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 6.901207e-01 | 0.161 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 4.006134e-01 | 0.397 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 3.136889e-01 | 0.504 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 2.007062e-01 | 0.697 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 1.197559e-01 | 0.922 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 3.371790e-01 | 0.472 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 2.852686e-01 | 0.545 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 4.283807e-01 | 0.368 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 5.243638e-01 | 0.280 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.362894e-01 | 0.360 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 1.786555e-01 | 0.748 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 6.034905e-01 | 0.219 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 2.238950e-01 | 0.650 | 1 | 0 |
| STAT3 nuclear events downstream of ALK signaling | R-HSA-9701898 | 1.385248e-01 | 0.858 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 6.187093e-01 | 0.209 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 6.450409e-01 | 0.190 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 3.235039e-01 | 0.490 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 1.707349e-01 | 0.768 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 2.236113e-01 | 0.651 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 3.506996e-01 | 0.455 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 5.972727e-01 | 0.224 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.916162e-01 | 0.407 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.573374e-01 | 0.589 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 3.731260e-01 | 0.428 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.957558e-01 | 0.305 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 5.614751e-01 | 0.251 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 6.754938e-01 | 0.170 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 6.762942e-01 | 0.170 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 6.861664e-01 | 0.164 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 7.046918e-01 | 0.152 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 2.923047e-01 | 0.534 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 2.353519e-01 | 0.628 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 3.535410e-01 | 0.452 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 3.080331e-01 | 0.511 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 6.794455e-01 | 0.168 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 6.728262e-01 | 0.172 | 0 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.385248e-01 | 0.858 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 2.608744e-01 | 0.584 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 2.887941e-01 | 0.539 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 3.547578e-01 | 0.450 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 3.547578e-01 | 0.450 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 3.547578e-01 | 0.450 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.916162e-01 | 0.407 | 0 | 0 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 4.025673e-01 | 0.395 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 4.956860e-01 | 0.305 | 0 | 0 |
| Release of Hh-Np from the secreting cell | R-HSA-5362798 | 5.649742e-01 | 0.248 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 5.649742e-01 | 0.248 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 5.807047e-01 | 0.236 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 6.467227e-01 | 0.189 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 6.465418e-01 | 0.189 | 0 | 0 |
| BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members | R-HSA-111453 | 6.816449e-01 | 0.166 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 1.941552e-01 | 0.712 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 6.825180e-01 | 0.166 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 5.536537e-01 | 0.257 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.122918e-01 | 0.673 | 0 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 3.642993e-01 | 0.439 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 3.135066e-01 | 0.504 | 0 | 0 |
| Regulation of BACH1 activity | R-HSA-9708530 | 6.154823e-01 | 0.211 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 6.254412e-01 | 0.204 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 5.777742e-01 | 0.238 | 0 | 0 |
| Formation of the nephric duct | R-HSA-9830364 | 2.236397e-01 | 0.650 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 5.327273e-01 | 0.273 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 4.283807e-01 | 0.368 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 5.431206e-01 | 0.265 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 5.431206e-01 | 0.265 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 5.682067e-01 | 0.245 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.236113e-01 | 0.651 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 6.465418e-01 | 0.189 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 4.611444e-01 | 0.336 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 2.972702e-01 | 0.527 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.680790e-01 | 0.572 | 0 | 0 |
| DSCAM interactions | R-HSA-376172 | 3.404010e-01 | 0.468 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 1.801954e-01 | 0.744 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 1.575531e-01 | 0.803 | 0 | 0 |
| Alpha-defensins | R-HSA-1462054 | 3.171349e-01 | 0.499 | 0 | 0 |
| Sensory perception of sour taste | R-HSA-9729555 | 4.643228e-01 | 0.333 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 1.360799e-01 | 0.866 | 0 | 0 |
| LTC4-CYSLTR mediated IL4 production | R-HSA-9664535 | 3.916162e-01 | 0.407 | 0 | 0 |
| Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion | R-HSA-434316 | 3.450760e-01 | 0.462 | 0 | 0 |
| Biosynthesis of DPAn-3-derived 13-series resolvins | R-HSA-9026403 | 5.172631e-01 | 0.286 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 5.172631e-01 | 0.286 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 5.649742e-01 | 0.248 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 6.079723e-01 | 0.216 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 5.807047e-01 | 0.236 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 6.495224e-01 | 0.187 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 6.608241e-01 | 0.180 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.816449e-01 | 0.166 | 0 | 0 |
| Dimerization of procaspase-8 | R-HSA-69416 | 6.816449e-01 | 0.166 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 3.958271e-01 | 0.402 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 3.827842e-01 | 0.417 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 1.348614e-01 | 0.870 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 1.347057e-01 | 0.871 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 3.645140e-01 | 0.438 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 3.655636e-01 | 0.437 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.640280e-01 | 0.578 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 2.425100e-01 | 0.615 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 4.858481e-01 | 0.313 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 6.064100e-01 | 0.217 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 6.064100e-01 | 0.217 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 3.281492e-01 | 0.484 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 4.817998e-01 | 0.317 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 6.666650e-01 | 0.176 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 4.844137e-01 | 0.315 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 4.386806e-01 | 0.358 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 2.168009e-01 | 0.664 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 5.943361e-01 | 0.226 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 2.407660e-01 | 0.618 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 2.068354e-01 | 0.684 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 1.532395e-01 | 0.815 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 3.822517e-01 | 0.418 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 5.877100e-01 | 0.231 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 6.666650e-01 | 0.176 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 3.779604e-01 | 0.423 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 3.502448e-01 | 0.456 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 1.774799e-01 | 0.751 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.103117e-01 | 0.292 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 2.052380e-01 | 0.688 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 2.052380e-01 | 0.688 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 5.877100e-01 | 0.231 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 3.368651e-01 | 0.473 | 0 | 0 |
| Formation of the anterior neural plate | R-HSA-9823739 | 3.169160e-01 | 0.499 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 2.048832e-01 | 0.688 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 2.320255e-01 | 0.634 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 6.788293e-01 | 0.168 | 0 | 0 |
| Phase 3 - rapid repolarisation | R-HSA-5576890 | 2.790228e-01 | 0.554 | 0 | 0 |
| Interleukin-18 signaling | R-HSA-9012546 | 3.171349e-01 | 0.499 | 0 | 0 |
| FLT3 signaling through SRC family kinases | R-HSA-9706374 | 4.643228e-01 | 0.333 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 2.617826e-01 | 0.582 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 5.172631e-01 | 0.286 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 3.822517e-01 | 0.418 | 0 | 0 |
| Acetylcholine inhibits contraction of outer hair cells | R-HSA-9667769 | 5.649742e-01 | 0.248 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 5.649742e-01 | 0.248 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 4.192978e-01 | 0.377 | 0 | 0 |
| NR1H2 & NR1H3 regulate gene expression linked to lipogenesis | R-HSA-9029558 | 5.277885e-01 | 0.278 | 0 | 0 |
| NADPH regeneration | R-HSA-389542 | 6.079723e-01 | 0.216 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 6.079723e-01 | 0.216 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 5.235890e-01 | 0.281 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 5.585132e-01 | 0.253 | 0 | 0 |
| Free fatty acids regulate insulin secretion | R-HSA-400451 | 5.807047e-01 | 0.236 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 5.698903e-01 | 0.244 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 6.154823e-01 | 0.211 | 0 | 0 |
| Passive transport by Aquaporins | R-HSA-432047 | 6.417949e-01 | 0.193 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 6.538453e-01 | 0.185 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.816449e-01 | 0.166 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 7.046918e-01 | 0.152 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 1.654428e-01 | 0.781 | 0 | 0 |
| Signaling by NTRK2 (TRKB) | R-HSA-9006115 | 6.667841e-01 | 0.176 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 6.702785e-01 | 0.174 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 3.494966e-01 | 0.457 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 2.236397e-01 | 0.650 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 5.848956e-01 | 0.233 | 0 | 0 |
| TNFs bind their physiological receptors | R-HSA-5669034 | 6.034905e-01 | 0.219 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 6.371824e-01 | 0.196 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 6.045100e-01 | 0.219 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 2.333364e-01 | 0.632 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 2.460484e-01 | 0.609 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 5.574533e-01 | 0.254 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 6.714386e-01 | 0.173 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 5.469388e-01 | 0.262 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 4.553656e-01 | 0.342 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 3.171349e-01 | 0.499 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 3.547578e-01 | 0.450 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 4.274940e-01 | 0.369 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 5.172631e-01 | 0.286 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 4.956860e-01 | 0.305 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 4.628404e-01 | 0.335 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 6.079723e-01 | 0.216 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 5.877100e-01 | 0.231 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.925813e-01 | 0.227 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 5.975521e-01 | 0.224 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 6.467227e-01 | 0.189 | 0 | 0 |
| Synthesis of PG | R-HSA-1483148 | 6.417949e-01 | 0.193 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 6.608241e-01 | 0.180 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 5.459918e-01 | 0.263 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 5.614751e-01 | 0.251 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 5.614751e-01 | 0.251 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 5.614751e-01 | 0.251 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 5.614751e-01 | 0.251 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 3.700102e-01 | 0.432 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in extracellular matrix, focal adhesion and epithelial-to-mesenchymal transition | R-HSA-9926550 | 2.196018e-01 | 0.658 | 0 | 0 |
| GAB1 signalosome | R-HSA-180292 | 4.283807e-01 | 0.368 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 6.534241e-01 | 0.185 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 3.577837e-01 | 0.446 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 3.169160e-01 | 0.499 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 5.211799e-01 | 0.283 | 0 | 0 |
| Negative regulation of activity of TFAP2 (AP-2) family transcription factors | R-HSA-8866904 | 6.816449e-01 | 0.166 | 0 | 0 |
| Activation of kainate receptors upon glutamate binding | R-HSA-451326 | 6.861664e-01 | 0.164 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.534911e-01 | 0.814 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 4.622252e-01 | 0.335 | 0 | 0 |
| Activated NTRK2 signals through FYN | R-HSA-9032500 | 6.816449e-01 | 0.166 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.339952e-01 | 0.631 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 4.555248e-01 | 0.341 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 6.154823e-01 | 0.211 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 2.196018e-01 | 0.658 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 2.887941e-01 | 0.539 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 5.584744e-01 | 0.253 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.916162e-01 | 0.407 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 5.614751e-01 | 0.251 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 4.553656e-01 | 0.342 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 3.779604e-01 | 0.423 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 1.761355e-01 | 0.754 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 6.034905e-01 | 0.219 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 5.406514e-01 | 0.267 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 6.901207e-01 | 0.161 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 7.090932e-01 | 0.149 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 7.121984e-01 | 0.147 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 7.121984e-01 | 0.147 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 7.121984e-01 | 0.147 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 7.130823e-01 | 0.147 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 7.130823e-01 | 0.147 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 7.130823e-01 | 0.147 | 0 | 0 |
| WNT mediated activation of DVL | R-HSA-201688 | 7.131167e-01 | 0.147 | 0 | 0 |
| CASP8 activity is inhibited | R-HSA-5218900 | 7.131167e-01 | 0.147 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 7.131167e-01 | 0.147 | 0 | 0 |
| Defects in biotin (Btn) metabolism | R-HSA-3323169 | 7.131167e-01 | 0.147 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 7.131167e-01 | 0.147 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 7.131167e-01 | 0.147 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 7.131167e-01 | 0.147 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 7.131167e-01 | 0.147 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 7.131167e-01 | 0.147 | 0 | 0 |
| AKT phosphorylates targets in the nucleus | R-HSA-198693 | 7.131167e-01 | 0.147 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 7.131167e-01 | 0.147 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 7.131167e-01 | 0.147 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 7.131167e-01 | 0.147 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 7.131167e-01 | 0.147 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 7.131167e-01 | 0.147 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 7.163440e-01 | 0.145 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 7.174343e-01 | 0.144 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.194269e-01 | 0.143 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.194269e-01 | 0.143 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 7.194269e-01 | 0.143 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 7.196452e-01 | 0.143 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 7.216304e-01 | 0.142 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 7.217077e-01 | 0.142 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 7.217077e-01 | 0.142 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 7.217077e-01 | 0.142 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.219191e-01 | 0.142 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 7.219191e-01 | 0.142 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 7.219191e-01 | 0.142 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 7.223684e-01 | 0.141 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 7.223684e-01 | 0.141 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 7.249388e-01 | 0.140 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 7.323381e-01 | 0.135 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 7.329415e-01 | 0.135 | 0 | 0 |
| Eicosanoid ligand-binding receptors | R-HSA-391903 | 7.329415e-01 | 0.135 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.333709e-01 | 0.135 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 7.343457e-01 | 0.134 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 7.343457e-01 | 0.134 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 7.382117e-01 | 0.132 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 7.392082e-01 | 0.131 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 7.392082e-01 | 0.131 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 7.414791e-01 | 0.130 | 0 | 0 |
| DNA replication initiation | R-HSA-68952 | 7.414791e-01 | 0.130 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 7.414791e-01 | 0.130 | 0 | 0 |
| EGFR Transactivation by Gastrin | R-HSA-2179392 | 7.414791e-01 | 0.130 | 0 | 0 |
| Cross-presentation of particulate exogenous antigens (phagosomes) | R-HSA-1236973 | 7.414791e-01 | 0.130 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 7.414791e-01 | 0.130 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 7.414791e-01 | 0.130 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 7.414791e-01 | 0.130 | 0 | 0 |
| Metal sequestration by antimicrobial proteins | R-HSA-6799990 | 7.414791e-01 | 0.130 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 7.414791e-01 | 0.130 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 7.414791e-01 | 0.130 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 7.414791e-01 | 0.130 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 7.414791e-01 | 0.130 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 7.464323e-01 | 0.127 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 7.487416e-01 | 0.126 | 0 | 0 |
| FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes | R-HSA-9615017 | 7.487416e-01 | 0.126 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 7.487416e-01 | 0.126 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 7.497023e-01 | 0.125 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 7.523978e-01 | 0.124 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 7.523978e-01 | 0.124 | 0 | 0 |
| Signalling to RAS | R-HSA-167044 | 7.523978e-01 | 0.124 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 7.523978e-01 | 0.124 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 7.523978e-01 | 0.124 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 7.552267e-01 | 0.122 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.580019e-01 | 0.120 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 7.580019e-01 | 0.120 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 7.584667e-01 | 0.120 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 7.590139e-01 | 0.120 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 7.616273e-01 | 0.118 | 0 | 0 |
| Presynaptic depolarization and calcium channel opening | R-HSA-112308 | 7.670389e-01 | 0.115 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.670389e-01 | 0.115 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.670389e-01 | 0.115 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 7.670389e-01 | 0.115 | 0 | 0 |
| Dissolution of Fibrin Clot | R-HSA-75205 | 7.670389e-01 | 0.115 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 7.670389e-01 | 0.115 | 0 | 0 |
| CD163 mediating an anti-inflammatory response | R-HSA-9662834 | 7.670389e-01 | 0.115 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.670389e-01 | 0.115 | 0 | 0 |
| Biosynthesis of DPAn-3-derived maresins | R-HSA-9026290 | 7.670389e-01 | 0.115 | 0 | 0 |
| Synthesis of PIPs at the ER membrane | R-HSA-1483248 | 7.670389e-01 | 0.115 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.670389e-01 | 0.115 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.692348e-01 | 0.114 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 7.697285e-01 | 0.114 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.704421e-01 | 0.113 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.704421e-01 | 0.113 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 7.704421e-01 | 0.113 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 7.706191e-01 | 0.113 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 7.706191e-01 | 0.113 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 7.706191e-01 | 0.113 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 7.711201e-01 | 0.113 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 7.731188e-01 | 0.112 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 7.756499e-01 | 0.110 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 7.800745e-01 | 0.108 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 7.817154e-01 | 0.107 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 7.848752e-01 | 0.105 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 7.848752e-01 | 0.105 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 7.856912e-01 | 0.105 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 7.856912e-01 | 0.105 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 7.856912e-01 | 0.105 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 7.876593e-01 | 0.104 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 7.876593e-01 | 0.104 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 7.876593e-01 | 0.104 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 7.882252e-01 | 0.103 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 7.885720e-01 | 0.103 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 7.885720e-01 | 0.103 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.900730e-01 | 0.102 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.900730e-01 | 0.102 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 7.900730e-01 | 0.102 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 7.900730e-01 | 0.102 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.900730e-01 | 0.102 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.900730e-01 | 0.102 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 7.900730e-01 | 0.102 | 0 | 0 |
| Sodium/Calcium exchangers | R-HSA-425561 | 7.900730e-01 | 0.102 | 0 | 0 |
| Uptake of dietary cobalamins into enterocytes | R-HSA-9758881 | 7.900730e-01 | 0.102 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 7.950979e-01 | 0.100 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 7.975607e-01 | 0.098 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 7.975607e-01 | 0.098 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 7.975607e-01 | 0.098 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 7.982005e-01 | 0.098 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 7.985484e-01 | 0.098 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 7.985484e-01 | 0.098 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.985484e-01 | 0.098 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 7.985484e-01 | 0.098 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 7.985484e-01 | 0.098 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 7.997665e-01 | 0.097 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.002303e-01 | 0.097 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.002303e-01 | 0.097 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 8.002303e-01 | 0.097 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 8.034716e-01 | 0.095 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 8.035738e-01 | 0.095 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 8.035738e-01 | 0.095 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 8.035738e-01 | 0.095 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 8.060918e-01 | 0.094 | 0 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 8.108308e-01 | 0.091 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 8.108308e-01 | 0.091 | 0 | 0 |
| Polymerase switching | R-HSA-69091 | 8.108308e-01 | 0.091 | 0 | 0 |
| Leading Strand Synthesis | R-HSA-69109 | 8.108308e-01 | 0.091 | 0 | 0 |
| IRAK1 recruits IKK complex | R-HSA-937039 | 8.108308e-01 | 0.091 | 0 | 0 |
| IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation | R-HSA-975144 | 8.108308e-01 | 0.091 | 0 | 0 |
| Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | R-HSA-9931530 | 8.108308e-01 | 0.091 | 0 | 0 |
| Activated NTRK2 signals through FRS2 and FRS3 | R-HSA-9028731 | 8.108308e-01 | 0.091 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 8.108308e-01 | 0.091 | 0 | 0 |
| Biosynthesis of DPAn-3-derived protectins and resolvins | R-HSA-9026286 | 8.108308e-01 | 0.091 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 8.108308e-01 | 0.091 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 8.108308e-01 | 0.091 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 8.108308e-01 | 0.091 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 8.108308e-01 | 0.091 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 8.108308e-01 | 0.091 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 8.108308e-01 | 0.091 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 8.114859e-01 | 0.091 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.116784e-01 | 0.091 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 8.116784e-01 | 0.091 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.119457e-01 | 0.090 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 8.146559e-01 | 0.089 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 8.149182e-01 | 0.089 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 8.149182e-01 | 0.089 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 8.175208e-01 | 0.088 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 8.184186e-01 | 0.087 | 0 | 0 |
| Assembly of active LPL and LIPC lipase complexes | R-HSA-8963889 | 8.184186e-01 | 0.087 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 8.184186e-01 | 0.087 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 8.195948e-01 | 0.086 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 8.216108e-01 | 0.085 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.216108e-01 | 0.085 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 8.225840e-01 | 0.085 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 8.227811e-01 | 0.085 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 8.237131e-01 | 0.084 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.282264e-01 | 0.082 | 0 | 0 |
| Cellular response to heat stress | R-HSA-3371556 | 8.282264e-01 | 0.082 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 8.295372e-01 | 0.081 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 8.295372e-01 | 0.081 | 0 | 0 |
| Chylomicron remodeling | R-HSA-8963901 | 8.295372e-01 | 0.081 | 0 | 0 |
| Mtb iron assimilation by chelation | R-HSA-1222449 | 8.295372e-01 | 0.081 | 0 | 0 |
| TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway | R-HSA-5676594 | 8.295372e-01 | 0.081 | 0 | 0 |
| Reversible hydration of carbon dioxide | R-HSA-1475029 | 8.295372e-01 | 0.081 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 8.295372e-01 | 0.081 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 8.295372e-01 | 0.081 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 8.295372e-01 | 0.081 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 8.295372e-01 | 0.081 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 8.295372e-01 | 0.081 | 0 | 0 |
| PI5P Regulates TP53 Acetylation | R-HSA-6811555 | 8.295372e-01 | 0.081 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 8.295372e-01 | 0.081 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 8.295372e-01 | 0.081 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 8.295372e-01 | 0.081 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 8.322495e-01 | 0.080 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 8.322495e-01 | 0.080 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 8.329621e-01 | 0.079 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 8.329621e-01 | 0.079 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 8.329621e-01 | 0.079 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.352560e-01 | 0.078 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 8.353642e-01 | 0.078 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 8.371359e-01 | 0.077 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 8.382006e-01 | 0.077 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 8.412533e-01 | 0.075 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 8.431472e-01 | 0.074 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 8.451218e-01 | 0.073 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 8.451218e-01 | 0.073 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 8.451218e-01 | 0.073 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 8.451218e-01 | 0.073 | 0 | 0 |
| Removal of the Flap Intermediate | R-HSA-69166 | 8.463947e-01 | 0.072 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 8.463947e-01 | 0.072 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 8.463947e-01 | 0.072 | 0 | 0 |
| Signaling by FGFR4 in disease | R-HSA-5655291 | 8.463947e-01 | 0.072 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 8.463947e-01 | 0.072 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 8.463947e-01 | 0.072 | 0 | 0 |
| Biosynthesis of E-series 18(R)-resolvins | R-HSA-9023661 | 8.463947e-01 | 0.072 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 8.463947e-01 | 0.072 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 8.463947e-01 | 0.072 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 8.463947e-01 | 0.072 | 0 | 0 |
| P2Y receptors | R-HSA-417957 | 8.463947e-01 | 0.072 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 8.463947e-01 | 0.072 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 8.488195e-01 | 0.071 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 8.488957e-01 | 0.071 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 8.521999e-01 | 0.069 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 8.525428e-01 | 0.069 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.540963e-01 | 0.068 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 8.570898e-01 | 0.067 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 8.570898e-01 | 0.067 | 0 | 0 |
| Signaling by BMP | R-HSA-201451 | 8.570898e-01 | 0.067 | 0 | 0 |
| Synthesis of PE | R-HSA-1483213 | 8.570898e-01 | 0.067 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 8.570898e-01 | 0.067 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 8.570898e-01 | 0.067 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 8.585259e-01 | 0.066 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 8.593223e-01 | 0.066 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 8.610926e-01 | 0.065 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.610926e-01 | 0.065 | 0 | 0 |
| Signaling by PDGFRA extracellular domain mutants | R-HSA-9673770 | 8.615861e-01 | 0.065 | 0 | 0 |
| Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants | R-HSA-9673767 | 8.615861e-01 | 0.065 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.615861e-01 | 0.065 | 0 | 0 |
| RNA Polymerase III Chain Elongation | R-HSA-73780 | 8.615861e-01 | 0.065 | 0 | 0 |
| G beta:gamma signalling through BTK | R-HSA-8964315 | 8.615861e-01 | 0.065 | 0 | 0 |
| Processive synthesis on the lagging strand | R-HSA-69183 | 8.615861e-01 | 0.065 | 0 | 0 |
| Telomere C-strand synthesis initiation | R-HSA-174430 | 8.615861e-01 | 0.065 | 0 | 0 |
| Lysosphingolipid and LPA receptors | R-HSA-419408 | 8.615861e-01 | 0.065 | 0 | 0 |
| Biotin transport and metabolism | R-HSA-196780 | 8.615861e-01 | 0.065 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 8.615861e-01 | 0.065 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.615861e-01 | 0.065 | 0 | 0 |
| Other semaphorin interactions | R-HSA-416700 | 8.615861e-01 | 0.065 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.615861e-01 | 0.065 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 8.660477e-01 | 0.062 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 8.660477e-01 | 0.062 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 8.660477e-01 | 0.062 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 8.660477e-01 | 0.062 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 8.670858e-01 | 0.062 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 8.682065e-01 | 0.061 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 8.688229e-01 | 0.061 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 8.691542e-01 | 0.061 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 8.692131e-01 | 0.061 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 8.695238e-01 | 0.061 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 8.728515e-01 | 0.059 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 8.751228e-01 | 0.058 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 8.751228e-01 | 0.058 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 8.752758e-01 | 0.058 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 8.752758e-01 | 0.058 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.752758e-01 | 0.058 | 0 | 0 |
| Activation of SMO | R-HSA-5635838 | 8.752758e-01 | 0.058 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 8.752758e-01 | 0.058 | 0 | 0 |
| Fructose catabolism | R-HSA-70350 | 8.752758e-01 | 0.058 | 0 | 0 |
| Induction of Cell-Cell Fusion | R-HSA-9733458 | 8.752758e-01 | 0.058 | 0 | 0 |
| Regulation of NF-kappa B signaling | R-HSA-9758274 | 8.752758e-01 | 0.058 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 8.752758e-01 | 0.058 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.752758e-01 | 0.058 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 8.775105e-01 | 0.057 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.785231e-01 | 0.056 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 8.785231e-01 | 0.056 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 8.785231e-01 | 0.056 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 8.785231e-01 | 0.056 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 8.785231e-01 | 0.056 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 8.835291e-01 | 0.054 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 8.835291e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 8.836483e-01 | 0.054 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 8.836483e-01 | 0.054 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 8.836483e-01 | 0.054 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 8.836483e-01 | 0.054 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 8.836483e-01 | 0.054 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.876123e-01 | 0.052 | 0 | 0 |
| GRB2 events in ERBB2 signaling | R-HSA-1963640 | 8.876123e-01 | 0.052 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 8.876123e-01 | 0.052 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 8.876123e-01 | 0.052 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 8.876123e-01 | 0.052 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 8.876123e-01 | 0.052 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.876123e-01 | 0.052 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 8.876123e-01 | 0.052 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.876123e-01 | 0.052 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 8.876123e-01 | 0.052 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 8.880891e-01 | 0.052 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 8.880891e-01 | 0.052 | 0 | 0 |
| DAP12 signaling | R-HSA-2424491 | 8.880891e-01 | 0.052 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 8.880891e-01 | 0.052 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 8.880891e-01 | 0.052 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 8.882832e-01 | 0.051 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 8.939663e-01 | 0.049 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.942988e-01 | 0.049 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 8.948691e-01 | 0.048 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 8.969521e-01 | 0.047 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 8.969521e-01 | 0.047 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 8.982303e-01 | 0.047 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 8.983320e-01 | 0.047 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 8.983320e-01 | 0.047 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.987293e-01 | 0.046 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 8.987293e-01 | 0.046 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 8.987293e-01 | 0.046 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.987293e-01 | 0.046 | 0 | 0 |
| Biosynthesis of aspirin-triggered D-series resolvins | R-HSA-9020265 | 8.987293e-01 | 0.046 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta) | R-HSA-5358606 | 8.987293e-01 | 0.046 | 0 | 0 |
| Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters | R-HSA-164938 | 8.987293e-01 | 0.046 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.987293e-01 | 0.046 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.987293e-01 | 0.046 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.987293e-01 | 0.046 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 8.989757e-01 | 0.046 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 8.991558e-01 | 0.046 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 8.991558e-01 | 0.046 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 8.991558e-01 | 0.046 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 9.029432e-01 | 0.044 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 9.049060e-01 | 0.043 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 9.051573e-01 | 0.043 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.051573e-01 | 0.043 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 9.054536e-01 | 0.043 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 9.061891e-01 | 0.043 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 9.070412e-01 | 0.042 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 9.072174e-01 | 0.042 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 9.073053e-01 | 0.042 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 9.087472e-01 | 0.042 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 9.087472e-01 | 0.042 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 9.087472e-01 | 0.042 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 9.087472e-01 | 0.042 | 0 | 0 |
| Biosynthesis of Lipoxins (LX) | R-HSA-2142700 | 9.087472e-01 | 0.042 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 9.087472e-01 | 0.042 | 0 | 0 |
| Organic anion transport by SLC5/17/25 transporters | R-HSA-428643 | 9.087472e-01 | 0.042 | 0 | 0 |
| Tie2 Signaling | R-HSA-210993 | 9.087472e-01 | 0.042 | 0 | 0 |
| Nucleotide-like (purinergic) receptors | R-HSA-418038 | 9.087472e-01 | 0.042 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.093393e-01 | 0.041 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 9.096122e-01 | 0.041 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 9.096122e-01 | 0.041 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.104185e-01 | 0.041 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 9.115471e-01 | 0.040 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 9.120317e-01 | 0.040 | 1 | 0 |
| Defective B3GALTL causes PpS | R-HSA-5083635 | 9.127483e-01 | 0.040 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 9.127752e-01 | 0.040 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.127752e-01 | 0.040 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.127752e-01 | 0.040 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.127752e-01 | 0.040 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 9.127752e-01 | 0.040 | 1 | 1 |
| Extension of Telomeres | R-HSA-180786 | 9.170530e-01 | 0.038 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 9.177746e-01 | 0.037 | 0 | 0 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 9.177746e-01 | 0.037 | 0 | 0 |
| mRNA decay by 3' to 5' exoribonuclease | R-HSA-429958 | 9.177746e-01 | 0.037 | 0 | 0 |
| Synthesis of 5-eicosatetraenoic acids | R-HSA-2142688 | 9.177746e-01 | 0.037 | 0 | 0 |
| Gastrin-CREB signalling pathway via PKC and MAPK | R-HSA-881907 | 9.177746e-01 | 0.037 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 9.177746e-01 | 0.037 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 9.177746e-01 | 0.037 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 9.177746e-01 | 0.037 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 9.177746e-01 | 0.037 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 9.184313e-01 | 0.037 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 9.189379e-01 | 0.037 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 9.197662e-01 | 0.036 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.197662e-01 | 0.036 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 9.197662e-01 | 0.036 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 9.198035e-01 | 0.036 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 9.210422e-01 | 0.036 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 9.211825e-01 | 0.036 | 1 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 9.220193e-01 | 0.035 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 9.235779e-01 | 0.035 | 0 | 0 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 9.259095e-01 | 0.033 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 9.259095e-01 | 0.033 | 0 | 0 |
| BBSome-mediated cargo-targeting to cilium | R-HSA-5620922 | 9.259095e-01 | 0.033 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 9.259095e-01 | 0.033 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 9.259095e-01 | 0.033 | 0 | 0 |
| Pregnenolone biosynthesis | R-HSA-196108 | 9.259095e-01 | 0.033 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.262501e-01 | 0.033 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 9.262501e-01 | 0.033 | 0 | 0 |
| Telomere Maintenance | R-HSA-157579 | 9.311495e-01 | 0.031 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.321804e-01 | 0.031 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.322369e-01 | 0.030 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.322369e-01 | 0.030 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.322369e-01 | 0.030 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 9.322369e-01 | 0.030 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.326768e-01 | 0.030 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 9.332400e-01 | 0.030 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 9.332400e-01 | 0.030 | 0 | 0 |
| Lagging Strand Synthesis | R-HSA-69186 | 9.332400e-01 | 0.030 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 9.332400e-01 | 0.030 | 0 | 0 |
| Biosynthesis of E-series 18(S)-resolvins | R-HSA-9018896 | 9.332400e-01 | 0.030 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 9.332400e-01 | 0.030 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 9.332400e-01 | 0.030 | 0 | 0 |
| PD-L1(CD274) glycosylation and translocation to plasma membrane | R-HSA-9931295 | 9.332400e-01 | 0.030 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 9.332400e-01 | 0.030 | 0 | 0 |
| Synthesis, secretion, and deacylation of Ghrelin | R-HSA-422085 | 9.332400e-01 | 0.030 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 9.332400e-01 | 0.030 | 0 | 0 |
| Parasite infection | R-HSA-9664407 | 9.341333e-01 | 0.030 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.341333e-01 | 0.030 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.341333e-01 | 0.030 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 9.349035e-01 | 0.029 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 9.351135e-01 | 0.029 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 9.351135e-01 | 0.029 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.377615e-01 | 0.028 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 9.377615e-01 | 0.028 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 9.377615e-01 | 0.028 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 9.377615e-01 | 0.028 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.378235e-01 | 0.028 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 9.398061e-01 | 0.027 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.398456e-01 | 0.027 | 0 | 0 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 9.398456e-01 | 0.027 | 0 | 0 |
| Inactivation of CSF3 (G-CSF) signaling | R-HSA-9705462 | 9.398456e-01 | 0.027 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 9.408294e-01 | 0.026 | 0 | 0 |
| O-glycosylation of TSR domain-containing proteins | R-HSA-5173214 | 9.428567e-01 | 0.026 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.428567e-01 | 0.026 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.428567e-01 | 0.026 | 0 | 0 |
| NCAM1 interactions | R-HSA-419037 | 9.428567e-01 | 0.026 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.436301e-01 | 0.025 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 9.441827e-01 | 0.025 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.441827e-01 | 0.025 | 0 | 0 |
| Regulation of IFNA/IFNB signaling | R-HSA-912694 | 9.457979e-01 | 0.024 | 0 | 0 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 9.457979e-01 | 0.024 | 0 | 0 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 9.457979e-01 | 0.024 | 0 | 0 |
| Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants | R-HSA-9670439 | 9.457979e-01 | 0.024 | 0 | 0 |
| Biosynthesis of D-series resolvins | R-HSA-9018676 | 9.457979e-01 | 0.024 | 0 | 0 |
| Signaling by KIT in disease | R-HSA-9669938 | 9.457979e-01 | 0.024 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 9.457979e-01 | 0.024 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 9.457979e-01 | 0.024 | 0 | 0 |
| Fructose metabolism | R-HSA-5652084 | 9.457979e-01 | 0.024 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 9.457979e-01 | 0.024 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 9.482621e-01 | 0.023 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 9.482621e-01 | 0.023 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 9.482621e-01 | 0.023 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 9.494450e-01 | 0.023 | 0 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.496975e-01 | 0.022 | 1 | 0 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.496975e-01 | 0.022 | 1 | 0 |
| Signaling by MET | R-HSA-6806834 | 9.504376e-01 | 0.022 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 9.511616e-01 | 0.022 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 9.511616e-01 | 0.022 | 0 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 9.511616e-01 | 0.022 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.511616e-01 | 0.022 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 9.511616e-01 | 0.022 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.511616e-01 | 0.022 | 0 | 0 |
| Biosynthesis of maresins | R-HSA-9018682 | 9.511616e-01 | 0.022 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.511616e-01 | 0.022 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 9.514473e-01 | 0.022 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 9.518804e-01 | 0.021 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.518804e-01 | 0.021 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 9.520624e-01 | 0.021 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 9.530754e-01 | 0.021 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 9.532359e-01 | 0.021 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 9.548087e-01 | 0.020 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.558650e-01 | 0.020 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 9.558650e-01 | 0.020 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 9.558650e-01 | 0.020 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 9.559948e-01 | 0.020 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 9.559948e-01 | 0.020 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 9.559948e-01 | 0.020 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.559948e-01 | 0.020 | 0 | 0 |
| Synthesis of dolichyl-phosphate | R-HSA-446199 | 9.559948e-01 | 0.020 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 9.563721e-01 | 0.019 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 9.563721e-01 | 0.019 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 9.563721e-01 | 0.019 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 9.588932e-01 | 0.018 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.592554e-01 | 0.018 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 9.594107e-01 | 0.018 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 9.595326e-01 | 0.018 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.595326e-01 | 0.018 | 0 | 0 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 9.603499e-01 | 0.018 | 0 | 0 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 9.603499e-01 | 0.018 | 0 | 0 |
| Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits | R-HSA-997272 | 9.603499e-01 | 0.018 | 0 | 0 |
| Activation of G protein gated Potassium channels | R-HSA-1296041 | 9.603499e-01 | 0.018 | 0 | 0 |
| G protein gated Potassium channels | R-HSA-1296059 | 9.603499e-01 | 0.018 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.603499e-01 | 0.018 | 0 | 0 |
| Polymerase switching on the C-strand of the telomere | R-HSA-174411 | 9.603499e-01 | 0.018 | 0 | 0 |
| Biosynthesis of electrophilic ω-3 PUFA oxo-derivatives | R-HSA-9027604 | 9.603499e-01 | 0.018 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 9.603499e-01 | 0.018 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.603499e-01 | 0.018 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.603499e-01 | 0.018 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 9.611425e-01 | 0.017 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 9.618592e-01 | 0.017 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 9.619555e-01 | 0.017 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 9.619555e-01 | 0.017 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.619555e-01 | 0.017 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.619555e-01 | 0.017 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 9.619757e-01 | 0.017 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 9.634438e-01 | 0.016 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 9.634945e-01 | 0.016 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.637564e-01 | 0.016 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 9.637564e-01 | 0.016 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.642743e-01 | 0.016 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.642743e-01 | 0.016 | 0 | 0 |
| Synthesis of IP2, IP, and Ins in the cytosol | R-HSA-1855183 | 9.642743e-01 | 0.016 | 0 | 0 |
| Sphingolipid catabolism | R-HSA-9845614 | 9.642743e-01 | 0.016 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.643166e-01 | 0.016 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 9.648023e-01 | 0.016 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 9.651451e-01 | 0.015 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.657158e-01 | 0.015 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.674474e-01 | 0.014 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 9.678104e-01 | 0.014 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 9.678104e-01 | 0.014 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 9.678104e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR3 in disease | R-HSA-5655332 | 9.678104e-01 | 0.014 | 0 | 0 |
| Phosphorylation of CD3 and TCR zeta chains | R-HSA-202427 | 9.678104e-01 | 0.014 | 0 | 0 |
| Biosynthesis of DPAn-3 SPMs | R-HSA-9025094 | 9.678104e-01 | 0.014 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 9.678104e-01 | 0.014 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 9.678104e-01 | 0.014 | 0 | 0 |
| Synthesis of bile acids and bile salts via 27-hydroxycholesterol | R-HSA-193807 | 9.678104e-01 | 0.014 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 9.685982e-01 | 0.014 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.688622e-01 | 0.014 | 0 | 0 |
| Defensins | R-HSA-1461973 | 9.688622e-01 | 0.014 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 9.697915e-01 | 0.013 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.699040e-01 | 0.013 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.699040e-01 | 0.013 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.709811e-01 | 0.013 | 0 | 0 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 9.709967e-01 | 0.013 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.709967e-01 | 0.013 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 9.709967e-01 | 0.013 | 0 | 0 |
| DAP12 interactions | R-HSA-2172127 | 9.714831e-01 | 0.013 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.714831e-01 | 0.013 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.721843e-01 | 0.012 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 9.728308e-01 | 0.012 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 9.738678e-01 | 0.011 | 0 | 0 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 9.738678e-01 | 0.011 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.738678e-01 | 0.011 | 0 | 0 |
| Biosynthesis of EPA-derived SPMs | R-HSA-9018679 | 9.738678e-01 | 0.011 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.738678e-01 | 0.011 | 0 | 0 |
| Activation of Matrix Metalloproteinases | R-HSA-1592389 | 9.738678e-01 | 0.011 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.738905e-01 | 0.011 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.738905e-01 | 0.011 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.738905e-01 | 0.011 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 9.761009e-01 | 0.011 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 9.761009e-01 | 0.011 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 9.761009e-01 | 0.011 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 9.762627e-01 | 0.010 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 9.762627e-01 | 0.010 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 9.764549e-01 | 0.010 | 0 | 0 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 9.764549e-01 | 0.010 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.764549e-01 | 0.010 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 9.766377e-01 | 0.010 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 9.781298e-01 | 0.010 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 9.781298e-01 | 0.010 | 0 | 0 |
| Synthesis of PC | R-HSA-1483191 | 9.781298e-01 | 0.010 | 0 | 0 |
| Interleukin-10 signaling | R-HSA-6783783 | 9.781883e-01 | 0.010 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.781883e-01 | 0.010 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.787859e-01 | 0.009 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 9.787859e-01 | 0.009 | 0 | 0 |
| Biosynthesis of DPA-derived SPMs | R-HSA-9018683 | 9.787859e-01 | 0.009 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.787859e-01 | 0.009 | 0 | 0 |
| Molecules associated with elastic fibres | R-HSA-2129379 | 9.787859e-01 | 0.009 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 9.787859e-01 | 0.009 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.787859e-01 | 0.009 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 9.797681e-01 | 0.009 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 9.798793e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein remodeling | R-HSA-8963899 | 9.799913e-01 | 0.009 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 9.799913e-01 | 0.009 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.806592e-01 | 0.008 | 0 | 0 |
| Inwardly rectifying K+ channels | R-HSA-1296065 | 9.808863e-01 | 0.008 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.808863e-01 | 0.008 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 9.808863e-01 | 0.008 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 9.813299e-01 | 0.008 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 9.816987e-01 | 0.008 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 9.824848e-01 | 0.008 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 9.825388e-01 | 0.008 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.825388e-01 | 0.008 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 9.825388e-01 | 0.008 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 9.827789e-01 | 0.008 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 9.827789e-01 | 0.008 | 0 | 0 |
| Recycling of bile acids and salts | R-HSA-159418 | 9.827789e-01 | 0.008 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.831793e-01 | 0.007 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.841148e-01 | 0.007 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.844841e-01 | 0.007 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 9.844841e-01 | 0.007 | 0 | 0 |
| Miscellaneous transport and binding events | R-HSA-5223345 | 9.844841e-01 | 0.007 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.844841e-01 | 0.007 | 0 | 0 |
| Glutamate and glutamine metabolism | R-HSA-8964539 | 9.844841e-01 | 0.007 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.860076e-01 | 0.006 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 9.860146e-01 | 0.006 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 9.860206e-01 | 0.006 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.860206e-01 | 0.006 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.860206e-01 | 0.006 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 9.860206e-01 | 0.006 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 9.860206e-01 | 0.006 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 9.860206e-01 | 0.006 | 0 | 0 |
| Phosphate bond hydrolysis by NUDT proteins | R-HSA-2393930 | 9.860206e-01 | 0.006 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.860206e-01 | 0.006 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 9.860206e-01 | 0.006 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 9.860206e-01 | 0.006 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 9.864699e-01 | 0.006 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 9.872194e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 9.874050e-01 | 0.006 | 0 | 0 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 9.874050e-01 | 0.006 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.874050e-01 | 0.006 | 0 | 0 |
| Defects in vitamin and cofactor metabolism | R-HSA-3296482 | 9.874050e-01 | 0.006 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 9.874050e-01 | 0.006 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 9.874050e-01 | 0.006 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.874331e-01 | 0.005 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 9.874694e-01 | 0.005 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.875585e-01 | 0.005 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.875585e-01 | 0.005 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.880185e-01 | 0.005 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.881023e-01 | 0.005 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.883228e-01 | 0.005 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.885377e-01 | 0.005 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.885377e-01 | 0.005 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 9.886524e-01 | 0.005 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.886524e-01 | 0.005 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 9.886524e-01 | 0.005 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 9.886524e-01 | 0.005 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 9.890614e-01 | 0.005 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 9.893332e-01 | 0.005 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 9.894425e-01 | 0.005 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 9.897763e-01 | 0.004 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 9.897763e-01 | 0.004 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.897763e-01 | 0.004 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 9.897763e-01 | 0.004 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 9.897763e-01 | 0.004 | 0 | 0 |
| Collagen chain trimerization | R-HSA-8948216 | 9.897763e-01 | 0.004 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 9.900993e-01 | 0.004 | 0 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.902580e-01 | 0.004 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 9.905091e-01 | 0.004 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 9.907890e-01 | 0.004 | 0 | 0 |
| Depurination | R-HSA-73927 | 9.907890e-01 | 0.004 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.907890e-01 | 0.004 | 0 | 0 |
| Elastic fibre formation | R-HSA-1566948 | 9.907890e-01 | 0.004 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 9.907890e-01 | 0.004 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.908182e-01 | 0.004 | 1 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.911043e-01 | 0.004 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.911043e-01 | 0.004 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 9.916377e-01 | 0.004 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.916410e-01 | 0.004 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.917014e-01 | 0.004 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.917014e-01 | 0.004 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.917014e-01 | 0.004 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.917625e-01 | 0.004 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.917625e-01 | 0.004 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.920243e-01 | 0.003 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.925235e-01 | 0.003 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 9.925235e-01 | 0.003 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.925377e-01 | 0.003 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.925869e-01 | 0.003 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.925869e-01 | 0.003 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.932346e-01 | 0.003 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.932346e-01 | 0.003 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.932642e-01 | 0.003 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.932642e-01 | 0.003 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.932642e-01 | 0.003 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 9.932642e-01 | 0.003 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.938268e-01 | 0.003 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.938268e-01 | 0.003 | 0 | 0 |
| Telomere C-strand (Lagging Strand) Synthesis | R-HSA-174417 | 9.939315e-01 | 0.003 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 9.939315e-01 | 0.003 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 9.939831e-01 | 0.003 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 9.940179e-01 | 0.003 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 9.941328e-01 | 0.003 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 9.942996e-01 | 0.002 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.945328e-01 | 0.002 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.945328e-01 | 0.002 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.945328e-01 | 0.002 | 0 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 9.945328e-01 | 0.002 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 9.945328e-01 | 0.002 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 9.946078e-01 | 0.002 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 9.947605e-01 | 0.002 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 9.948043e-01 | 0.002 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.948627e-01 | 0.002 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 9.950745e-01 | 0.002 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 9.950864e-01 | 0.002 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.952487e-01 | 0.002 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.955626e-01 | 0.002 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.955626e-01 | 0.002 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 9.955626e-01 | 0.002 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.955626e-01 | 0.002 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 9.957437e-01 | 0.002 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 9.957625e-01 | 0.002 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.961046e-01 | 0.002 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 9.961660e-01 | 0.002 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.962749e-01 | 0.002 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 9.963985e-01 | 0.002 | 0 | 0 |
| Nicotinate metabolism | R-HSA-196807 | 9.964490e-01 | 0.002 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.964490e-01 | 0.002 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.965863e-01 | 0.001 | 1 | 1 |
| Cellular responses to stimuli | R-HSA-8953897 | 9.966153e-01 | 0.001 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 9.967554e-01 | 0.001 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.967634e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.967634e-01 | 0.001 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 9.967634e-01 | 0.001 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 9.968240e-01 | 0.001 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.970067e-01 | 0.001 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.973668e-01 | 0.001 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.975512e-01 | 0.001 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.978029e-01 | 0.001 | 0 | 0 |
| Complex IV assembly | R-HSA-9864848 | 9.978629e-01 | 0.001 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 9.978629e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.979688e-01 | 0.001 | 1 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.979688e-01 | 0.001 | 1 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 9.981495e-01 | 0.001 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.981495e-01 | 0.001 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.983079e-01 | 0.001 | 1 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.983625e-01 | 0.001 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.984376e-01 | 0.001 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 9.984859e-01 | 0.001 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.985926e-01 | 0.001 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 9.985926e-01 | 0.001 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.986032e-01 | 0.001 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 9.986238e-01 | 0.001 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.986567e-01 | 0.001 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.987285e-01 | 0.001 | 0 | 0 |
| Digestion | R-HSA-8935690 | 9.987321e-01 | 0.001 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.987491e-01 | 0.001 | 1 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.988427e-01 | 0.001 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.989001e-01 | 0.000 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 9.989468e-01 | 0.000 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 9.990790e-01 | 0.000 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 9.991276e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.991384e-01 | 0.000 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.991651e-01 | 0.000 | 0 | 0 |
| Endogenous sterols | R-HSA-211976 | 9.992479e-01 | 0.000 | 0 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.992479e-01 | 0.000 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.992703e-01 | 0.000 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 9.993225e-01 | 0.000 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.993824e-01 | 0.000 | 0 | 0 |
| Digestion and absorption | R-HSA-8963743 | 9.993897e-01 | 0.000 | 0 | 0 |
| Latent infection - Other responses of Mtb to phagocytosis | R-HSA-1222499 | 9.995048e-01 | 0.000 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 9.995063e-01 | 0.000 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.995919e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol | R-HSA-193368 | 9.995982e-01 | 0.000 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 9.996290e-01 | 0.000 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 9.996395e-01 | 0.000 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 9.996395e-01 | 0.000 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.996628e-01 | 0.000 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.996647e-01 | 0.000 | 0 | 0 |
| Protein folding | R-HSA-391251 | 9.997214e-01 | 0.000 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 9.997359e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.997437e-01 | 0.000 | 0 | 0 |
| FCGR activation | R-HSA-2029481 | 9.997469e-01 | 0.000 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.997581e-01 | 0.000 | 0 | 0 |
| Purine catabolism | R-HSA-74259 | 9.997617e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.997854e-01 | 0.000 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 9.998016e-01 | 0.000 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.998259e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.998259e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.998275e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.998408e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.998708e-01 | 0.000 | 0 | 0 |
| SLC-mediated transport of organic anions | R-HSA-9955298 | 9.998728e-01 | 0.000 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.998728e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.998826e-01 | 0.000 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.998998e-01 | 0.000 | 0 | 0 |
| Biosynthesis of DHA-derived SPMs | R-HSA-9018677 | 9.999070e-01 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 9.999093e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999129e-01 | 0.000 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.999207e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999276e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999278e-01 | 0.000 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 9.999553e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.999595e-01 | 0.000 | 0 | 0 |
| Class C/3 (Metabotropic glutamate/pheromone receptors) | R-HSA-420499 | 9.999597e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.999667e-01 | 0.000 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.999673e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.999673e-01 | 0.000 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 9.999698e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999859e-01 | 0.000 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.999878e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999885e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999932e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999938e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999967e-01 | 0.000 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.999983e-01 | 0.000 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.999985e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.999986e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999986e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.999992e-01 | 0.000 | 0 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999992e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999995e-01 | 0.000 | 0 | 0 |
| Regulation of Complement cascade | R-HSA-977606 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.999995e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999997e-01 | 0.000 | 0 | 0 |
| Nucleotide catabolism | R-HSA-8956319 | 9.999997e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 9.999997e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999998e-01 | 0.000 | 0 | 0 |
| Synthesis of substrates in N-glycan biosythesis | R-HSA-446219 | 9.999998e-01 | 0.000 | 0 | 0 |
| Translation | R-HSA-72766 | 9.999999e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999999e-01 | 0.000 | 0 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999999e-01 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 9.999999e-01 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of specialized proresolving mediators (SPMs) | R-HSA-9018678 | 1.000000e+00 | 0.000 | 0 | 0 |
| Complement cascade | R-HSA-166658 | 1.000000e+00 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 1.000000e+00 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 1.000000e+00 | 0.000 | 0 | 0 |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | R-HSA-446193 | 1.000000e+00 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 1.000000e+00 | 0.000 | 0 | 0 |
| Cytochrome P450 - arranged by substrate type | R-HSA-211897 | 1.000000e+00 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 1.000000e+00 | 0.000 | 0 | 0 |
| Disease | R-HSA-1643685 | 1.000000e+00 | 0.000 | 1 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 1.000000e+00 | 0.000 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 1.000000e+00 | 0.000 | 1 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |
Top15 pathways (red highlights are reference pathways)
Compared with reference pathways
Motif of predicted substrate sequence
Reactome pathways of predicted substrates
Download
| name | reactome_id | p | -log10p | ref_path | ref_path_lowest |
|---|---|---|---|---|---|
| Cellular response to heat stress | R-HSA-3371556 | 1.059153e-12 | 11.975 | 0 | 0 |
| HSF1-dependent transactivation | R-HSA-3371571 | 1.331157e-12 | 11.876 | 0 | 0 |
| Attenuation phase | R-HSA-3371568 | 1.902589e-12 | 11.721 | 0 | 0 |
| Regulation of HSF1-mediated heat shock response | R-HSA-3371453 | 1.837319e-11 | 10.736 | 0 | 0 |
| Eukaryotic Translation Initiation | R-HSA-72613 | 2.347029e-10 | 9.629 | 0 | 0 |
| Cap-dependent Translation Initiation | R-HSA-72737 | 2.347029e-10 | 9.629 | 0 | 0 |
| GTP hydrolysis and joining of the 60S ribosomal subunit | R-HSA-72706 | 3.511837e-10 | 9.454 | 0 | 0 |
| Cellular responses to stress | R-HSA-2262752 | 3.366984e-10 | 9.473 | 0 | 0 |
| Formation of a pool of free 40S subunits | R-HSA-72689 | 7.661390e-10 | 9.116 | 0 | 0 |
| Signaling by ROBO receptors | R-HSA-376176 | 9.144147e-10 | 9.039 | 0 | 0 |
| Cellular responses to stimuli | R-HSA-8953897 | 1.024877e-09 | 8.989 | 0 | 0 |
| L13a-mediated translational silencing of Ceruloplasmin expression | R-HSA-156827 | 1.253076e-09 | 8.902 | 0 | 0 |
| Axon guidance | R-HSA-422475 | 3.351017e-09 | 8.475 | 0 | 0 |
| Nervous system development | R-HSA-9675108 | 8.752343e-09 | 8.058 | 0 | 0 |
| Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC) | R-HSA-975956 | 1.246006e-08 | 7.904 | 0 | 0 |
| HSF1 activation | R-HSA-3371511 | 1.558824e-08 | 7.807 | 0 | 0 |
| Apoptotic execution phase | R-HSA-75153 | 2.418574e-08 | 7.616 | 0 | 0 |
| Nonsense-Mediated Decay (NMD) | R-HSA-927802 | 3.118732e-08 | 7.506 | 0 | 0 |
| Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | R-HSA-975957 | 3.118732e-08 | 7.506 | 0 | 0 |
| Eukaryotic Translation Elongation | R-HSA-156842 | 5.393966e-08 | 7.268 | 0 | 0 |
| Peptide chain elongation | R-HSA-156902 | 6.698422e-08 | 7.174 | 0 | 0 |
| Chromatin organization | R-HSA-4839726 | 1.502521e-07 | 6.823 | 0 | 0 |
| Formation of the beta-catenin:TCF transactivating complex | R-HSA-201722 | 1.573199e-07 | 6.803 | 0 | 0 |
| ZNF598 and the Ribosome-associated Quality Trigger (RQT) complex dissociate a ribosome stalled on a no-go mRNA | R-HSA-9954716 | 3.216518e-07 | 6.493 | 0 | 0 |
| Chromatin modifying enzymes | R-HSA-3247509 | 3.603946e-07 | 6.443 | 0 | 0 |
| PELO:HBS1L and ABCE1 dissociate a ribosome on a non-stop mRNA | R-HSA-9954714 | 4.099252e-07 | 6.387 | 0 | 0 |
| Cell-Cell communication | R-HSA-1500931 | 5.169436e-07 | 6.287 | 0 | 0 |
| Response of EIF2AK4 (GCN2) to amino acid deficiency | R-HSA-9633012 | 6.077734e-07 | 6.216 | 0 | 0 |
| Cell Cycle | R-HSA-1640170 | 7.712572e-07 | 6.113 | 0 | 0 |
| SRP-dependent cotranslational protein targeting to membrane | R-HSA-1799339 | 1.183791e-06 | 5.927 | 0 | 0 |
| Major pathway of rRNA processing in the nucleolus and cytosol | R-HSA-6791226 | 1.148678e-06 | 5.940 | 0 | 0 |
| Eukaryotic Translation Termination | R-HSA-72764 | 1.215250e-06 | 5.915 | 0 | 0 |
| Metabolism of RNA | R-HSA-8953854 | 1.215859e-06 | 5.915 | 0 | 0 |
| Influenza Infection | R-HSA-168255 | 1.400834e-06 | 5.854 | 0 | 0 |
| rRNA processing in the nucleus and cytosol | R-HSA-8868773 | 1.679566e-06 | 5.775 | 0 | 0 |
| HATs acetylate histones | R-HSA-3214847 | 2.389155e-06 | 5.622 | 0 | 0 |
| Influenza Viral RNA Transcription and Replication | R-HSA-168273 | 2.425563e-06 | 5.615 | 0 | 0 |
| Cell junction organization | R-HSA-446728 | 2.863814e-06 | 5.543 | 0 | 0 |
| Estrogen-dependent gene expression | R-HSA-9018519 | 3.017682e-06 | 5.520 | 0 | 0 |
| Selenocysteine synthesis | R-HSA-2408557 | 3.305042e-06 | 5.481 | 0 | 0 |
| Nonhomologous End-Joining (NHEJ) | R-HSA-5693571 | 3.339837e-06 | 5.476 | 0 | 0 |
| Regulation of PD-L1(CD274) transcription | R-HSA-9909649 | 3.611788e-06 | 5.442 | 0 | 0 |
| Mitotic Prophase | R-HSA-68875 | 4.105733e-06 | 5.387 | 0 | 0 |
| Viral mRNA Translation | R-HSA-192823 | 4.533057e-06 | 5.344 | 0 | 0 |
| M Phase | R-HSA-68886 | 4.525804e-06 | 5.344 | 0 | 0 |
| Nucleosome assembly | R-HSA-774815 | 6.347623e-06 | 5.197 | 0 | 0 |
| Deposition of new CENPA-containing nucleosomes at the centromere | R-HSA-606279 | 6.347623e-06 | 5.197 | 0 | 0 |
| Condensation of Prophase Chromosomes | R-HSA-2299718 | 8.054625e-06 | 5.094 | 0 | 0 |
| Cell Cycle, Mitotic | R-HSA-69278 | 8.082031e-06 | 5.092 | 0 | 0 |
| Regulation of CDH1 Gene Transcription | R-HSA-9764560 | 7.912745e-06 | 5.102 | 0 | 0 |
| Meiotic synapsis | R-HSA-1221632 | 1.044609e-05 | 4.981 | 0 | 0 |
| Negative Regulation of CDH1 Gene Transcription | R-HSA-9764725 | 1.270564e-05 | 4.896 | 0 | 0 |
| Cell Cycle Checkpoints | R-HSA-69620 | 1.839536e-05 | 4.735 | 0 | 0 |
| Regulation of Homotypic Cell-Cell Adhesion | R-HSA-9759476 | 2.099322e-05 | 4.678 | 0 | 0 |
| ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression | R-HSA-427389 | 2.301249e-05 | 4.638 | 0 | 0 |
| Regulation of expression of SLITs and ROBOs | R-HSA-9010553 | 2.451755e-05 | 4.611 | 0 | 0 |
| Positive epigenetic regulation of rRNA expression | R-HSA-5250913 | 3.020834e-05 | 4.520 | 0 | 0 |
| Antiviral mechanism by IFN-stimulated genes | R-HSA-1169410 | 3.065974e-05 | 4.513 | 0 | 0 |
| PRC2 methylates histones and DNA | R-HSA-212300 | 3.443235e-05 | 4.463 | 0 | 0 |
| Signal Transduction | R-HSA-162582 | 3.366519e-05 | 4.473 | 1 | 0 |
| Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks | R-HSA-5693565 | 3.505386e-05 | 4.455 | 0 | 0 |
| B-WICH complex positively regulates rRNA expression | R-HSA-5250924 | 3.666947e-05 | 4.436 | 0 | 0 |
| Adherens junctions interactions | R-HSA-418990 | 4.085512e-05 | 4.389 | 0 | 0 |
| Apoptotic cleavage of cellular proteins | R-HSA-111465 | 3.953039e-05 | 4.403 | 0 | 0 |
| Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs) | R-HSA-9845323 | 4.226541e-05 | 4.374 | 0 | 0 |
| DNA Double Strand Break Response | R-HSA-5693606 | 4.675227e-05 | 4.330 | 0 | 0 |
| Cellular response to starvation | R-HSA-9711097 | 4.731894e-05 | 4.325 | 0 | 0 |
| G2/M DNA damage checkpoint | R-HSA-69473 | 5.008586e-05 | 4.300 | 0 | 0 |
| Processing of Capped Intron-Containing Pre-mRNA | R-HSA-72203 | 5.267044e-05 | 4.278 | 0 | 0 |
| Ribosome-associated quality control | R-HSA-9948299 | 5.900388e-05 | 4.229 | 0 | 0 |
| DNA Damage/Telomere Stress Induced Senescence | R-HSA-2559586 | 6.074287e-05 | 4.217 | 0 | 0 |
| rRNA processing | R-HSA-72312 | 6.807653e-05 | 4.167 | 0 | 0 |
| Resolution of Sister Chromatid Cohesion | R-HSA-2500257 | 7.978120e-05 | 4.098 | 0 | 0 |
| Cell-cell junction organization | R-HSA-421270 | 8.270462e-05 | 4.082 | 0 | 0 |
| Replacement of protamines by nucleosomes in the male pronucleus | R-HSA-9821993 | 8.337736e-05 | 4.079 | 0 | 0 |
| Regulation of endogenous retroelements by the Human Silencing Hub (HUSH) complex | R-HSA-9843970 | 8.395728e-05 | 4.076 | 0 | 0 |
| Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S | R-HSA-72662 | 9.412627e-05 | 4.026 | 0 | 0 |
| Transcriptional regulation by small RNAs | R-HSA-5578749 | 1.069854e-04 | 3.971 | 0 | 0 |
| Translation initiation complex formation | R-HSA-72649 | 1.460107e-04 | 3.836 | 0 | 0 |
| Post NMDA receptor activation events | R-HSA-438064 | 1.465471e-04 | 3.834 | 1 | 0 |
| Apoptosis induced DNA fragmentation | R-HSA-140342 | 1.682969e-04 | 3.774 | 0 | 0 |
| G2/M Checkpoints | R-HSA-69481 | 1.776674e-04 | 3.750 | 0 | 0 |
| Packaging Of Telomere Ends | R-HSA-171306 | 1.887117e-04 | 3.724 | 0 | 0 |
| RNA Polymerase I Promoter Opening | R-HSA-73728 | 1.887117e-04 | 3.724 | 0 | 0 |
| Assembly of the ORC complex at the origin of replication | R-HSA-68616 | 2.032976e-04 | 3.692 | 0 | 0 |
| Ribosomal scanning and start codon recognition | R-HSA-72702 | 2.072391e-04 | 3.684 | 0 | 0 |
| Diseases of signal transduction by growth factor receptors and second messengers | R-HSA-5663202 | 2.276444e-04 | 3.643 | 0 | 0 |
| Regulation of Expression and Function of Type I Classical Cadherins | R-HSA-9764274 | 2.284368e-04 | 3.641 | 0 | 0 |
| Regulation of CDH1 Expression and Function | R-HSA-9764265 | 2.284368e-04 | 3.641 | 0 | 0 |
| TCF dependent signaling in response to WNT | R-HSA-201681 | 2.688564e-04 | 3.570 | 0 | 0 |
| DAG and IP3 signaling | R-HSA-1489509 | 2.935638e-04 | 3.532 | 1 | 0 |
| DNA methylation | R-HSA-5334118 | 3.090099e-04 | 3.510 | 0 | 0 |
| Inhibition of DNA recombination at telomere | R-HSA-9670095 | 3.103934e-04 | 3.508 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected pyrimidine | R-HSA-110328 | 3.172837e-04 | 3.499 | 0 | 0 |
| E3 ubiquitin ligases ubiquitinate target proteins | R-HSA-8866654 | 3.222706e-04 | 3.492 | 0 | 0 |
| mRNA Splicing - Major Pathway | R-HSA-72163 | 3.392343e-04 | 3.470 | 0 | 0 |
| Formation of the ternary complex, and subsequently, the 43S complex | R-HSA-72695 | 3.526915e-04 | 3.453 | 0 | 0 |
| Recycling pathway of L1 | R-HSA-437239 | 4.217168e-04 | 3.375 | 0 | 0 |
| Regulation of endogenous retroelements | R-HSA-9842860 | 4.961898e-04 | 3.304 | 0 | 0 |
| Activation of NMDA receptors and postsynaptic events | R-HSA-442755 | 4.961898e-04 | 3.304 | 1 | 0 |
| EML4 and NUDC in mitotic spindle formation | R-HSA-9648025 | 5.170947e-04 | 3.286 | 0 | 0 |
| Ribosome Quality Control (RQC) complex extracts and degrades nascent peptide | R-HSA-9954709 | 5.287859e-04 | 3.277 | 0 | 0 |
| Mitotic Anaphase | R-HSA-68882 | 5.516764e-04 | 3.258 | 0 | 0 |
| Factors involved in megakaryocyte development and platelet production | R-HSA-983231 | 5.585413e-04 | 3.253 | 0 | 0 |
| Mitotic Metaphase and Anaphase | R-HSA-2555396 | 5.948709e-04 | 3.226 | 0 | 0 |
| Recognition and association of DNA glycosylase with site containing an affected purine | R-HSA-110330 | 6.062526e-04 | 3.217 | 0 | 0 |
| Mitotic Prometaphase | R-HSA-68877 | 6.186453e-04 | 3.209 | 0 | 0 |
| Defective pyroptosis | R-HSA-9710421 | 6.576208e-04 | 3.182 | 0 | 0 |
| Apoptosis | R-HSA-109581 | 6.952888e-04 | 3.158 | 0 | 0 |
| ESR-mediated signaling | R-HSA-8939211 | 7.260331e-04 | 3.139 | 0 | 0 |
| mRNA Splicing | R-HSA-72172 | 8.111311e-04 | 3.091 | 0 | 0 |
| Mitochondrial unfolded protein response (UPRmt) | R-HSA-9841251 | 7.505624e-04 | 3.125 | 0 | 0 |
| Formation of Senescence-Associated Heterochromatin Foci (SAHF) | R-HSA-2559584 | 8.189796e-04 | 3.087 | 0 | 0 |
| Signaling by BRAF and RAF1 fusions | R-HSA-6802952 | 8.378478e-04 | 3.077 | 0 | 0 |
| Cellular Senescence | R-HSA-2559583 | 8.421399e-04 | 3.075 | 0 | 0 |
| Assembly of the pre-replicative complex | R-HSA-68867 | 8.992387e-04 | 3.046 | 0 | 0 |
| Transport of Mature mRNA derived from an Intron-Containing Transcript | R-HSA-159236 | 9.355784e-04 | 3.029 | 0 | 0 |
| Activation of AMPK downstream of NMDARs | R-HSA-9619483 | 9.374818e-04 | 3.028 | 0 | 0 |
| mRNA 3'-end processing | R-HSA-72187 | 9.652821e-04 | 3.015 | 0 | 0 |
| Processing of DNA double-strand break ends | R-HSA-5693607 | 1.015996e-03 | 2.993 | 0 | 0 |
| Transport of Mature Transcript to Cytoplasm | R-HSA-72202 | 1.148049e-03 | 2.940 | 0 | 0 |
| PKMTs methylate histone lysines | R-HSA-3214841 | 1.224804e-03 | 2.912 | 0 | 0 |
| Chromatin modifications during the maternal to zygotic transition (MZT) | R-HSA-9821002 | 1.224804e-03 | 2.912 | 0 | 0 |
| Protein ubiquitination | R-HSA-8852135 | 1.210038e-03 | 2.917 | 0 | 0 |
| TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation | R-HSA-8869496 | 1.247438e-03 | 2.904 | 0 | 0 |
| RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function | R-HSA-8936459 | 1.261191e-03 | 2.899 | 0 | 0 |
| Formation of the embryonic stem cell BAF (esBAF) complex | R-HSA-9933946 | 1.539981e-03 | 2.812 | 0 | 0 |
| HDACs deacetylate histones | R-HSA-3214815 | 1.513213e-03 | 2.820 | 0 | 0 |
| Regulation of endogenous retroelements by KRAB-ZFP proteins | R-HSA-9843940 | 1.633827e-03 | 2.787 | 0 | 0 |
| Oncogenic MAPK signaling | R-HSA-6802957 | 1.635114e-03 | 2.786 | 0 | 0 |
| Calmodulin induced events | R-HSA-111933 | 1.609676e-03 | 2.793 | 1 | 0 |
| CaM pathway | R-HSA-111997 | 1.609676e-03 | 2.793 | 1 | 0 |
| Cell-extracellular matrix interactions | R-HSA-446353 | 1.539981e-03 | 2.812 | 0 | 0 |
| Meiosis | R-HSA-1500620 | 1.635114e-03 | 2.786 | 0 | 0 |
| Separation of Sister Chromatids | R-HSA-2467813 | 1.635475e-03 | 2.786 | 0 | 0 |
| Ca-dependent events | R-HSA-111996 | 1.713662e-03 | 2.766 | 1 | 0 |
| Cleavage of the damaged pyrimidine | R-HSA-110329 | 1.713662e-03 | 2.766 | 0 | 0 |
| Depyrimidination | R-HSA-73928 | 1.713662e-03 | 2.766 | 0 | 0 |
| Formation of the dystrophin-glycoprotein complex (DGC) | R-HSA-9913351 | 1.738422e-03 | 2.760 | 0 | 0 |
| Deactivation of the beta-catenin transactivating complex | R-HSA-3769402 | 1.920253e-03 | 2.717 | 0 | 0 |
| SIRT1 negatively regulates rRNA expression | R-HSA-427359 | 1.920253e-03 | 2.717 | 0 | 0 |
| Cleavage of the damaged purine | R-HSA-110331 | 1.920253e-03 | 2.717 | 0 | 0 |
| Nuclear Envelope (NE) Reassembly | R-HSA-2995410 | 2.208257e-03 | 2.656 | 0 | 0 |
| PKR-mediated signaling | R-HSA-9833482 | 2.208257e-03 | 2.656 | 0 | 0 |
| Transport of the SLBP independent Mature mRNA | R-HSA-159227 | 2.528823e-03 | 2.597 | 0 | 0 |
| Regulation of MECP2 expression and activity | R-HSA-9022692 | 2.528823e-03 | 2.597 | 0 | 0 |
| Translocation of SLC2A4 (GLUT4) to the plasma membrane | R-HSA-1445148 | 2.363084e-03 | 2.627 | 0 | 0 |
| Gap junction trafficking | R-HSA-190828 | 2.352559e-03 | 2.628 | 0 | 0 |
| Depurination | R-HSA-73927 | 2.277920e-03 | 2.642 | 0 | 0 |
| Recruitment of NuMA to mitotic centrosomes | R-HSA-380320 | 2.546670e-03 | 2.594 | 0 | 0 |
| DNA Replication Pre-Initiation | R-HSA-69002 | 2.587350e-03 | 2.587 | 0 | 0 |
| DNA Double-Strand Break Repair | R-HSA-5693532 | 2.614782e-03 | 2.583 | 0 | 0 |
| Transport of Mature mRNA Derived from an Intronless Transcript | R-HSA-159231 | 2.687743e-03 | 2.571 | 0 | 0 |
| Transcriptional Regulation by E2F6 | R-HSA-8953750 | 2.687743e-03 | 2.571 | 0 | 0 |
| Formation of annular gap junctions | R-HSA-196025 | 2.956140e-03 | 2.529 | 0 | 0 |
| Kinesins | R-HSA-983189 | 2.989981e-03 | 2.524 | 0 | 0 |
| Transport of the SLBP Dependant Mature mRNA | R-HSA-159230 | 3.019869e-03 | 2.520 | 0 | 0 |
| Transport of Mature mRNAs Derived from Intronless Transcripts | R-HSA-159234 | 3.155063e-03 | 2.501 | 0 | 0 |
| Signaling by moderate kinase activity BRAF mutants | R-HSA-6802946 | 3.173545e-03 | 2.498 | 0 | 0 |
| Paradoxical activation of RAF signaling by kinase inactive BRAF | R-HSA-6802955 | 3.173545e-03 | 2.498 | 0 | 0 |
| Signaling downstream of RAS mutants | R-HSA-9649948 | 3.173545e-03 | 2.498 | 0 | 0 |
| RNA Polymerase II Transcription Termination | R-HSA-73856 | 3.394518e-03 | 2.469 | 0 | 0 |
| HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of ligand | R-HSA-3371497 | 3.199134e-03 | 2.495 | 0 | 0 |
| Aggrephagy | R-HSA-9646399 | 3.155063e-03 | 2.501 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of HSCs | R-HSA-8939236 | 3.435875e-03 | 2.464 | 0 | 0 |
| Signaling by RAS mutants | R-HSA-6802949 | 3.173545e-03 | 2.498 | 0 | 0 |
| PLC beta mediated events | R-HSA-112043 | 3.394518e-03 | 2.469 | 1 | 0 |
| Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | R-HSA-190840 | 3.449278e-03 | 2.462 | 0 | 0 |
| Transcriptional regulation by RUNX1 | R-HSA-8878171 | 3.644480e-03 | 2.438 | 0 | 0 |
| Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3 | R-HSA-5625886 | 3.685485e-03 | 2.434 | 0 | 0 |
| Regulation of CDH11 Expression and Function | R-HSA-9759475 | 3.986886e-03 | 2.399 | 0 | 0 |
| RNA Polymerase I Transcription | R-HSA-73864 | 4.169710e-03 | 2.380 | 0 | 0 |
| Gap junction degradation | R-HSA-190873 | 4.258482e-03 | 2.371 | 0 | 0 |
| Regulation of CDH11 gene transcription | R-HSA-9762293 | 4.258482e-03 | 2.371 | 0 | 0 |
| Signaling by RAF1 mutants | R-HSA-9656223 | 4.284867e-03 | 2.368 | 0 | 0 |
| Assembly and cell surface presentation of NMDA receptors | R-HSA-9609736 | 4.284867e-03 | 2.368 | 0 | 0 |
| Transport of connexons to the plasma membrane | R-HSA-190872 | 4.376639e-03 | 2.359 | 0 | 0 |
| Gene Silencing by RNA | R-HSA-211000 | 4.553618e-03 | 2.342 | 0 | 0 |
| Drug resistance in ERBB2 KD mutants | R-HSA-9665230 | 5.330162e-03 | 2.273 | 0 | 0 |
| Drug-mediated inhibition of ERBB2 signaling | R-HSA-9652282 | 5.330162e-03 | 2.273 | 0 | 0 |
| Resistance of ERBB2 KD mutants to tesevatinib | R-HSA-9665245 | 5.330162e-03 | 2.273 | 0 | 0 |
| Resistance of ERBB2 KD mutants to sapitinib | R-HSA-9665244 | 5.330162e-03 | 2.273 | 0 | 0 |
| Resistance of ERBB2 KD mutants to lapatinib | R-HSA-9665251 | 5.330162e-03 | 2.273 | 0 | 0 |
| Resistance of ERBB2 KD mutants to osimertinib | R-HSA-9665247 | 5.330162e-03 | 2.273 | 0 | 0 |
| Drug resistance in ERBB2 TMD/JMD mutants | R-HSA-9665737 | 5.330162e-03 | 2.273 | 0 | 0 |
| Resistance of ERBB2 KD mutants to neratinib | R-HSA-9665246 | 5.330162e-03 | 2.273 | 0 | 0 |
| Resistance of ERBB2 KD mutants to AEE788 | R-HSA-9665250 | 5.330162e-03 | 2.273 | 0 | 0 |
| Resistance of ERBB2 KD mutants to trastuzumab | R-HSA-9665233 | 5.330162e-03 | 2.273 | 0 | 0 |
| Resistance of ERBB2 KD mutants to afatinib | R-HSA-9665249 | 5.330162e-03 | 2.273 | 0 | 0 |
| HCMV Early Events | R-HSA-9609690 | 4.954279e-03 | 2.305 | 0 | 0 |
| Nuclear Envelope Breakdown | R-HSA-2980766 | 5.217799e-03 | 2.283 | 0 | 0 |
| Programmed Cell Death | R-HSA-5357801 | 5.285265e-03 | 2.277 | 0 | 0 |
| Gap junction trafficking and regulation | R-HSA-157858 | 4.824997e-03 | 2.317 | 0 | 0 |
| Death Receptor Signaling | R-HSA-73887 | 5.360264e-03 | 2.271 | 0 | 0 |
| Oxidative Stress Induced Senescence | R-HSA-2559580 | 5.560184e-03 | 2.255 | 0 | 0 |
| Signaling by WNT | R-HSA-195721 | 5.595998e-03 | 2.252 | 0 | 0 |
| Selective autophagy | R-HSA-9663891 | 5.713600e-03 | 2.243 | 0 | 0 |
| Signaling by high-kinase activity BRAF mutants | R-HSA-6802948 | 5.790454e-03 | 2.237 | 0 | 0 |
| Selenoamino acid metabolism | R-HSA-2408522 | 5.845645e-03 | 2.233 | 0 | 0 |
| CaMK IV-mediated phosphorylation of CREB | R-HSA-111932 | 5.925524e-03 | 2.227 | 0 | 0 |
| SWI/SNF chromatin remodelers | R-HSA-9932451 | 6.313048e-03 | 2.200 | 0 | 0 |
| ATP-dependent chromatin remodelers | R-HSA-9932444 | 6.313048e-03 | 2.200 | 0 | 0 |
| Formation of neuronal progenitor and neuronal BAF (npBAF and nBAF) | R-HSA-9934037 | 6.781617e-03 | 2.169 | 0 | 0 |
| Post-chaperonin tubulin folding pathway | R-HSA-389977 | 6.781617e-03 | 2.169 | 0 | 0 |
| COPI-dependent Golgi-to-ER retrograde traffic | R-HSA-6811434 | 6.794997e-03 | 2.168 | 0 | 0 |
| G-protein mediated events | R-HSA-112040 | 6.859742e-03 | 2.164 | 1 | 0 |
| ISG15 antiviral mechanism | R-HSA-1169408 | 6.965766e-03 | 2.157 | 0 | 0 |
| RNA Polymerase I Promoter Clearance | R-HSA-73854 | 7.715320e-03 | 2.113 | 0 | 0 |
| Regulation of Expression and Function of Type II Classical Cadherins | R-HSA-9764260 | 7.831361e-03 | 2.106 | 0 | 0 |
| RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known | R-HSA-8939243 | 7.831361e-03 | 2.106 | 0 | 0 |
| Regulation of CDH11 mRNA translation by microRNAs | R-HSA-9759811 | 8.005476e-03 | 2.097 | 0 | 0 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | R-HSA-141444 | 9.286417e-03 | 2.032 | 0 | 0 |
| Amplification of signal from the kinetochores | R-HSA-141424 | 9.286417e-03 | 2.032 | 0 | 0 |
| Hedgehog 'off' state | R-HSA-5610787 | 9.621829e-03 | 2.017 | 0 | 0 |
| p75 NTR receptor-mediated signalling | R-HSA-193704 | 8.839845e-03 | 2.054 | 0 | 0 |
| Mitotic Spindle Checkpoint | R-HSA-69618 | 9.621829e-03 | 2.017 | 0 | 0 |
| Chromosome Maintenance | R-HSA-73886 | 8.531401e-03 | 2.069 | 0 | 0 |
| Viral Infection Pathways | R-HSA-9824446 | 9.385467e-03 | 2.028 | 0 | 0 |
| Base-Excision Repair, AP Site Formation | R-HSA-73929 | 9.034153e-03 | 2.044 | 0 | 0 |
| Maternal to zygotic transition (MZT) | R-HSA-9816359 | 9.925499e-03 | 2.003 | 0 | 0 |
| Initiation of Nuclear Envelope (NE) Reformation | R-HSA-2995383 | 1.005118e-02 | 1.998 | 0 | 0 |
| Activation of RAC1 | R-HSA-428540 | 1.054428e-02 | 1.977 | 0 | 0 |
| SARS-CoV-1 modulates host translation machinery | R-HSA-9735869 | 1.058440e-02 | 1.975 | 0 | 0 |
| Processing of Intronless Pre-mRNAs | R-HSA-77595 | 1.076139e-02 | 1.968 | 0 | 0 |
| L1CAM interactions | R-HSA-373760 | 1.123352e-02 | 1.949 | 0 | 0 |
| MAP2K and MAPK activation | R-HSA-5674135 | 1.166614e-02 | 1.933 | 0 | 0 |
| Epigenetic regulation of gene expression | R-HSA-212165 | 1.174936e-02 | 1.930 | 0 | 0 |
| HIV Life Cycle | R-HSA-162587 | 1.193126e-02 | 1.923 | 0 | 0 |
| Diseases of programmed cell death | R-HSA-9645723 | 1.216516e-02 | 1.915 | 0 | 0 |
| Macroautophagy | R-HSA-1632852 | 1.264374e-02 | 1.898 | 0 | 0 |
| Cell death signalling via NRAGE, NRIF and NADE | R-HSA-204998 | 1.269568e-02 | 1.896 | 0 | 0 |
| Homology Directed Repair | R-HSA-5693538 | 1.303210e-02 | 1.885 | 0 | 0 |
| Diseases of Telomere Maintenance | R-HSA-9673013 | 1.333974e-02 | 1.875 | 0 | 0 |
| Alternative Lengthening of Telomeres (ALT) | R-HSA-9006821 | 1.333974e-02 | 1.875 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere | R-HSA-9670621 | 1.333974e-02 | 1.875 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to ATRX Mutations | R-HSA-9670615 | 1.333974e-02 | 1.875 | 0 | 0 |
| Loss of MECP2 binding ability to 5hmC-DNA | R-HSA-9022534 | 1.333974e-02 | 1.875 | 0 | 0 |
| Defective Inhibition of DNA Recombination at Telomere Due to DAXX Mutations | R-HSA-9670613 | 1.333974e-02 | 1.875 | 0 | 0 |
| Senescence-Associated Secretory Phenotype (SASP) | R-HSA-2559582 | 1.366093e-02 | 1.865 | 0 | 0 |
| COPI-mediated anterograde transport | R-HSA-6807878 | 1.390015e-02 | 1.857 | 0 | 0 |
| Signaling by cytosolic FGFR1 fusion mutants | R-HSA-1839117 | 1.611587e-02 | 1.793 | 0 | 0 |
| Formation of tubulin folding intermediates by CCT/TriC | R-HSA-389960 | 1.691621e-02 | 1.772 | 0 | 0 |
| Cooperation of Prefoldin and TriC/CCT in actin and tubulin folding | R-HSA-389958 | 1.672818e-02 | 1.777 | 0 | 0 |
| Metabolism of non-coding RNA | R-HSA-194441 | 1.566768e-02 | 1.805 | 0 | 0 |
| snRNP Assembly | R-HSA-191859 | 1.566768e-02 | 1.805 | 0 | 0 |
| CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde | R-HSA-442729 | 1.612210e-02 | 1.793 | 0 | 0 |
| Chaperone Mediated Autophagy | R-HSA-9613829 | 1.611587e-02 | 1.793 | 0 | 0 |
| Epigenetic regulation by WDR5-containing histone modifying complexes | R-HSA-9917777 | 1.737056e-02 | 1.760 | 0 | 0 |
| HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | R-HSA-5693567 | 1.590091e-02 | 1.799 | 0 | 0 |
| Regulation of PD-L1(CD274) expression | R-HSA-9909648 | 1.806909e-02 | 1.743 | 0 | 0 |
| Depolymerization of the Nuclear Lamina | R-HSA-4419969 | 1.611587e-02 | 1.793 | 0 | 0 |
| RNA Polymerase I Promoter Escape | R-HSA-73772 | 1.729253e-02 | 1.762 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in DNA replication, damage repair and senescence | R-HSA-9825895 | 1.612210e-02 | 1.793 | 0 | 0 |
| Apoptotic cleavage of cell adhesion proteins | R-HSA-351906 | 1.612210e-02 | 1.793 | 0 | 0 |
| Meiotic recombination | R-HSA-912446 | 1.549792e-02 | 1.810 | 0 | 0 |
| SARS-CoV-1-host interactions | R-HSA-9692914 | 1.676174e-02 | 1.776 | 0 | 0 |
| Reproduction | R-HSA-1474165 | 1.862293e-02 | 1.730 | 0 | 0 |
| SARS-CoV-2-host interactions | R-HSA-9705683 | 1.889197e-02 | 1.724 | 0 | 0 |
| Autophagy | R-HSA-9612973 | 1.957971e-02 | 1.708 | 0 | 0 |
| VEGFA-VEGFR2 Pathway | R-HSA-4420097 | 1.967719e-02 | 1.706 | 0 | 0 |
| G alpha (12/13) signalling events | R-HSA-416482 | 2.001647e-02 | 1.699 | 0 | 0 |
| TP53 Regulates Transcription of DNA Repair Genes | R-HSA-6796648 | 2.001647e-02 | 1.699 | 0 | 0 |
| NS1 Mediated Effects on Host Pathways | R-HSA-168276 | 2.058495e-02 | 1.686 | 0 | 0 |
| Transcriptional regulation of granulopoiesis | R-HSA-9616222 | 2.111567e-02 | 1.675 | 0 | 0 |
| Golgi-to-ER retrograde transport | R-HSA-8856688 | 2.118829e-02 | 1.674 | 0 | 0 |
| Formation of the polybromo-BAF (pBAF) complex | R-HSA-9933939 | 2.132231e-02 | 1.671 | 0 | 0 |
| Regulated proteolysis of p75NTR | R-HSA-193692 | 2.136332e-02 | 1.670 | 0 | 0 |
| Inactivation of CDC42 and RAC1 | R-HSA-428543 | 2.136332e-02 | 1.670 | 0 | 0 |
| GP1b-IX-V activation signalling | R-HSA-430116 | 2.136332e-02 | 1.670 | 0 | 0 |
| Unwinding of DNA | R-HSA-176974 | 2.136332e-02 | 1.670 | 0 | 0 |
| Sealing of the nuclear envelope (NE) by ESCRT-III | R-HSA-9668328 | 2.202408e-02 | 1.657 | 0 | 0 |
| NoRC negatively regulates rRNA expression | R-HSA-427413 | 2.258292e-02 | 1.646 | 0 | 0 |
| Myogenesis | R-HSA-525793 | 2.301300e-02 | 1.638 | 0 | 0 |
| Nephrin family interactions | R-HSA-373753 | 2.307408e-02 | 1.637 | 0 | 0 |
| Interactions of Rev with host cellular proteins | R-HSA-177243 | 2.320400e-02 | 1.634 | 0 | 0 |
| Loss of proteins required for interphase microtubule organization from the centrosome | R-HSA-380284 | 2.321130e-02 | 1.634 | 0 | 0 |
| Loss of Nlp from mitotic centrosomes | R-HSA-380259 | 2.321130e-02 | 1.634 | 0 | 0 |
| Semaphorin interactions | R-HSA-373755 | 2.321130e-02 | 1.634 | 0 | 0 |
| Signaling by membrane-tethered fusions of PDGFRA or PDGFRB | R-HSA-9673768 | 2.363570e-02 | 1.626 | 0 | 0 |
| Loss of phosphorylation of MECP2 at T308 | R-HSA-9022535 | 2.363570e-02 | 1.626 | 0 | 0 |
| LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production | R-HSA-3134973 | 2.363570e-02 | 1.626 | 0 | 0 |
| DEx/H-box helicases activate type I IFN and inflammatory cytokines production | R-HSA-3134963 | 2.363570e-02 | 1.626 | 0 | 0 |
| Developmental Lineages of the Mammary Gland | R-HSA-9924644 | 2.464884e-02 | 1.608 | 0 | 0 |
| DNA Damage Recognition in GG-NER | R-HSA-5696394 | 2.507313e-02 | 1.601 | 0 | 0 |
| Late Phase of HIV Life Cycle | R-HSA-162599 | 2.530499e-02 | 1.597 | 0 | 0 |
| Amyloid fiber formation | R-HSA-977225 | 2.572264e-02 | 1.590 | 0 | 0 |
| NRAGE signals death through JNK | R-HSA-193648 | 2.604336e-02 | 1.584 | 0 | 0 |
| DCC mediated attractive signaling | R-HSA-418885 | 2.608379e-02 | 1.584 | 0 | 0 |
| Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation | R-HSA-8950505 | 2.785565e-02 | 1.555 | 0 | 0 |
| Membrane Trafficking | R-HSA-199991 | 2.793679e-02 | 1.554 | 0 | 0 |
| Breakdown of the nuclear lamina | R-HSA-352238 | 2.836440e-02 | 1.547 | 0 | 0 |
| RAF activation | R-HSA-5673000 | 2.840520e-02 | 1.547 | 0 | 0 |
| Nuclear import of Rev protein | R-HSA-180746 | 2.840520e-02 | 1.547 | 0 | 0 |
| RNA Polymerase II Pre-transcription Events | R-HSA-674695 | 2.919404e-02 | 1.535 | 0 | 0 |
| Intra-Golgi and retrograde Golgi-to-ER traffic | R-HSA-6811442 | 2.939902e-02 | 1.532 | 0 | 0 |
| AURKA Activation by TPX2 | R-HSA-8854518 | 3.041509e-02 | 1.517 | 0 | 0 |
| Nuclear Pore Complex (NPC) Disassembly | R-HSA-3301854 | 3.203104e-02 | 1.494 | 0 | 0 |
| MTOR signalling | R-HSA-165159 | 3.247421e-02 | 1.488 | 0 | 0 |
| Negative feedback regulation of MAPK pathway | R-HSA-5674499 | 3.314195e-02 | 1.480 | 0 | 0 |
| Activation of the pre-replicative complex | R-HSA-68962 | 3.941648e-02 | 1.404 | 0 | 0 |
| Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC) | R-HSA-5619107 | 3.941648e-02 | 1.404 | 0 | 0 |
| Vpr-mediated nuclear import of PICs | R-HSA-180910 | 4.020257e-02 | 1.396 | 0 | 0 |
| Formation of RNA Pol II elongation complex | R-HSA-112382 | 3.896949e-02 | 1.409 | 0 | 0 |
| Regulation of cytoskeletal remodeling and cell spreading by IPP complex components | R-HSA-446388 | 3.314195e-02 | 1.480 | 0 | 0 |
| Neurexins and neuroligins | R-HSA-6794361 | 3.896949e-02 | 1.409 | 0 | 0 |
| Signaling by ALK fusions and activated point mutants | R-HSA-9725370 | 3.346386e-02 | 1.475 | 0 | 0 |
| Signaling by ALK in cancer | R-HSA-9700206 | 3.346386e-02 | 1.475 | 0 | 0 |
| Signaling by VEGF | R-HSA-194138 | 3.963468e-02 | 1.402 | 0 | 0 |
| MHC class II antigen presentation | R-HSA-2132295 | 3.313629e-02 | 1.480 | 0 | 0 |
| Regulation of TP53 Activity | R-HSA-5633007 | 4.073720e-02 | 1.390 | 0 | 0 |
| Deubiquitination | R-HSA-5688426 | 4.103545e-02 | 1.387 | 0 | 0 |
| Prefoldin mediated transfer of substrate to CCT/TriC | R-HSA-389957 | 4.245099e-02 | 1.372 | 0 | 0 |
| Constitutive Signaling by AKT1 E17K in Cancer | R-HSA-5674400 | 4.245099e-02 | 1.372 | 0 | 0 |
| RNA Polymerase II Transcription Elongation | R-HSA-75955 | 4.269848e-02 | 1.370 | 0 | 0 |
| NF-kB is activated and signals survival | R-HSA-209560 | 4.277585e-02 | 1.369 | 0 | 0 |
| Signaling by Receptor Tyrosine Kinases | R-HSA-9006934 | 4.408142e-02 | 1.356 | 0 | 0 |
| Signaling by Hippo | R-HSA-2028269 | 4.421873e-02 | 1.354 | 0 | 0 |
| Regulation of NFE2L2 gene expression | R-HSA-9818749 | 4.434079e-02 | 1.353 | 0 | 0 |
| IP3 and IP4 transport between cytosol and nucleus | R-HSA-1855196 | 4.446639e-02 | 1.352 | 0 | 0 |
| IP6 and IP7 transport between cytosol and nucleus | R-HSA-1855229 | 4.446639e-02 | 1.352 | 0 | 0 |
| The role of GTSE1 in G2/M progression after G2 checkpoint | R-HSA-8852276 | 4.458363e-02 | 1.351 | 0 | 0 |
| tRNA processing in the nucleus | R-HSA-6784531 | 4.458363e-02 | 1.351 | 0 | 0 |
| Rev-mediated nuclear export of HIV RNA | R-HSA-165054 | 4.476515e-02 | 1.349 | 0 | 0 |
| Opioid Signalling | R-HSA-111885 | 4.635240e-02 | 1.334 | 1 | 0 |
| Negative epigenetic regulation of rRNA expression | R-HSA-5250941 | 4.645146e-02 | 1.333 | 0 | 0 |
| SARS-CoV-2 modulates host translation machinery | R-HSA-9754678 | 4.666330e-02 | 1.331 | 0 | 0 |
| Export of Viral Ribonucleoproteins from Nucleus | R-HSA-168274 | 4.843598e-02 | 1.315 | 0 | 0 |
| Processing of Capped Intronless Pre-mRNA | R-HSA-75067 | 4.851852e-02 | 1.314 | 0 | 0 |
| CD209 (DC-SIGN) signaling | R-HSA-5621575 | 4.851852e-02 | 1.314 | 0 | 0 |
| Activation of anterior HOX genes in hindbrain development during early embryogenesis | R-HSA-5617472 | 4.932117e-02 | 1.307 | 0 | 0 |
| Activation of HOX genes during differentiation | R-HSA-5619507 | 4.932117e-02 | 1.307 | 0 | 0 |
| HCMV Infection | R-HSA-9609646 | 4.986709e-02 | 1.302 | 0 | 0 |
| COPI-independent Golgi-to-ER retrograde traffic | R-HSA-6811436 | 5.086883e-02 | 1.294 | 0 | 0 |
| Ephrin signaling | R-HSA-3928664 | 5.159390e-02 | 1.287 | 0 | 0 |
| PKA activation | R-HSA-163615 | 5.159390e-02 | 1.287 | 0 | 0 |
| PKA activation in glucagon signalling | R-HSA-164378 | 5.159390e-02 | 1.287 | 0 | 0 |
| AKT phosphorylates targets in the cytosol | R-HSA-198323 | 5.185835e-02 | 1.285 | 0 | 0 |
| Intracellular signaling by second messengers | R-HSA-9006925 | 5.296406e-02 | 1.276 | 1 | 0 |
| Telomere Maintenance | R-HSA-157579 | 5.303844e-02 | 1.275 | 0 | 0 |
| Recruitment of mitotic centrosome proteins and complexes | R-HSA-380270 | 5.320830e-02 | 1.274 | 0 | 0 |
| Signaling by Nuclear Receptors | R-HSA-9006931 | 5.412873e-02 | 1.267 | 0 | 0 |
| Interactions of Vpr with host cellular proteins | R-HSA-176033 | 5.487825e-02 | 1.261 | 0 | 0 |
| TGFBR3 expression | R-HSA-9839394 | 5.509381e-02 | 1.259 | 0 | 0 |
| IPs transport between nucleus and cytosol | R-HSA-1855170 | 5.576691e-02 | 1.254 | 0 | 0 |
| Nuclear RNA decay | R-HSA-9930044 | 5.576691e-02 | 1.254 | 0 | 0 |
| Activation of ATR in response to replication stress | R-HSA-176187 | 5.576691e-02 | 1.254 | 0 | 0 |
| Cohesin Loading onto Chromatin | R-HSA-2470946 | 5.717152e-02 | 1.243 | 0 | 0 |
| SHOC2 M1731 mutant abolishes MRAS complex function | R-HSA-9726840 | 5.717152e-02 | 1.243 | 0 | 0 |
| Uptake and function of diphtheria toxin | R-HSA-5336415 | 5.717152e-02 | 1.243 | 0 | 0 |
| G2/M Transition | R-HSA-69275 | 5.869533e-02 | 1.231 | 0 | 0 |
| Developmental Biology | R-HSA-1266738 | 5.926505e-02 | 1.227 | 0 | 0 |
| Abortive elongation of HIV-1 transcript in the absence of Tat | R-HSA-167242 | 5.964424e-02 | 1.224 | 0 | 0 |
| Rap1 signalling | R-HSA-392517 | 5.964424e-02 | 1.224 | 0 | 0 |
| Regulation of PLK1 Activity at G2/M Transition | R-HSA-2565942 | 6.127623e-02 | 1.213 | 0 | 0 |
| Centrosome maturation | R-HSA-380287 | 6.140912e-02 | 1.212 | 0 | 0 |
| CREB1 phosphorylation through the activation of Adenylate Cyclase | R-HSA-442720 | 6.190791e-02 | 1.208 | 1 | 1 |
| Regulation of Glucokinase by Glucokinase Regulatory Protein | R-HSA-170822 | 6.202847e-02 | 1.207 | 0 | 0 |
| Developmental Cell Lineages of the Integumentary System | R-HSA-9734779 | 6.252721e-02 | 1.204 | 0 | 0 |
| APC truncation mutants are not K63 polyubiquitinated | R-HSA-5467333 | 8.287207e-02 | 1.082 | 0 | 0 |
| Axonal growth stimulation | R-HSA-209563 | 7.045560e-02 | 1.152 | 0 | 0 |
| Loss of MECP2 binding ability to 5mC-DNA | R-HSA-9022538 | 7.045560e-02 | 1.152 | 0 | 0 |
| Axonal growth inhibition (RHOA activation) | R-HSA-193634 | 7.154828e-02 | 1.145 | 0 | 0 |
| Type I hemidesmosome assembly | R-HSA-446107 | 7.154828e-02 | 1.145 | 0 | 0 |
| Signaling by MRAS-complex mutants | R-HSA-9660537 | 7.154828e-02 | 1.145 | 0 | 0 |
| Gain-of-function MRAS complexes activate RAF signaling | R-HSA-9726842 | 7.154828e-02 | 1.145 | 0 | 0 |
| NRIF signals cell death from the nucleus | R-HSA-205043 | 7.290549e-02 | 1.137 | 0 | 0 |
| Formation of the canonical BAF (cBAF) complex | R-HSA-9933937 | 7.290549e-02 | 1.137 | 0 | 0 |
| Sema3A PAK dependent Axon repulsion | R-HSA-399954 | 8.482304e-02 | 1.071 | 0 | 0 |
| IRF3-mediated induction of type I IFN | R-HSA-3270619 | 8.482304e-02 | 1.071 | 0 | 0 |
| Interaction between L1 and Ankyrins | R-HSA-445095 | 6.978186e-02 | 1.156 | 0 | 0 |
| Developmental Lineage of Mammary Gland Alveolar Cells | R-HSA-9927426 | 6.870194e-02 | 1.163 | 0 | 0 |
| Developmental Lineage of Mammary Gland Luminal Epithelial Cells | R-HSA-9927418 | 7.258724e-02 | 1.139 | 0 | 0 |
| Transcription of the HIV genome | R-HSA-167172 | 7.060355e-02 | 1.151 | 0 | 0 |
| p75NTR signals via NF-kB | R-HSA-193639 | 8.482304e-02 | 1.071 | 0 | 0 |
| PKA-mediated phosphorylation of CREB | R-HSA-111931 | 7.775888e-02 | 1.109 | 1 | 1 |
| EPH-Ephrin signaling | R-HSA-2682334 | 6.469379e-02 | 1.189 | 0 | 0 |
| CLEC7A (Dectin-1) induces NFAT activation | R-HSA-5607763 | 7.290549e-02 | 1.137 | 0 | 0 |
| Mitotic G2-G2/M phases | R-HSA-453274 | 6.399018e-02 | 1.194 | 0 | 0 |
| Negative regulation of MAPK pathway | R-HSA-5675221 | 6.634142e-02 | 1.178 | 0 | 0 |
| Formation of WDR5-containing histone-modifying complexes | R-HSA-9772755 | 7.578841e-02 | 1.120 | 0 | 0 |
| HIV Infection | R-HSA-162906 | 6.506374e-02 | 1.187 | 0 | 0 |
| Regulation of TP53 Degradation | R-HSA-6804757 | 8.328722e-02 | 1.079 | 0 | 0 |
| Co-inhibition by PD-1 | R-HSA-389948 | 6.991727e-02 | 1.155 | 0 | 0 |
| Regulation of PTEN gene transcription | R-HSA-8943724 | 7.563803e-02 | 1.121 | 0 | 0 |
| DNA Replication | R-HSA-69306 | 7.351142e-02 | 1.134 | 0 | 0 |
| DNA Repair | R-HSA-73894 | 6.796666e-02 | 1.168 | 0 | 0 |
| Glucagon-like Peptide-1 (GLP1) regulates insulin secretion | R-HSA-381676 | 7.258724e-02 | 1.139 | 0 | 0 |
| Glycolysis | R-HSA-70171 | 6.370489e-02 | 1.196 | 0 | 0 |
| G1/S-Specific Transcription | R-HSA-69205 | 8.328722e-02 | 1.079 | 0 | 0 |
| NOTCH4 Intracellular Domain Regulates Transcription | R-HSA-9013695 | 7.775888e-02 | 1.109 | 0 | 0 |
| Gap junction assembly | R-HSA-190861 | 6.870194e-02 | 1.163 | 0 | 0 |
| SARS-CoV-1 Infection | R-HSA-9678108 | 8.486673e-02 | 1.071 | 0 | 0 |
| Interleukin-12 signaling | R-HSA-9020591 | 6.580688e-02 | 1.182 | 0 | 0 |
| Translation | R-HSA-72766 | 8.491792e-02 | 1.071 | 0 | 0 |
| Developmental Lineage of Mammary Gland Myoepithelial Cells | R-HSA-9927432 | 8.651565e-02 | 1.063 | 0 | 0 |
| DARPP-32 events | R-HSA-180024 | 8.651565e-02 | 1.063 | 0 | 0 |
| p75NTR regulates axonogenesis | R-HSA-193697 | 8.736664e-02 | 1.059 | 0 | 0 |
| NFE2L2 regulating MDR associated enzymes | R-HSA-9818032 | 8.736664e-02 | 1.059 | 0 | 0 |
| Lipophagy | R-HSA-9613354 | 8.736664e-02 | 1.059 | 0 | 0 |
| ALK mutants bind TKIs | R-HSA-9700645 | 8.736664e-02 | 1.059 | 0 | 0 |
| Activation of RAC1 downstream of NMDARs | R-HSA-9619229 | 8.736664e-02 | 1.059 | 0 | 0 |
| Caspase-mediated cleavage of cytoskeletal proteins | R-HSA-264870 | 8.736664e-02 | 1.059 | 0 | 0 |
| NEP/NS2 Interacts with the Cellular Export Machinery | R-HSA-168333 | 9.339145e-02 | 1.030 | 0 | 0 |
| Anchoring of the basal body to the plasma membrane | R-HSA-5620912 | 9.418142e-02 | 1.026 | 0 | 0 |
| Base Excision Repair | R-HSA-73884 | 9.418142e-02 | 1.026 | 0 | 0 |
| MECP2 regulates transcription of genes involved in GABA signaling | R-HSA-9022927 | 9.600248e-02 | 1.018 | 0 | 0 |
| Inhibition of TSC complex formation by PKB | R-HSA-165181 | 9.600248e-02 | 1.018 | 0 | 0 |
| FGFR2 alternative splicing | R-HSA-6803529 | 9.849299e-02 | 1.007 | 0 | 0 |
| mTORC1-mediated signalling | R-HSA-166208 | 9.849299e-02 | 1.007 | 0 | 0 |
| Pre-NOTCH Transcription and Translation | R-HSA-1912408 | 9.962663e-02 | 1.002 | 0 | 0 |
| Interferon Signaling | R-HSA-913531 | 1.005742e-01 | 0.998 | 0 | 0 |
| mRNA Splicing - Minor Pathway | R-HSA-72165 | 1.010109e-01 | 0.996 | 0 | 0 |
| Regulation of CDH11 function | R-HSA-9762292 | 1.045090e-01 | 0.981 | 0 | 0 |
| TICAM1,TRAF6-dependent induction of TAK1 complex | R-HSA-9014325 | 1.045090e-01 | 0.981 | 0 | 0 |
| PI3K/AKT activation | R-HSA-198203 | 1.045090e-01 | 0.981 | 0 | 0 |
| Establishment of Sister Chromatid Cohesion | R-HSA-2468052 | 1.045090e-01 | 0.981 | 0 | 0 |
| Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | R-HSA-9851695 | 1.064609e-01 | 0.973 | 0 | 0 |
| MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis | R-HSA-9841922 | 1.064609e-01 | 0.973 | 0 | 0 |
| Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | R-HSA-9818564 | 1.064609e-01 | 0.973 | 0 | 0 |
| Regulation of TP53 Expression and Degradation | R-HSA-6806003 | 1.082259e-01 | 0.966 | 0 | 0 |
| Non-integrin membrane-ECM interactions | R-HSA-3000171 | 1.112291e-01 | 0.954 | 0 | 0 |
| Clathrin-mediated endocytosis | R-HSA-8856828 | 1.122629e-01 | 0.950 | 0 | 0 |
| Protein-protein interactions at synapses | R-HSA-6794362 | 1.145731e-01 | 0.941 | 0 | 0 |
| Regulation of CDH1 Function | R-HSA-9764561 | 1.159298e-01 | 0.936 | 0 | 0 |
| Ub-specific processing proteases | R-HSA-5689880 | 1.163246e-01 | 0.934 | 0 | 0 |
| Nuclear events stimulated by ALK signaling in cancer | R-HSA-9725371 | 1.172575e-01 | 0.931 | 0 | 0 |
| Formation of HIV elongation complex in the absence of HIV Tat | R-HSA-167152 | 1.173340e-01 | 0.931 | 0 | 0 |
| TRAF6 mediated NF-kB activation | R-HSA-933542 | 1.217093e-01 | 0.915 | 0 | 0 |
| Signaling by APC mutants | R-HSA-4839744 | 1.228493e-01 | 0.911 | 0 | 0 |
| APC truncation mutants have impaired AXIN binding | R-HSA-5467337 | 1.228493e-01 | 0.911 | 0 | 0 |
| Truncations of AMER1 destabilize the destruction complex | R-HSA-5467348 | 1.228493e-01 | 0.911 | 0 | 0 |
| AXIN missense mutants destabilize the destruction complex | R-HSA-5467340 | 1.228493e-01 | 0.911 | 0 | 0 |
| SMAC (DIABLO) binds to IAPs | R-HSA-111463 | 1.237004e-01 | 0.908 | 0 | 0 |
| SMAC(DIABLO)-mediated dissociation of IAP:caspase complexes | R-HSA-111464 | 1.237004e-01 | 0.908 | 0 | 0 |
| IRS activation | R-HSA-74713 | 1.237004e-01 | 0.908 | 0 | 0 |
| Enhanced binding of GP1BA variant to VWF multimer:collagen | R-HSA-9845620 | 1.237004e-01 | 0.908 | 0 | 0 |
| Defective F9 activation | R-HSA-9673221 | 1.237004e-01 | 0.908 | 0 | 0 |
| Defective binding of VWF variant to GPIb:IX:V | R-HSA-9846298 | 1.237004e-01 | 0.908 | 0 | 0 |
| Regulation of T cell activation by CD28 family | R-HSA-388841 | 1.245964e-01 | 0.904 | 0 | 0 |
| FGFR1 mutant receptor activation | R-HSA-1839124 | 1.259112e-01 | 0.900 | 0 | 0 |
| M-decay: degradation of maternal mRNAs by maternally stored factors | R-HSA-9820841 | 1.268266e-01 | 0.897 | 0 | 0 |
| Transport of Ribonucleoproteins into the Host Nucleus | R-HSA-168271 | 1.268266e-01 | 0.897 | 0 | 0 |
| Response of endothelial cells to shear stress | R-HSA-9860931 | 1.309990e-01 | 0.883 | 0 | 0 |
| ER to Golgi Anterograde Transport | R-HSA-199977 | 1.319587e-01 | 0.880 | 0 | 0 |
| Signaling by Hedgehog | R-HSA-5358351 | 1.323128e-01 | 0.878 | 0 | 0 |
| Sema4D in semaphorin signaling | R-HSA-400685 | 1.341896e-01 | 0.872 | 0 | 0 |
| Chaperonin-mediated protein folding | R-HSA-390466 | 1.345034e-01 | 0.871 | 0 | 0 |
| Interleukin-12 family signaling | R-HSA-447115 | 1.345034e-01 | 0.871 | 0 | 0 |
| Cellular responses to mechanical stimuli | R-HSA-9855142 | 1.378974e-01 | 0.860 | 0 | 0 |
| ZBP1(DAI) mediated induction of type I IFNs | R-HSA-1606322 | 1.408803e-01 | 0.851 | 0 | 0 |
| Signaling by GSK3beta mutants | R-HSA-5339716 | 1.422562e-01 | 0.847 | 0 | 0 |
| NFE2L2 regulates pentose phosphate pathway genes | R-HSA-9818028 | 1.422562e-01 | 0.847 | 0 | 0 |
| Mitotic Telophase/Cytokinesis | R-HSA-68884 | 1.422562e-01 | 0.847 | 0 | 0 |
| Signaling by AXIN mutants | R-HSA-4839735 | 1.422562e-01 | 0.847 | 0 | 0 |
| Signaling by AMER1 mutants | R-HSA-4839748 | 1.422562e-01 | 0.847 | 0 | 0 |
| Cytosolic sensors of pathogen-associated DNA | R-HSA-1834949 | 1.443302e-01 | 0.841 | 0 | 0 |
| Regulation of PAK-2p34 activity by PS-GAP/RHG10 | R-HSA-211728 | 1.588809e-01 | 0.799 | 0 | 0 |
| TICAM1 deficiency - HSE | R-HSA-5602566 | 1.588809e-01 | 0.799 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH6 | R-HSA-5632968 | 1.588809e-01 | 0.799 | 0 | 0 |
| SMAC, XIAP-regulated apoptotic response | R-HSA-111469 | 1.530180e-01 | 0.815 | 0 | 0 |
| CDH11 homotypic and heterotypic interactions | R-HSA-9833576 | 1.530180e-01 | 0.815 | 0 | 0 |
| IkBA variant leads to EDA-ID | R-HSA-5603029 | 1.530180e-01 | 0.815 | 0 | 0 |
| SLIT2:ROBO1 increases RHOA activity | R-HSA-8985586 | 1.530180e-01 | 0.815 | 0 | 0 |
| Activation of caspases through apoptosome-mediated cleavage | R-HSA-111459 | 1.530180e-01 | 0.815 | 0 | 0 |
| Loss of MECP2 binding ability to the NCoR/SMRT complex | R-HSA-9022537 | 1.530180e-01 | 0.815 | 0 | 0 |
| RUNX3 regulates YAP1-mediated transcription | R-HSA-8951671 | 1.834970e-01 | 0.736 | 0 | 0 |
| E2F-enabled inhibition of pre-replication complex formation | R-HSA-113507 | 1.834970e-01 | 0.736 | 0 | 0 |
| RAS signaling downstream of NF1 loss-of-function variants | R-HSA-6802953 | 1.834970e-01 | 0.736 | 0 | 0 |
| MECP2 regulates transcription factors | R-HSA-9022707 | 2.147440e-01 | 0.668 | 0 | 0 |
| RUNX3 regulates WNT signaling | R-HSA-8951430 | 2.147440e-01 | 0.668 | 0 | 0 |
| NOSTRIN mediated eNOS trafficking | R-HSA-203641 | 2.147440e-01 | 0.668 | 0 | 0 |
| Binding of TCF/LEF:CTNNB1 to target gene promoters | R-HSA-4411364 | 2.147440e-01 | 0.668 | 0 | 0 |
| IFNG signaling activates MAPKs | R-HSA-9732724 | 2.147440e-01 | 0.668 | 0 | 0 |
| SLBP independent Processing of Histone Pre-mRNAs | R-HSA-111367 | 2.147440e-01 | 0.668 | 0 | 0 |
| SOS-mediated signalling | R-HSA-112412 | 2.147440e-01 | 0.668 | 0 | 0 |
| Repression of WNT target genes | R-HSA-4641265 | 1.625971e-01 | 0.789 | 0 | 0 |
| Pervasive developmental disorders | R-HSA-9005895 | 1.625971e-01 | 0.789 | 0 | 0 |
| Disorders of Nervous System Development | R-HSA-9697154 | 1.625971e-01 | 0.789 | 0 | 0 |
| Loss of function of MECP2 in Rett syndrome | R-HSA-9005891 | 1.625971e-01 | 0.789 | 0 | 0 |
| Signaling by CTNNB1 phospho-site mutants | R-HSA-4839743 | 1.625971e-01 | 0.789 | 0 | 0 |
| CTNNB1 S37 mutants aren't phosphorylated | R-HSA-5358749 | 1.625971e-01 | 0.789 | 0 | 0 |
| CTNNB1 T41 mutants aren't phosphorylated | R-HSA-5358752 | 1.625971e-01 | 0.789 | 0 | 0 |
| CTNNB1 S45 mutants aren't phosphorylated | R-HSA-5358751 | 1.625971e-01 | 0.789 | 0 | 0 |
| CTNNB1 S33 mutants aren't phosphorylated | R-HSA-5358747 | 1.625971e-01 | 0.789 | 0 | 0 |
| Formation of the non-canonical BAF (ncBAF) complex | R-HSA-9933947 | 1.837395e-01 | 0.736 | 0 | 0 |
| Formation of the HIV-1 Early Elongation Complex | R-HSA-167158 | 1.747694e-01 | 0.758 | 0 | 0 |
| HIV elongation arrest and recovery | R-HSA-167287 | 1.747694e-01 | 0.758 | 0 | 0 |
| Formation of the Early Elongation Complex | R-HSA-113418 | 1.747694e-01 | 0.758 | 0 | 0 |
| Pausing and recovery of HIV elongation | R-HSA-167290 | 1.747694e-01 | 0.758 | 0 | 0 |
| mRNA Capping | R-HSA-72086 | 1.892324e-01 | 0.723 | 0 | 0 |
| Formation of HIV-1 elongation complex containing HIV-1 Tat | R-HSA-167200 | 2.114091e-01 | 0.675 | 0 | 0 |
| Carboxyterminal post-translational modifications of tubulin | R-HSA-8955332 | 2.030344e-01 | 0.692 | 0 | 0 |
| Transcriptional Regulation by MECP2 | R-HSA-8986944 | 1.638098e-01 | 0.786 | 0 | 0 |
| EPHB-mediated forward signaling | R-HSA-3928662 | 1.684194e-01 | 0.774 | 0 | 0 |
| Energy dependent regulation of mTOR by LKB1-AMPK | R-HSA-380972 | 2.041048e-01 | 0.690 | 0 | 0 |
| Downregulation of ERBB2 signaling | R-HSA-8863795 | 2.041048e-01 | 0.690 | 0 | 0 |
| Negative regulation of NMDA receptor-mediated neuronal transmission | R-HSA-9617324 | 2.078252e-01 | 0.682 | 0 | 0 |
| RUNX3 regulates NOTCH signaling | R-HSA-8941856 | 1.625971e-01 | 0.789 | 0 | 0 |
| Sema4D induced cell migration and growth-cone collapse | R-HSA-416572 | 1.732258e-01 | 0.761 | 0 | 0 |
| Protein folding | R-HSA-391251 | 1.795730e-01 | 0.746 | 0 | 0 |
| Ion homeostasis | R-HSA-5578775 | 1.946616e-01 | 0.711 | 0 | 0 |
| Frs2-mediated activation | R-HSA-170968 | 1.837395e-01 | 0.736 | 0 | 0 |
| Formation of definitive endoderm | R-HSA-9823730 | 1.732258e-01 | 0.761 | 0 | 0 |
| Epithelial-Mesenchymal Transition (EMT) during gastrulation | R-HSA-9758919 | 1.530180e-01 | 0.815 | 0 | 0 |
| Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex | R-HSA-75035 | 1.837395e-01 | 0.736 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation | R-HSA-975163 | 2.055538e-01 | 0.687 | 0 | 0 |
| Retrograde transport at the Trans-Golgi-Network | R-HSA-6811440 | 2.030344e-01 | 0.692 | 0 | 0 |
| Neurotransmitter receptors and postsynaptic signal transmission | R-HSA-112314 | 2.157248e-01 | 0.666 | 1 | 0 |
| Constitutive Signaling by Overexpressed ERBB2 | R-HSA-9634285 | 1.625971e-01 | 0.789 | 0 | 0 |
| rRNA modification in the nucleus and cytosol | R-HSA-6790901 | 1.673116e-01 | 0.776 | 0 | 0 |
| Regulation of mRNA stability by proteins that bind AU-rich elements | R-HSA-450531 | 1.610162e-01 | 0.793 | 0 | 0 |
| Intraflagellar transport | R-HSA-5620924 | 2.151396e-01 | 0.667 | 0 | 0 |
| TNF signaling | R-HSA-75893 | 1.946616e-01 | 0.711 | 0 | 0 |
| Defects of platelet adhesion to exposed collagen | R-HSA-9823587 | 1.530180e-01 | 0.815 | 0 | 0 |
| Nef and signal transduction | R-HSA-164944 | 1.834970e-01 | 0.736 | 0 | 0 |
| CHL1 interactions | R-HSA-447041 | 2.147440e-01 | 0.668 | 0 | 0 |
| Protein hydroxylation | R-HSA-9629569 | 1.732258e-01 | 0.761 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in pigmentation | R-HSA-9824585 | 1.796574e-01 | 0.746 | 0 | 0 |
| Signaling by TGFBR3 | R-HSA-9839373 | 1.912012e-01 | 0.719 | 0 | 0 |
| SARS-CoV-2 activates/modulates innate and adaptive immune responses | R-HSA-9705671 | 1.605663e-01 | 0.794 | 0 | 0 |
| RUNX1 regulates expression of components of tight junctions | R-HSA-8935964 | 1.530180e-01 | 0.815 | 0 | 0 |
| Signaling by NTRK1 (TRKA) | R-HSA-187037 | 1.826773e-01 | 0.738 | 0 | 0 |
| STING mediated induction of host immune responses | R-HSA-1834941 | 1.567407e-01 | 0.805 | 0 | 0 |
| Sensory processing of sound by inner hair cells of the cochlea | R-HSA-9662360 | 2.169368e-01 | 0.664 | 0 | 0 |
| Transcriptional Regulation by TP53 | R-HSA-3700989 | 1.943849e-01 | 0.711 | 0 | 0 |
| CLEC7A/inflammasome pathway | R-HSA-5660668 | 1.530180e-01 | 0.815 | 0 | 0 |
| Role of ABL in ROBO-SLIT signaling | R-HSA-428890 | 2.147440e-01 | 0.668 | 0 | 0 |
| Regulation of PTEN localization | R-HSA-8948747 | 2.147440e-01 | 0.668 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in cell cycle and proliferation | R-HSA-9825892 | 2.078252e-01 | 0.682 | 0 | 0 |
| Glucose metabolism | R-HSA-70326 | 1.703381e-01 | 0.769 | 0 | 0 |
| MITF-M-regulated melanocyte development | R-HSA-9730414 | 2.216255e-01 | 0.654 | 0 | 0 |
| Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | R-HSA-8864260 | 1.684194e-01 | 0.774 | 0 | 0 |
| MITF-M-dependent gene expression | R-HSA-9856651 | 2.118533e-01 | 0.674 | 0 | 0 |
| SARS-CoV-2 Infection | R-HSA-9694516 | 1.585868e-01 | 0.800 | 0 | 0 |
| Sensory processing of sound by outer hair cells of the cochlea | R-HSA-9662361 | 1.946616e-01 | 0.711 | 0 | 0 |
| HIV Transcription Elongation | R-HSA-167169 | 2.250137e-01 | 0.648 | 0 | 0 |
| Tat-mediated elongation of the HIV-1 transcript | R-HSA-167246 | 2.250137e-01 | 0.648 | 0 | 0 |
| TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain | R-HSA-6804115 | 2.258152e-01 | 0.646 | 0 | 0 |
| TRAF6-mediated induction of TAK1 complex within TLR4 complex | R-HSA-937072 | 2.279146e-01 | 0.642 | 0 | 0 |
| Beta-catenin phosphorylation cascade | R-HSA-196299 | 2.279146e-01 | 0.642 | 0 | 0 |
| RIP-mediated NFkB activation via ZBP1 | R-HSA-1810476 | 2.279146e-01 | 0.642 | 0 | 0 |
| SARS-CoV-1 targets host intracellular signalling and regulatory pathways | R-HSA-9735871 | 2.279146e-01 | 0.642 | 0 | 0 |
| Protein methylation | R-HSA-8876725 | 2.279146e-01 | 0.642 | 0 | 0 |
| Interactions of Tat with host cellular proteins | R-HSA-176034 | 2.285944e-01 | 0.641 | 0 | 0 |
| NFG and proNGF binds to p75NTR | R-HSA-205017 | 2.285944e-01 | 0.641 | 0 | 0 |
| Defective SLC4A4 causes renal tubular acidosis, proximal, with ocular abnormalities and mental retardation (pRTA-OA) | R-HSA-5619054 | 2.285944e-01 | 0.641 | 0 | 0 |
| Defective SLC6A2 causes orthostatic intolerance (OI) | R-HSA-5619109 | 2.285944e-01 | 0.641 | 0 | 0 |
| Signaling by TCF7L2 mutants | R-HSA-5339700 | 2.285944e-01 | 0.641 | 0 | 0 |
| TRAF3 deficiency - HSE | R-HSA-5602571 | 2.285944e-01 | 0.641 | 0 | 0 |
| TWIK-releated acid-sensitive K+ channel (TASK) | R-HSA-1299316 | 2.285944e-01 | 0.641 | 0 | 0 |
| Defective Mismatch Repair Associated With MSH2 | R-HSA-5632928 | 2.285944e-01 | 0.641 | 0 | 0 |
| Inhibition of Host mRNA Processing and RNA Silencing | R-HSA-168315 | 2.285944e-01 | 0.641 | 0 | 0 |
| G0 and Early G1 | R-HSA-1538133 | 2.349292e-01 | 0.629 | 0 | 0 |
| High laminar flow shear stress activates signaling by PIEZO1 and PECAM1:CDH5:KDR in endothelial cells | R-HSA-9856530 | 2.361625e-01 | 0.627 | 0 | 0 |
| VEGFR2 mediated vascular permeability | R-HSA-5218920 | 2.388932e-01 | 0.622 | 0 | 0 |
| Signaling by ERBB2 | R-HSA-1227986 | 2.396725e-01 | 0.620 | 0 | 0 |
| SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | R-HSA-77588 | 2.464227e-01 | 0.608 | 0 | 0 |
| Adrenoceptors | R-HSA-390696 | 2.464227e-01 | 0.608 | 0 | 0 |
| ROBO receptors bind AKAP5 | R-HSA-9010642 | 2.464227e-01 | 0.608 | 0 | 0 |
| Cargo trafficking to the periciliary membrane | R-HSA-5620920 | 2.491648e-01 | 0.604 | 0 | 0 |
| Stimulation of the cell death response by PAK-2p34 | R-HSA-211736 | 2.925338e-01 | 0.534 | 0 | 0 |
| Glycogen storage disease type XV (GYG1) | R-HSA-3814836 | 2.925338e-01 | 0.534 | 0 | 0 |
| Glycogen storage disease type 0 (muscle GYS1) | R-HSA-3828062 | 2.925338e-01 | 0.534 | 0 | 0 |
| Defective SLC6A5 causes hyperekplexia 3 (HKPX3) | R-HSA-5619089 | 2.925338e-01 | 0.534 | 0 | 0 |
| AMPK inhibits chREBP transcriptional activation activity | R-HSA-163680 | 2.782472e-01 | 0.556 | 0 | 0 |
| 5-Phosphoribose 1-diphosphate biosynthesis | R-HSA-73843 | 2.782472e-01 | 0.556 | 0 | 0 |
| TLR3-mediated TICAM1-dependent programmed cell death | R-HSA-9013957 | 4.049623e-01 | 0.393 | 0 | 0 |
| NADE modulates death signalling | R-HSA-205025 | 4.049623e-01 | 0.393 | 0 | 0 |
| NFE2L2 regulating ER-stress associated genes | R-HSA-9818035 | 4.049623e-01 | 0.393 | 0 | 0 |
| GRB7 events in ERBB2 signaling | R-HSA-1306955 | 4.049623e-01 | 0.393 | 0 | 0 |
| Signaling by MAP2K mutants | R-HSA-9652169 | 4.049623e-01 | 0.393 | 0 | 0 |
| MECP2 regulates transcription of neuronal ligands | R-HSA-9022702 | 3.099759e-01 | 0.509 | 0 | 0 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 3.099759e-01 | 0.509 | 0 | 0 |
| 2-LTR circle formation | R-HSA-164843 | 3.099759e-01 | 0.509 | 0 | 0 |
| Phosphorylation of the APC/C | R-HSA-176412 | 2.507016e-01 | 0.601 | 0 | 0 |
| TRAF3-dependent IRF activation pathway | R-HSA-918233 | 2.738008e-01 | 0.563 | 0 | 0 |
| NFE2L2 regulating inflammation associated genes | R-HSA-9818026 | 4.542919e-01 | 0.343 | 0 | 0 |
| FLT3 signaling by CBL mutants | R-HSA-9706377 | 4.542919e-01 | 0.343 | 0 | 0 |
| Signaling by EGFRvIII in Cancer | R-HSA-5637812 | 2.971051e-01 | 0.527 | 0 | 0 |
| Constitutive Signaling by EGFRvIII | R-HSA-5637810 | 2.971051e-01 | 0.527 | 0 | 0 |
| TICAM1-dependent activation of IRF3/IRF7 | R-HSA-9013973 | 3.723699e-01 | 0.429 | 0 | 0 |
| Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | R-HSA-9931512 | 3.723699e-01 | 0.429 | 0 | 0 |
| MECP2 regulates neuronal receptors and channels | R-HSA-9022699 | 3.009403e-01 | 0.522 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Cyclin B | R-HSA-174048 | 3.439366e-01 | 0.464 | 0 | 0 |
| p75NTR recruits signalling complexes | R-HSA-209543 | 4.027284e-01 | 0.395 | 0 | 0 |
| Z-decay: degradation of maternal mRNAs by zygotically expressed factors | R-HSA-9820865 | 4.027284e-01 | 0.395 | 0 | 0 |
| Scavenging by Class F Receptors | R-HSA-3000484 | 4.027284e-01 | 0.395 | 0 | 0 |
| Loss-of-function mutations in DBT cause MSUD2 | R-HSA-9865113 | 4.995347e-01 | 0.301 | 0 | 0 |
| Loss-of-function mutations in DLD cause MSUD3/DLDD | R-HSA-9907570 | 4.995347e-01 | 0.301 | 0 | 0 |
| Disassembly of the destruction complex and recruitment of AXIN to the membrane | R-HSA-4641262 | 3.202173e-01 | 0.495 | 0 | 0 |
| TNFR1-induced NF-kappa-B signaling pathway | R-HSA-5357956 | 3.202173e-01 | 0.495 | 0 | 0 |
| Tat-mediated HIV elongation arrest and recovery | R-HSA-167243 | 3.202173e-01 | 0.495 | 0 | 0 |
| Pausing and recovery of Tat-mediated HIV elongation | R-HSA-167238 | 3.202173e-01 | 0.495 | 0 | 0 |
| Transcription of E2F targets under negative control by DREAM complex | R-HSA-1362277 | 3.672864e-01 | 0.435 | 0 | 0 |
| NFE2L2 regulating tumorigenic genes | R-HSA-9818030 | 4.323693e-01 | 0.364 | 0 | 0 |
| Formation of axial mesoderm | R-HSA-9796292 | 4.323693e-01 | 0.364 | 0 | 0 |
| PDH complex synthesizes acetyl-CoA from PYR | R-HSA-9861559 | 4.323693e-01 | 0.364 | 0 | 0 |
| Orc1 removal from chromatin | R-HSA-68949 | 2.659150e-01 | 0.575 | 0 | 0 |
| Signaling by Ligand-Responsive EGFR Variants in Cancer | R-HSA-5637815 | 3.904866e-01 | 0.408 | 0 | 0 |
| Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants | R-HSA-1236382 | 3.904866e-01 | 0.408 | 0 | 0 |
| Late endosomal microautophagy | R-HSA-9615710 | 3.589797e-01 | 0.445 | 0 | 0 |
| Unblocking of NMDA receptors, glutamate binding and activation | R-HSA-438066 | 4.134671e-01 | 0.384 | 0 | 0 |
| YAP1- and WWTR1 (TAZ)-stimulated gene expression | R-HSA-2032785 | 4.612031e-01 | 0.336 | 0 | 0 |
| MAP3K8 (TPL2)-dependent MAPK1/3 activation | R-HSA-5684264 | 4.612031e-01 | 0.336 | 0 | 0 |
| Notch-HLH transcription pathway | R-HSA-350054 | 4.361650e-01 | 0.360 | 0 | 0 |
| Erythropoietin activates RAS | R-HSA-9027284 | 4.891600e-01 | 0.311 | 0 | 0 |
| TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) | R-HSA-2173791 | 4.891600e-01 | 0.311 | 0 | 0 |
| ERBB2 Regulates Cell Motility | R-HSA-6785631 | 4.891600e-01 | 0.311 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE | R-HSA-77075 | 4.585245e-01 | 0.339 | 0 | 0 |
| RNA Pol II CTD phosphorylation and interaction with CE during HIV infection | R-HSA-167160 | 4.585245e-01 | 0.339 | 0 | 0 |
| GLI3 is processed to GLI3R by the proteasome | R-HSA-5610785 | 4.177750e-01 | 0.379 | 0 | 0 |
| Deadenylation of mRNA | R-HSA-429947 | 4.804963e-01 | 0.318 | 0 | 0 |
| RNA polymerase II transcribes snRNA genes | R-HSA-6807505 | 4.379471e-01 | 0.359 | 0 | 0 |
| Developmental Lineage of Pancreatic Ductal Cells | R-HSA-9925563 | 4.988950e-01 | 0.302 | 0 | 0 |
| Neutrophil degranulation | R-HSA-6798695 | 4.806498e-01 | 0.318 | 0 | 0 |
| EGFR downregulation | R-HSA-182971 | 3.976892e-01 | 0.400 | 0 | 0 |
| Cyclin A/B1/B2 associated events during G2/M transition | R-HSA-69273 | 2.508056e-01 | 0.601 | 0 | 0 |
| Downregulation of ERBB2:ERBB3 signaling | R-HSA-1358803 | 4.027284e-01 | 0.395 | 0 | 0 |
| Integration of provirus | R-HSA-162592 | 3.723699e-01 | 0.429 | 0 | 0 |
| Golgi Associated Vesicle Biogenesis | R-HSA-432722 | 2.791028e-01 | 0.554 | 0 | 0 |
| Global Genome Nucleotide Excision Repair (GG-NER) | R-HSA-5696399 | 4.016454e-01 | 0.396 | 0 | 0 |
| Regulation of the apoptosome activity | R-HSA-9627069 | 3.099759e-01 | 0.509 | 0 | 0 |
| Disorders of Developmental Biology | R-HSA-9675151 | 2.738008e-01 | 0.563 | 0 | 0 |
| Cytochrome c-mediated apoptotic response | R-HSA-111461 | 3.723699e-01 | 0.429 | 0 | 0 |
| Platelet Aggregation (Plug Formation) | R-HSA-76009 | 4.840935e-01 | 0.315 | 0 | 0 |
| Formation of apoptosome | R-HSA-111458 | 3.099759e-01 | 0.509 | 0 | 0 |
| MET activates RAP1 and RAC1 | R-HSA-8875555 | 3.099759e-01 | 0.509 | 0 | 0 |
| Switching of origins to a post-replicative state | R-HSA-69052 | 2.714885e-01 | 0.566 | 0 | 0 |
| Regulation of glycolysis by fructose 2,6-bisphosphate metabolism | R-HSA-9634600 | 2.507016e-01 | 0.601 | 0 | 0 |
| GLI proteins bind promoters of Hh responsive genes to promote transcription | R-HSA-5635851 | 4.995347e-01 | 0.301 | 0 | 0 |
| AUF1 (hnRNP D0) binds and destabilizes mRNA | R-HSA-450408 | 3.165224e-01 | 0.500 | 0 | 0 |
| NOTCH1 Intracellular Domain Regulates Transcription | R-HSA-2122947 | 3.718808e-01 | 0.430 | 0 | 0 |
| Mitochondrial protein import | R-HSA-1268020 | 4.026131e-01 | 0.395 | 0 | 0 |
| Nuclear events mediated by NFE2L2 | R-HSA-9759194 | 3.871362e-01 | 0.412 | 0 | 0 |
| Signaling by ERBB2 TMD/JMD mutants | R-HSA-9665686 | 2.628654e-01 | 0.580 | 0 | 0 |
| Listeria monocytogenes entry into host cells | R-HSA-8876384 | 4.134671e-01 | 0.384 | 0 | 0 |
| Calcineurin activates NFAT | R-HSA-2025928 | 2.782472e-01 | 0.556 | 0 | 0 |
| Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA | R-HSA-428359 | 3.099759e-01 | 0.509 | 0 | 0 |
| IRF3 mediated activation of type 1 IFN | R-HSA-1606341 | 4.542919e-01 | 0.343 | 0 | 0 |
| Resolution of AP sites via the single-nucleotide replacement pathway | R-HSA-110381 | 4.542919e-01 | 0.343 | 0 | 0 |
| Post-transcriptional silencing by small RNAs | R-HSA-426496 | 4.542919e-01 | 0.343 | 0 | 0 |
| Glucagon signaling in metabolic regulation | R-HSA-163359 | 2.669408e-01 | 0.574 | 0 | 0 |
| Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer | R-HSA-2894858 | 3.747722e-01 | 0.426 | 0 | 0 |
| Signaling by NOTCH1 PEST Domain Mutants in Cancer | R-HSA-2644602 | 3.747722e-01 | 0.426 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants | R-HSA-2894862 | 3.747722e-01 | 0.426 | 0 | 0 |
| Constitutive Signaling by NOTCH1 PEST Domain Mutants | R-HSA-2644606 | 3.747722e-01 | 0.426 | 0 | 0 |
| KEAP1-NFE2L2 pathway | R-HSA-9755511 | 4.952677e-01 | 0.305 | 0 | 0 |
| Signaling by WNT in cancer | R-HSA-4791275 | 4.169105e-01 | 0.380 | 0 | 0 |
| InlB-mediated entry of Listeria monocytogenes into host cell | R-HSA-8875360 | 4.891600e-01 | 0.311 | 0 | 0 |
| MyD88-independent TLR4 cascade | R-HSA-166166 | 4.861484e-01 | 0.313 | 0 | 0 |
| Signaling by FLT3 fusion proteins | R-HSA-9703465 | 3.009403e-01 | 0.522 | 0 | 0 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 4.321694e-01 | 0.364 | 0 | 0 |
| TRIF (TICAM1)-mediated TLR4 signaling | R-HSA-937061 | 4.861484e-01 | 0.313 | 0 | 0 |
| Elevation of cytosolic Ca2+ levels | R-HSA-139853 | 2.971051e-01 | 0.527 | 0 | 0 |
| Toxicity of botulinum toxin type E (botE) | R-HSA-5250992 | 4.995347e-01 | 0.301 | 0 | 0 |
| PKA-mediated phosphorylation of key metabolic factors | R-HSA-163358 | 4.995347e-01 | 0.301 | 0 | 0 |
| Aryl hydrocarbon receptor signalling | R-HSA-8937144 | 4.995347e-01 | 0.301 | 0 | 0 |
| Metabolism of nitric oxide: NOS3 activation and regulation | R-HSA-202131 | 3.501913e-01 | 0.456 | 0 | 0 |
| CRMPs in Sema3A signaling | R-HSA-399956 | 4.612031e-01 | 0.336 | 0 | 0 |
| Dopamine Neurotransmitter Release Cycle | R-HSA-212676 | 4.361650e-01 | 0.360 | 0 | 0 |
| Diseases of mitotic cell cycle | R-HSA-9675126 | 4.169105e-01 | 0.380 | 0 | 0 |
| Signaling by ERBB2 KD Mutants | R-HSA-9664565 | 3.589797e-01 | 0.445 | 0 | 0 |
| Signaling by ERBB2 in Cancer | R-HSA-1227990 | 3.783645e-01 | 0.422 | 0 | 0 |
| eNOS activation | R-HSA-203615 | 4.735659e-01 | 0.325 | 0 | 0 |
| PTEN Regulation | R-HSA-6807070 | 4.814571e-01 | 0.317 | 0 | 0 |
| Platelet sensitization by LDL | R-HSA-432142 | 3.205145e-01 | 0.494 | 0 | 0 |
| Prolonged ERK activation events | R-HSA-169893 | 2.507016e-01 | 0.601 | 0 | 0 |
| Interleukin-33 signaling | R-HSA-9014843 | 2.925338e-01 | 0.534 | 0 | 0 |
| Localization of the PINCH-ILK-PARVIN complex to focal adhesions | R-HSA-446343 | 2.925338e-01 | 0.534 | 0 | 0 |
| Signalling to ERK5 | R-HSA-198765 | 2.925338e-01 | 0.534 | 0 | 0 |
| Regulation of cortical dendrite branching | R-HSA-8985801 | 2.925338e-01 | 0.534 | 0 | 0 |
| MET interacts with TNS proteins | R-HSA-8875513 | 3.511770e-01 | 0.454 | 0 | 0 |
| Negative regulation of TCF-dependent signaling by DVL-interacting proteins | R-HSA-5368598 | 3.511770e-01 | 0.454 | 0 | 0 |
| Activation of BIM and translocation to mitochondria | R-HSA-111446 | 3.511770e-01 | 0.454 | 0 | 0 |
| Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells | R-HSA-210744 | 2.507016e-01 | 0.601 | 0 | 0 |
| Bicarbonate transporters | R-HSA-425381 | 3.414063e-01 | 0.467 | 0 | 0 |
| Reelin signalling pathway | R-HSA-8866376 | 4.542919e-01 | 0.343 | 0 | 0 |
| Signaling by FGFR2 IIIa TM | R-HSA-8851708 | 3.439366e-01 | 0.464 | 0 | 0 |
| Phosphorylation of Emi1 | R-HSA-176417 | 4.995347e-01 | 0.301 | 0 | 0 |
| Noncanonical activation of NOTCH3 | R-HSA-9017802 | 4.995347e-01 | 0.301 | 0 | 0 |
| Ceramide signalling | R-HSA-193681 | 4.995347e-01 | 0.301 | 0 | 0 |
| CDC6 association with the ORC:origin complex | R-HSA-68689 | 4.995347e-01 | 0.301 | 0 | 0 |
| Synthesis of PS | R-HSA-1483101 | 4.995347e-01 | 0.301 | 0 | 0 |
| Negative regulation of MET activity | R-HSA-6807004 | 3.672864e-01 | 0.435 | 0 | 0 |
| Viral Messenger RNA Synthesis | R-HSA-168325 | 2.514443e-01 | 0.600 | 0 | 0 |
| ADORA2B mediated anti-inflammatory cytokines production | R-HSA-9660821 | 4.840935e-01 | 0.315 | 1 | 1 |
| Regulation of TNFR1 signaling | R-HSA-5357905 | 3.264819e-01 | 0.486 | 0 | 0 |
| Signaling by FGFR1 in disease | R-HSA-5655302 | 2.530217e-01 | 0.597 | 0 | 0 |
| Cilium Assembly | R-HSA-5617833 | 3.556256e-01 | 0.449 | 0 | 0 |
| HCMV Late Events | R-HSA-9610379 | 2.621017e-01 | 0.582 | 0 | 0 |
| Transcriptional regulation by RUNX3 | R-HSA-8878159 | 4.577867e-01 | 0.339 | 0 | 0 |
| Early Phase of HIV Life Cycle | R-HSA-162594 | 3.904866e-01 | 0.408 | 0 | 0 |
| SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription | R-HSA-2173796 | 3.333191e-01 | 0.477 | 0 | 0 |
| Rab regulation of trafficking | R-HSA-9007101 | 4.604906e-01 | 0.337 | 0 | 0 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 4.891600e-01 | 0.311 | 0 | 0 |
| Vesicle-mediated transport | R-HSA-5653656 | 3.617096e-01 | 0.442 | 0 | 0 |
| Effects of PIP2 hydrolysis | R-HSA-114508 | 2.669408e-01 | 0.574 | 0 | 0 |
| MAP kinase activation | R-HSA-450294 | 3.886890e-01 | 0.410 | 0 | 0 |
| Signaling by NOTCH1 | R-HSA-1980143 | 4.410286e-01 | 0.356 | 0 | 0 |
| Gene expression (Transcription) | R-HSA-74160 | 3.284819e-01 | 0.483 | 0 | 0 |
| HuR (ELAVL1) binds and stabilizes mRNA | R-HSA-450520 | 2.782472e-01 | 0.556 | 0 | 0 |
| Signal attenuation | R-HSA-74749 | 3.099759e-01 | 0.509 | 0 | 0 |
| PTK6 Regulates Proteins Involved in RNA Processing | R-HSA-8849468 | 4.542919e-01 | 0.343 | 0 | 0 |
| Pre-NOTCH Expression and Processing | R-HSA-1912422 | 2.905483e-01 | 0.537 | 0 | 0 |
| RUNX2 regulates osteoblast differentiation | R-HSA-8940973 | 3.395810e-01 | 0.469 | 0 | 0 |
| Intrinsic Pathway for Apoptosis | R-HSA-109606 | 4.774853e-01 | 0.321 | 0 | 0 |
| HDMs demethylate histones | R-HSA-3214842 | 2.818042e-01 | 0.550 | 0 | 0 |
| Signaling by NOTCH1 in Cancer | R-HSA-2644603 | 3.747722e-01 | 0.426 | 0 | 0 |
| FLT3 signaling in disease | R-HSA-9682385 | 3.165224e-01 | 0.500 | 0 | 0 |
| IRAK2 mediated activation of TAK1 complex | R-HSA-937042 | 2.782472e-01 | 0.556 | 0 | 0 |
| NOTCH4 Activation and Transmission of Signal to the Nucleus | R-HSA-9013700 | 2.782472e-01 | 0.556 | 0 | 0 |
| Mitochondrial calcium ion transport | R-HSA-8949215 | 4.134671e-01 | 0.384 | 0 | 0 |
| Vitamin B2 (riboflavin) metabolism | R-HSA-196843 | 4.612031e-01 | 0.336 | 0 | 0 |
| SARS-CoV-2 targets host intracellular signalling and regulatory pathways | R-HSA-9755779 | 4.891600e-01 | 0.311 | 0 | 0 |
| Cargo recognition for clathrin-mediated endocytosis | R-HSA-8856825 | 4.104493e-01 | 0.387 | 0 | 0 |
| CLEC7A (Dectin-1) signaling | R-HSA-5607764 | 4.464060e-01 | 0.350 | 0 | 0 |
| Signaling by Non-Receptor Tyrosine Kinases | R-HSA-9006927 | 2.755092e-01 | 0.560 | 0 | 0 |
| Signaling by PTK6 | R-HSA-8848021 | 2.755092e-01 | 0.560 | 0 | 0 |
| RNA Polymerase II Transcription | R-HSA-73857 | 3.884023e-01 | 0.411 | 0 | 0 |
| Host Interactions of HIV factors | R-HSA-162909 | 3.114310e-01 | 0.507 | 0 | 0 |
| TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | R-HSA-975138 | 4.646504e-01 | 0.333 | 0 | 0 |
| Caspase activation via Dependence Receptors in the absence of ligand | R-HSA-418889 | 2.782472e-01 | 0.556 | 0 | 0 |
| Transcription of E2F targets under negative control by p107 (RBL1) and p130 (RBL2) in complex with HDAC1 | R-HSA-1362300 | 2.507016e-01 | 0.601 | 0 | 0 |
| Nectin/Necl trans heterodimerization | R-HSA-420597 | 4.542919e-01 | 0.343 | 0 | 0 |
| Smooth Muscle Contraction | R-HSA-445355 | 2.791028e-01 | 0.554 | 0 | 0 |
| Regulation of KIT signaling | R-HSA-1433559 | 4.612031e-01 | 0.336 | 0 | 0 |
| S Phase | R-HSA-69242 | 3.663116e-01 | 0.436 | 0 | 0 |
| Integration of energy metabolism | R-HSA-163685 | 4.529354e-01 | 0.344 | 0 | 0 |
| Ion transport by P-type ATPases | R-HSA-936837 | 4.304139e-01 | 0.366 | 0 | 0 |
| Signaling by MET | R-HSA-6806834 | 4.920180e-01 | 0.308 | 0 | 0 |
| NGF-stimulated transcription | R-HSA-9031628 | 3.566964e-01 | 0.448 | 0 | 0 |
| Adaptive Immune System | R-HSA-1280218 | 3.211151e-01 | 0.493 | 0 | 0 |
| Organelle biogenesis and maintenance | R-HSA-1852241 | 4.815499e-01 | 0.317 | 0 | 0 |
| Signaling by NOTCH | R-HSA-157118 | 4.024355e-01 | 0.395 | 0 | 0 |
| G1/S Transition | R-HSA-69206 | 3.297971e-01 | 0.482 | 0 | 0 |
| RUNX2 regulates bone development | R-HSA-8941326 | 3.165224e-01 | 0.500 | 0 | 0 |
| Interleukin-3, Interleukin-5 and GM-CSF signaling | R-HSA-512988 | 4.345414e-01 | 0.362 | 0 | 0 |
| Diseases of Mismatch Repair (MMR) | R-HSA-5423599 | 3.511770e-01 | 0.454 | 0 | 0 |
| p75NTR negatively regulates cell cycle via SC1 | R-HSA-193670 | 4.049623e-01 | 0.393 | 0 | 0 |
| RHOBTB3 ATPase cycle | R-HSA-9706019 | 3.414063e-01 | 0.467 | 0 | 0 |
| Interleukin-36 pathway | R-HSA-9014826 | 4.542919e-01 | 0.343 | 0 | 0 |
| Sema4D mediated inhibition of cell attachment and migration | R-HSA-416550 | 3.723699e-01 | 0.429 | 0 | 0 |
| RUNX3 regulates CDKN1A transcription | R-HSA-8941855 | 4.995347e-01 | 0.301 | 0 | 0 |
| Signalling to p38 via RIT and RIN | R-HSA-187706 | 4.995347e-01 | 0.301 | 0 | 0 |
| Retrograde neurotrophin signalling | R-HSA-177504 | 4.612031e-01 | 0.336 | 0 | 0 |
| Vasopressin regulates renal water homeostasis via Aquaporins | R-HSA-432040 | 4.840935e-01 | 0.315 | 0 | 0 |
| Mitotic G1 phase and G1/S transition | R-HSA-453279 | 3.488281e-01 | 0.457 | 0 | 0 |
| Netrin-1 signaling | R-HSA-373752 | 2.966390e-01 | 0.528 | 0 | 0 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 3.840275e-01 | 0.416 | 0 | 0 |
| TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain | R-HSA-6803205 | 4.361650e-01 | 0.360 | 0 | 0 |
| MyD88 cascade initiated on plasma membrane | R-HSA-975871 | 4.691319e-01 | 0.329 | 0 | 0 |
| Nuclear Events (kinase and transcription factor activation) | R-HSA-198725 | 3.894049e-01 | 0.410 | 0 | 0 |
| Toll Like Receptor 5 (TLR5) Cascade | R-HSA-168176 | 4.691319e-01 | 0.329 | 0 | 0 |
| Toll Like Receptor 10 (TLR10) Cascade | R-HSA-168142 | 4.691319e-01 | 0.329 | 0 | 0 |
| Transcriptional Regulation by VENTX | R-HSA-8853884 | 4.009275e-01 | 0.397 | 0 | 0 |
| MyD88 dependent cascade initiated on endosome | R-HSA-975155 | 4.754200e-01 | 0.323 | 0 | 0 |
| Basigin interactions | R-HSA-210991 | 3.904866e-01 | 0.408 | 0 | 0 |
| Expression of BMAL (ARNTL), CLOCK, and NPAS2 | R-HSA-9931509 | 3.671050e-01 | 0.435 | 0 | 0 |
| Signaling by NOTCH4 | R-HSA-9013694 | 4.152445e-01 | 0.382 | 0 | 0 |
| Cardiogenesis | R-HSA-9733709 | 4.359881e-01 | 0.361 | 0 | 0 |
| Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer | R-HSA-2173793 | 4.774853e-01 | 0.321 | 0 | 0 |
| Signaling by TGF-beta Receptor Complex | R-HSA-170834 | 4.577867e-01 | 0.339 | 0 | 0 |
| Positive Regulation of CDH1 Gene Transcription | R-HSA-9764790 | 3.099759e-01 | 0.509 | 0 | 0 |
| Regulation of TP53 Activity through Acetylation | R-HSA-6804758 | 2.508056e-01 | 0.601 | 0 | 0 |
| TBC/RABGAPs | R-HSA-8854214 | 4.511999e-01 | 0.346 | 0 | 0 |
| Toll Like Receptor 9 (TLR9) Cascade | R-HSA-168138 | 4.294477e-01 | 0.367 | 0 | 0 |
| The NLRP3 inflammasome | R-HSA-844456 | 3.439366e-01 | 0.464 | 0 | 0 |
| RMTs methylate histone arginines | R-HSA-3214858 | 2.966390e-01 | 0.528 | 0 | 0 |
| Signaling by ERBB2 ECD mutants | R-HSA-9665348 | 3.205145e-01 | 0.494 | 0 | 0 |
| Turbulent (oscillatory, disturbed) flow shear stress activates signaling by PIEZO1 and integrins in endothelial cells | R-HSA-9860927 | 4.920004e-01 | 0.308 | 0 | 0 |
| Activation, myristolyation of BID and translocation to mitochondria | R-HSA-75108 | 2.925338e-01 | 0.534 | 0 | 0 |
| SARS-CoV-2 targets PDZ proteins in cell-cell junction | R-HSA-9705677 | 4.049623e-01 | 0.393 | 0 | 0 |
| Dopamine receptors | R-HSA-390651 | 4.049623e-01 | 0.393 | 0 | 0 |
| Assembly and release of respiratory syncytial virus (RSV) virions | R-HSA-9820962 | 3.099759e-01 | 0.509 | 0 | 0 |
| Defective factor IX causes hemophilia B | R-HSA-9668250 | 3.099759e-01 | 0.509 | 0 | 0 |
| NrCAM interactions | R-HSA-447038 | 4.542919e-01 | 0.343 | 0 | 0 |
| Estrogen-dependent nuclear events downstream of ESR-membrane signaling | R-HSA-9634638 | 4.585245e-01 | 0.339 | 0 | 0 |
| Signaling by TGFB family members | R-HSA-9006936 | 4.728342e-01 | 0.325 | 0 | 0 |
| Regulation of TP53 Activity through Phosphorylation | R-HSA-6804756 | 3.104756e-01 | 0.508 | 0 | 0 |
| Sensory processing of sound | R-HSA-9659379 | 3.414277e-01 | 0.467 | 0 | 0 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.511999e-01 | 0.346 | 0 | 0 |
| Signaling by NOTCH2 | R-HSA-1980145 | 4.735659e-01 | 0.325 | 0 | 0 |
| NOTCH2 intracellular domain regulates transcription | R-HSA-2197563 | 4.027284e-01 | 0.395 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9683610 | 4.323693e-01 | 0.364 | 0 | 0 |
| Signaling by NTRKs | R-HSA-166520 | 3.663116e-01 | 0.436 | 0 | 0 |
| Respiratory syncytial virus genome replication | R-HSA-9834752 | 2.782472e-01 | 0.556 | 0 | 0 |
| Interleukin-1 processing | R-HSA-448706 | 2.782472e-01 | 0.556 | 0 | 0 |
| Alpha-protein kinase 1 signaling pathway | R-HSA-9645460 | 3.414063e-01 | 0.467 | 0 | 0 |
| Regulation of CDH19 Expression and Function | R-HSA-9764302 | 4.995347e-01 | 0.301 | 0 | 0 |
| Regulation of TP53 Activity through Association with Co-factors | R-HSA-6804759 | 4.323693e-01 | 0.364 | 0 | 0 |
| Inositol phosphate metabolism | R-HSA-1483249 | 3.880177e-01 | 0.411 | 0 | 0 |
| Signaling by FGFR in disease | R-HSA-1226099 | 2.828665e-01 | 0.548 | 0 | 0 |
| Respiratory Syncytial Virus Infection Pathway | R-HSA-9820952 | 3.577485e-01 | 0.446 | 0 | 0 |
| Synthesis of IP3 and IP4 in the cytosol | R-HSA-1855204 | 4.359881e-01 | 0.361 | 0 | 0 |
| Specification of primordial germ cells | R-HSA-9827857 | 2.971051e-01 | 0.527 | 0 | 0 |
| ChREBP activates metabolic gene expression | R-HSA-163765 | 3.414063e-01 | 0.467 | 0 | 0 |
| SARS-CoV Infections | R-HSA-9679506 | 3.965483e-01 | 0.402 | 0 | 0 |
| TYSND1 cleaves peroxisomal proteins | R-HSA-9033500 | 4.995347e-01 | 0.301 | 0 | 0 |
| Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models | R-HSA-8862803 | 4.804963e-01 | 0.318 | 0 | 0 |
| Neurodegenerative Diseases | R-HSA-8863678 | 4.804963e-01 | 0.318 | 0 | 0 |
| DNA strand elongation | R-HSA-69190 | 4.169105e-01 | 0.380 | 0 | 0 |
| Platelet Adhesion to exposed collagen | R-HSA-75892 | 4.323693e-01 | 0.364 | 0 | 0 |
| XBP1(S) activates chaperone genes | R-HSA-381038 | 3.104756e-01 | 0.508 | 0 | 0 |
| Signaling by Leptin | R-HSA-2586552 | 3.099759e-01 | 0.509 | 0 | 0 |
| IRE1alpha activates chaperones | R-HSA-381070 | 3.778847e-01 | 0.423 | 0 | 0 |
| Signaling by PDGFR in disease | R-HSA-9671555 | 4.134671e-01 | 0.384 | 0 | 0 |
| Transmission across Chemical Synapses | R-HSA-112315 | 5.008301e-01 | 0.300 | 1 | 0 |
| Tight junction interactions | R-HSA-420029 | 5.020374e-01 | 0.299 | 0 | 0 |
| Long-term potentiation | R-HSA-9620244 | 5.020374e-01 | 0.299 | 0 | 0 |
| VEGFR2 mediated cell proliferation | R-HSA-5218921 | 5.020374e-01 | 0.299 | 0 | 0 |
| Interleukin-7 signaling | R-HSA-1266695 | 5.020374e-01 | 0.299 | 0 | 0 |
| Interleukin-1 signaling | R-HSA-9020702 | 5.028695e-01 | 0.299 | 0 | 0 |
| MAPK family signaling cascades | R-HSA-5683057 | 5.063014e-01 | 0.296 | 0 | 0 |
| RET signaling | R-HSA-8853659 | 5.101596e-01 | 0.292 | 0 | 0 |
| Degradation of beta-catenin by the destruction complex | R-HSA-195253 | 5.122999e-01 | 0.290 | 0 | 0 |
| Interleukin-17 signaling | R-HSA-448424 | 5.122999e-01 | 0.290 | 0 | 0 |
| KSRP (KHSRP) binds and destabilizes mRNA | R-HSA-450604 | 5.161872e-01 | 0.287 | 0 | 0 |
| GRB2:SOS provides linkage to MAPK signaling for Integrins | R-HSA-354194 | 5.161872e-01 | 0.287 | 0 | 0 |
| Defective GALNT3 causes HFTC | R-HSA-5083625 | 5.161872e-01 | 0.287 | 0 | 0 |
| Defective GALNT12 causes CRCS1 | R-HSA-5083636 | 5.161872e-01 | 0.287 | 0 | 0 |
| Aberrant regulation of mitotic exit in cancer due to RB1 defects | R-HSA-9687136 | 5.161872e-01 | 0.287 | 0 | 0 |
| Negative regulation of FLT3 | R-HSA-9706369 | 5.161872e-01 | 0.287 | 0 | 0 |
| Receptor-type tyrosine-protein phosphatases | R-HSA-388844 | 5.161872e-01 | 0.287 | 0 | 0 |
| EPH-ephrin mediated repulsion of cells | R-HSA-3928665 | 5.162722e-01 | 0.287 | 0 | 0 |
| TAK1-dependent IKK and NF-kappa-B activation | R-HSA-445989 | 5.162722e-01 | 0.287 | 0 | 0 |
| Toll Like Receptor 7/8 (TLR7/8) Cascade | R-HSA-168181 | 5.180166e-01 | 0.286 | 0 | 0 |
| Signaling by EGFR in Cancer | R-HSA-1643713 | 5.231107e-01 | 0.281 | 0 | 0 |
| Postmitotic nuclear pore complex (NPC) reformation | R-HSA-9615933 | 5.231107e-01 | 0.281 | 0 | 0 |
| Glutamate Neurotransmitter Release Cycle | R-HSA-210500 | 5.231107e-01 | 0.281 | 0 | 0 |
| Caspase activation via extrinsic apoptotic signalling pathway | R-HSA-5357769 | 5.231107e-01 | 0.281 | 0 | 0 |
| Ovarian tumor domain proteases | R-HSA-5689896 | 5.280178e-01 | 0.277 | 0 | 0 |
| Ion channel transport | R-HSA-983712 | 5.313179e-01 | 0.275 | 0 | 0 |
| GPER1 signaling | R-HSA-9634597 | 5.320434e-01 | 0.274 | 0 | 0 |
| Muscle contraction | R-HSA-397014 | 5.365761e-01 | 0.270 | 0 | 0 |
| Antigen processing: Ubiquitination & Proteasome degradation | R-HSA-983168 | 5.366131e-01 | 0.270 | 0 | 0 |
| trans-Golgi Network Vesicle Budding | R-HSA-199992 | 5.387150e-01 | 0.269 | 0 | 0 |
| Small interfering RNA (siRNA) biogenesis | R-HSA-426486 | 5.410290e-01 | 0.267 | 0 | 0 |
| Signaling by LTK in cancer | R-HSA-9842640 | 5.410290e-01 | 0.267 | 0 | 0 |
| STAT5 Activation | R-HSA-9645135 | 5.410290e-01 | 0.267 | 0 | 0 |
| Erythropoietin activates STAT5 | R-HSA-9027283 | 5.410290e-01 | 0.267 | 0 | 0 |
| G2/M DNA replication checkpoint | R-HSA-69478 | 5.410290e-01 | 0.267 | 0 | 0 |
| Autointegration results in viral DNA circles | R-HSA-177539 | 5.410290e-01 | 0.267 | 0 | 0 |
| H139Hfs13* PPM1K causes a mild variant of MSUD | R-HSA-9912529 | 5.410290e-01 | 0.267 | 0 | 0 |
| Branched-chain ketoacid dehydrogenase kinase deficiency | R-HSA-9912481 | 5.410290e-01 | 0.267 | 0 | 0 |
| Loss-of-function mutations in BCKDHA or BCKDHB cause MSUD | R-HSA-9865125 | 5.410290e-01 | 0.267 | 0 | 0 |
| PTK6 promotes HIF1A stabilization | R-HSA-8857538 | 5.410290e-01 | 0.267 | 0 | 0 |
| Toxicity of botulinum toxin type D (botD) | R-HSA-5250955 | 5.410290e-01 | 0.267 | 0 | 0 |
| Toxicity of botulinum toxin type F (botF) | R-HSA-5250981 | 5.410290e-01 | 0.267 | 0 | 0 |
| Neurofascin interactions | R-HSA-447043 | 5.410290e-01 | 0.267 | 0 | 0 |
| Integration of viral DNA into host genomic DNA | R-HSA-175567 | 5.410290e-01 | 0.267 | 0 | 0 |
| Activation of NIMA Kinases NEK9, NEK6, NEK7 | R-HSA-2980767 | 5.410290e-01 | 0.267 | 0 | 0 |
| HDL clearance | R-HSA-8964011 | 5.410290e-01 | 0.267 | 0 | 0 |
| Lipid particle organization | R-HSA-8964572 | 5.410290e-01 | 0.267 | 0 | 0 |
| Transport to the Golgi and subsequent modification | R-HSA-948021 | 5.419104e-01 | 0.266 | 0 | 0 |
| Activation of IRF3, IRF7 mediated by TBK1, IKKε (IKBKE) | R-HSA-936964 | 5.422467e-01 | 0.266 | 0 | 0 |
| The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CLOCK) complex | R-HSA-9931521 | 5.422467e-01 | 0.266 | 0 | 0 |
| mRNA decay by 5' to 3' exoribonuclease | R-HSA-430039 | 5.422467e-01 | 0.266 | 0 | 0 |
| Inactivation of APC/C via direct inhibition of the APC/C complex | R-HSA-141430 | 5.422467e-01 | 0.266 | 0 | 0 |
| Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components | R-HSA-141405 | 5.422467e-01 | 0.266 | 0 | 0 |
| Coenzyme A biosynthesis | R-HSA-196783 | 5.422467e-01 | 0.266 | 0 | 0 |
| Defects of contact activation system (CAS) and kallikrein/kinin system (KKS) | R-HSA-9651496 | 5.422467e-01 | 0.266 | 0 | 0 |
| Cristae formation | R-HSA-8949613 | 5.436847e-01 | 0.265 | 0 | 0 |
| Synthesis of active ubiquitin: roles of E1 and E2 enzymes | R-HSA-8866652 | 5.436847e-01 | 0.265 | 0 | 0 |
| Defective Intrinsic Pathway for Apoptosis | R-HSA-9734009 | 5.436847e-01 | 0.265 | 0 | 0 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 5.455181e-01 | 0.263 | 0 | 0 |
| MET promotes cell motility | R-HSA-8875878 | 5.455522e-01 | 0.263 | 0 | 0 |
| DNA Damage Bypass | R-HSA-73893 | 5.475787e-01 | 0.262 | 0 | 0 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.521220e-01 | 0.258 | 0 | 0 |
| DDX58/IFIH1-mediated induction of interferon-alpha/beta | R-HSA-168928 | 5.557059e-01 | 0.255 | 0 | 0 |
| Nucleotide Excision Repair | R-HSA-5696398 | 5.576388e-01 | 0.254 | 0 | 0 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.617012e-01 | 0.250 | 0 | 0 |
| Differentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin | R-HSA-9725554 | 5.627423e-01 | 0.250 | 0 | 0 |
| Respiratory syncytial virus (RSV) genome replication, transcription and translation | R-HSA-9820965 | 5.627423e-01 | 0.250 | 0 | 0 |
| Regulation of RAS by GAPs | R-HSA-5658442 | 5.628626e-01 | 0.250 | 0 | 0 |
| Heme signaling | R-HSA-9707616 | 5.635421e-01 | 0.249 | 0 | 0 |
| Insulin receptor recycling | R-HSA-77387 | 5.637332e-01 | 0.249 | 0 | 0 |
| Inflammasomes | R-HSA-622312 | 5.637332e-01 | 0.249 | 0 | 0 |
| Signaling by ERBB4 | R-HSA-1236394 | 5.645302e-01 | 0.248 | 0 | 0 |
| RAB GEFs exchange GTP for GDP on RABs | R-HSA-8876198 | 5.656976e-01 | 0.247 | 0 | 0 |
| p130Cas linkage to MAPK signaling for integrins | R-HSA-372708 | 5.673132e-01 | 0.246 | 0 | 0 |
| Defective C1GALT1C1 causes TNPS | R-HSA-5083632 | 5.673132e-01 | 0.246 | 0 | 0 |
| Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase | R-HSA-176407 | 5.673132e-01 | 0.246 | 0 | 0 |
| Regulation of NPAS4 gene expression | R-HSA-9768759 | 5.673132e-01 | 0.246 | 0 | 0 |
| Platelet degranulation | R-HSA-114608 | 5.710806e-01 | 0.243 | 0 | 0 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 5.738879e-01 | 0.241 | 0 | 0 |
| C-type lectin receptors (CLRs) | R-HSA-5621481 | 5.766783e-01 | 0.239 | 0 | 0 |
| PP2A-mediated dephosphorylation of key metabolic factors | R-HSA-163767 | 5.790852e-01 | 0.237 | 0 | 0 |
| TRIF-mediated programmed cell death | R-HSA-2562578 | 5.790852e-01 | 0.237 | 0 | 0 |
| Recycling of eIF2:GDP | R-HSA-72731 | 5.790852e-01 | 0.237 | 0 | 0 |
| PTK6 Expression | R-HSA-8849473 | 5.790852e-01 | 0.237 | 0 | 0 |
| Activated NTRK3 signals through PI3K | R-HSA-9603381 | 5.790852e-01 | 0.237 | 0 | 0 |
| Activation of PUMA and translocation to mitochondria | R-HSA-139915 | 5.790852e-01 | 0.237 | 0 | 0 |
| VLDL clearance | R-HSA-8964046 | 5.790852e-01 | 0.237 | 0 | 0 |
| Cation-coupled Chloride cotransporters | R-HSA-426117 | 5.790852e-01 | 0.237 | 0 | 0 |
| POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation | R-HSA-2892245 | 5.790852e-01 | 0.237 | 0 | 0 |
| Displacement of DNA glycosylase by APEX1 | R-HSA-110357 | 5.790852e-01 | 0.237 | 0 | 0 |
| RNA Polymerase II Transcription Pre-Initiation And Promoter Opening | R-HSA-73779 | 5.795705e-01 | 0.237 | 0 | 0 |
| Formation of Incision Complex in GG-NER | R-HSA-5696395 | 5.795705e-01 | 0.237 | 0 | 0 |
| Diseases of Immune System | R-HSA-5260271 | 5.795705e-01 | 0.237 | 0 | 0 |
| Diseases associated with the TLR signaling cascade | R-HSA-5602358 | 5.795705e-01 | 0.237 | 0 | 0 |
| Platelet calcium homeostasis | R-HSA-418360 | 5.832346e-01 | 0.234 | 0 | 0 |
| MAPK targets/ Nuclear events mediated by MAP kinases | R-HSA-450282 | 5.832346e-01 | 0.234 | 0 | 0 |
| RAF/MAP kinase cascade | R-HSA-5673001 | 5.833243e-01 | 0.234 | 0 | 0 |
| Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways | R-HSA-168643 | 5.906999e-01 | 0.229 | 0 | 0 |
| Apoptotic factor-mediated response | R-HSA-111471 | 5.913722e-01 | 0.228 | 0 | 0 |
| Serotonin Neurotransmitter Release Cycle | R-HSA-181429 | 5.913722e-01 | 0.228 | 0 | 0 |
| SARS-CoV-1 activates/modulates innate immune responses | R-HSA-9692916 | 5.926205e-01 | 0.227 | 0 | 0 |
| Uptake and actions of bacterial toxins | R-HSA-5339562 | 5.926205e-01 | 0.227 | 0 | 0 |
| Regulation of insulin secretion | R-HSA-422356 | 6.000023e-01 | 0.222 | 0 | 0 |
| SHC1 events in ERBB2 signaling | R-HSA-1250196 | 6.021719e-01 | 0.220 | 0 | 0 |
| NOTCH3 Intracellular Domain Regulates Transcription | R-HSA-9013508 | 6.021719e-01 | 0.220 | 0 | 0 |
| Activation of BH3-only proteins | R-HSA-114452 | 6.021719e-01 | 0.220 | 0 | 0 |
| GABA synthesis, release, reuptake and degradation | R-HSA-888590 | 6.021719e-01 | 0.220 | 0 | 0 |
| RNA Polymerase II HIV Promoter Escape | R-HSA-167162 | 6.120822e-01 | 0.213 | 0 | 0 |
| Degradation of GLI2 by the proteasome | R-HSA-5610783 | 6.120822e-01 | 0.213 | 0 | 0 |
| HIV Transcription Initiation | R-HSA-167161 | 6.120822e-01 | 0.213 | 0 | 0 |
| RNA Polymerase II Transcription Initiation | R-HSA-75953 | 6.120822e-01 | 0.213 | 0 | 0 |
| ALKBH3 mediated reversal of alkylation damage | R-HSA-112126 | 6.139881e-01 | 0.212 | 0 | 0 |
| phospho-PLA2 pathway | R-HSA-111995 | 6.139881e-01 | 0.212 | 0 | 0 |
| Regulation of TBK1, IKKε-mediated activation of IRF3, IRF7 upon TLR3 ligation | R-HSA-9828211 | 6.139881e-01 | 0.212 | 0 | 0 |
| MET receptor recycling | R-HSA-8875656 | 6.139881e-01 | 0.212 | 0 | 0 |
| Myoclonic epilepsy of Lafora | R-HSA-3785653 | 6.139881e-01 | 0.212 | 0 | 0 |
| Regulation of NPAS4 mRNA translation | R-HSA-9768778 | 6.139881e-01 | 0.212 | 0 | 0 |
| RUNX1 regulates transcription of genes involved in differentiation of myeloid cells | R-HSA-8939246 | 6.139881e-01 | 0.212 | 0 | 0 |
| Downregulation of ERBB4 signaling | R-HSA-1253288 | 6.139881e-01 | 0.212 | 0 | 0 |
| TGFBR3 PTM regulation | R-HSA-9839383 | 6.139881e-01 | 0.212 | 0 | 0 |
| PTK6 Regulates RTKs and Their Effectors AKT1 and DOK1 | R-HSA-8849469 | 6.139881e-01 | 0.212 | 0 | 0 |
| Sodium/Proton exchangers | R-HSA-425986 | 6.139881e-01 | 0.212 | 0 | 0 |
| Regulation of signaling by CBL | R-HSA-912631 | 6.144185e-01 | 0.212 | 0 | 0 |
| Germ layer formation at gastrulation | R-HSA-9754189 | 6.144185e-01 | 0.212 | 0 | 0 |
| E2F mediated regulation of DNA replication | R-HSA-113510 | 6.144185e-01 | 0.212 | 0 | 0 |
| Maturation of nucleoprotein | R-HSA-9694631 | 6.144185e-01 | 0.212 | 0 | 0 |
| Diseases of hemostasis | R-HSA-9671793 | 6.144185e-01 | 0.212 | 0 | 0 |
| Respiratory syncytial virus (RSV) attachment and entry | R-HSA-9820960 | 6.205321e-01 | 0.207 | 0 | 0 |
| Evasion by RSV of host interferon responses | R-HSA-9833109 | 6.205321e-01 | 0.207 | 0 | 0 |
| Trafficking of AMPA receptors | R-HSA-399719 | 6.205321e-01 | 0.207 | 0 | 0 |
| Downstream signal transduction | R-HSA-186763 | 6.205321e-01 | 0.207 | 0 | 0 |
| Generic Transcription Pathway | R-HSA-212436 | 6.223184e-01 | 0.206 | 0 | 0 |
| RNA Polymerase I Transcription Initiation | R-HSA-73762 | 6.277419e-01 | 0.202 | 0 | 0 |
| Signaling by NOTCH3 | R-HSA-9012852 | 6.350640e-01 | 0.197 | 0 | 0 |
| Response to elevated platelet cytosolic Ca2+ | R-HSA-76005 | 6.364170e-01 | 0.196 | 0 | 0 |
| VxPx cargo-targeting to cilium | R-HSA-5620916 | 6.364546e-01 | 0.196 | 0 | 0 |
| Insertion of tail-anchored proteins into the endoplasmic reticulum membrane | R-HSA-9609523 | 6.364546e-01 | 0.196 | 0 | 0 |
| Creatine metabolism | R-HSA-71288 | 6.364546e-01 | 0.196 | 0 | 0 |
| Signaling by FGFR2 | R-HSA-5654738 | 6.376407e-01 | 0.195 | 0 | 0 |
| RNA Polymerase II Promoter Escape | R-HSA-73776 | 6.429917e-01 | 0.192 | 0 | 0 |
| Toxicity of botulinum toxin type A (botA) | R-HSA-5250968 | 6.459986e-01 | 0.190 | 0 | 0 |
| APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway | R-HSA-5649702 | 6.459986e-01 | 0.190 | 0 | 0 |
| Activation of the AP-1 family of transcription factors | R-HSA-450341 | 6.459986e-01 | 0.190 | 0 | 0 |
| ARMS-mediated activation | R-HSA-170984 | 6.459986e-01 | 0.190 | 0 | 0 |
| Regulation of signaling by NODAL | R-HSA-1433617 | 6.459986e-01 | 0.190 | 0 | 0 |
| MASTL Facilitates Mitotic Progression | R-HSA-2465910 | 6.459986e-01 | 0.190 | 0 | 0 |
| Activation of the TFAP2 (AP-2) family of transcription factors | R-HSA-8866907 | 6.459986e-01 | 0.190 | 0 | 0 |
| Regulation of NPAS4 gene transcription | R-HSA-9768777 | 6.459986e-01 | 0.190 | 0 | 0 |
| Cellular response to mitochondrial stress | R-HSA-9840373 | 6.459986e-01 | 0.190 | 0 | 0 |
| Developmental Cell Lineages | R-HSA-9734767 | 6.465630e-01 | 0.189 | 0 | 0 |
| Signaling by EGFR | R-HSA-177929 | 6.485914e-01 | 0.188 | 0 | 0 |
| Integrin signaling | R-HSA-354192 | 6.554879e-01 | 0.183 | 0 | 0 |
| Regulation of necroptotic cell death | R-HSA-5675482 | 6.554879e-01 | 0.183 | 0 | 0 |
| Glutamate binding, activation of AMPA receptors and synaptic plasticity | R-HSA-399721 | 6.554879e-01 | 0.183 | 0 | 0 |
| APC-Cdc20 mediated degradation of Nek2A | R-HSA-179409 | 6.574894e-01 | 0.182 | 0 | 0 |
| Acetylcholine Neurotransmitter Release Cycle | R-HSA-264642 | 6.574894e-01 | 0.182 | 0 | 0 |
| JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 | R-HSA-450321 | 6.574894e-01 | 0.182 | 0 | 0 |
| TNFR1-induced proapoptotic signaling | R-HSA-5357786 | 6.574894e-01 | 0.182 | 0 | 0 |
| ERK/MAPK targets | R-HSA-198753 | 6.574894e-01 | 0.182 | 0 | 0 |
| Zygotic genome activation (ZGA) | R-HSA-9819196 | 6.574894e-01 | 0.182 | 0 | 0 |
| NOTCH2 Activation and Transmission of Signal to the Nucleus | R-HSA-2979096 | 6.574894e-01 | 0.182 | 0 | 0 |
| Intrinsic Pathway of Fibrin Clot Formation | R-HSA-140837 | 6.574894e-01 | 0.182 | 0 | 0 |
| TP53 Regulates Transcription of Cell Cycle Genes | R-HSA-6791312 | 6.617975e-01 | 0.179 | 0 | 0 |
| Neuronal System | R-HSA-112316 | 6.618028e-01 | 0.179 | 1 | 0 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 6.664612e-01 | 0.176 | 0 | 0 |
| RSV-host interactions | R-HSA-9833110 | 6.718913e-01 | 0.173 | 0 | 0 |
| Striated Muscle Contraction | R-HSA-390522 | 6.720749e-01 | 0.173 | 0 | 0 |
| Association of TriC/CCT with target proteins during biosynthesis | R-HSA-390471 | 6.720749e-01 | 0.173 | 0 | 0 |
| EGR2 and SOX10-mediated initiation of Schwann cell myelination | R-HSA-9619665 | 6.720749e-01 | 0.173 | 0 | 0 |
| Vitamin B5 (pantothenate) metabolism | R-HSA-199220 | 6.720749e-01 | 0.173 | 0 | 0 |
| RNA Polymerase II Transcription Initiation And Promoter Clearance | R-HSA-76042 | 6.722364e-01 | 0.172 | 0 | 0 |
| Erythropoietin activates Phospholipase C gamma (PLCG) | R-HSA-9027277 | 6.753564e-01 | 0.170 | 0 | 0 |
| WNT5A-dependent internalization of FZD2, FZD5 and ROR2 | R-HSA-5140745 | 6.753564e-01 | 0.170 | 0 | 0 |
| Folding of actin by CCT/TriC | R-HSA-390450 | 6.753564e-01 | 0.170 | 0 | 0 |
| Binding and entry of HIV virion | R-HSA-173107 | 6.753564e-01 | 0.170 | 0 | 0 |
| Activation of PPARGC1A (PGC-1alpha) by phosphorylation | R-HSA-2151209 | 6.753564e-01 | 0.170 | 0 | 0 |
| Ion influx/efflux at host-pathogen interface | R-HSA-6803544 | 6.753564e-01 | 0.170 | 0 | 0 |
| Pexophagy | R-HSA-9664873 | 6.753564e-01 | 0.170 | 0 | 0 |
| Receptor Mediated Mitophagy | R-HSA-8934903 | 6.753564e-01 | 0.170 | 0 | 0 |
| Maturation of spike protein | R-HSA-9683686 | 6.753564e-01 | 0.170 | 0 | 0 |
| Josephin domain DUBs | R-HSA-5689877 | 6.753564e-01 | 0.170 | 0 | 0 |
| Tandem pore domain potassium channels | R-HSA-1296346 | 6.753564e-01 | 0.170 | 0 | 0 |
| Ras activation upon Ca2+ influx through NMDA receptor | R-HSA-442982 | 6.775376e-01 | 0.169 | 0 | 0 |
| activated TAK1 mediates p38 MAPK activation | R-HSA-450302 | 6.775376e-01 | 0.169 | 0 | 0 |
| FOXO-mediated transcription of cell cycle genes | R-HSA-9617828 | 6.775376e-01 | 0.169 | 0 | 0 |
| Transcriptional and post-translational regulation of MITF-M expression and activity | R-HSA-9856649 | 6.781861e-01 | 0.169 | 0 | 0 |
| Deadenylation-dependent mRNA decay | R-HSA-429914 | 6.872278e-01 | 0.163 | 0 | 0 |
| Mitophagy | R-HSA-5205647 | 6.880669e-01 | 0.162 | 0 | 0 |
| Signaling by CSF1 (M-CSF) in myeloid cells | R-HSA-9680350 | 6.880669e-01 | 0.162 | 0 | 0 |
| NOD1/2 Signaling Pathway | R-HSA-168638 | 6.880669e-01 | 0.162 | 0 | 0 |
| MAPK6/MAPK4 signaling | R-HSA-5687128 | 6.928091e-01 | 0.159 | 0 | 0 |
| Mitochondrial biogenesis | R-HSA-1592230 | 6.954013e-01 | 0.158 | 0 | 0 |
| Fcgamma receptor (FCGR) dependent phagocytosis | R-HSA-2029480 | 6.955490e-01 | 0.158 | 0 | 0 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 6.966180e-01 | 0.157 | 0 | 0 |
| Downregulation of TGF-beta receptor signaling | R-HSA-2173788 | 6.966180e-01 | 0.157 | 0 | 0 |
| NOTCH3 Activation and Transmission of Signal to the Nucleus | R-HSA-9013507 | 6.966180e-01 | 0.157 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in lysosome biogenesis and autophagy | R-HSA-9857377 | 6.966180e-01 | 0.157 | 0 | 0 |
| Synthesis of DNA | R-HSA-69239 | 7.002124e-01 | 0.155 | 0 | 0 |
| Ca2+ pathway | R-HSA-4086398 | 7.008242e-01 | 0.154 | 0 | 0 |
| PECAM1 interactions | R-HSA-210990 | 7.022811e-01 | 0.153 | 0 | 0 |
| NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 | R-HSA-933543 | 7.022811e-01 | 0.153 | 0 | 0 |
| LGI-ADAM interactions | R-HSA-5682910 | 7.022811e-01 | 0.153 | 0 | 0 |
| InlA-mediated entry of Listeria monocytogenes into host cells | R-HSA-8876493 | 7.022811e-01 | 0.153 | 0 | 0 |
| Regulation of localization of FOXO transcription factors | R-HSA-9614399 | 7.022811e-01 | 0.153 | 0 | 0 |
| vRNP Assembly | R-HSA-192905 | 7.022811e-01 | 0.153 | 0 | 0 |
| FGFRL1 modulation of FGFR1 signaling | R-HSA-5658623 | 7.022811e-01 | 0.153 | 0 | 0 |
| Synthesis of PI | R-HSA-1483226 | 7.022811e-01 | 0.153 | 0 | 0 |
| SARS-CoV-2 modulates autophagy | R-HSA-9754560 | 7.022811e-01 | 0.153 | 0 | 0 |
| Suppression of apoptosis | R-HSA-9635465 | 7.022811e-01 | 0.153 | 0 | 0 |
| Transport of RCbl within the body | R-HSA-9758890 | 7.022811e-01 | 0.153 | 0 | 0 |
| Presynaptic phase of homologous DNA pairing and strand exchange | R-HSA-5693616 | 7.034665e-01 | 0.153 | 0 | 0 |
| Oncogene Induced Senescence | R-HSA-2559585 | 7.034665e-01 | 0.153 | 0 | 0 |
| Signalling to ERKs | R-HSA-187687 | 7.034665e-01 | 0.153 | 0 | 0 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 7.041504e-01 | 0.152 | 0 | 0 |
| Stimuli-sensing channels | R-HSA-2672351 | 7.093003e-01 | 0.149 | 0 | 0 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 7.113292e-01 | 0.148 | 0 | 0 |
| Aquaporin-mediated transport | R-HSA-445717 | 7.113292e-01 | 0.148 | 0 | 0 |
| MyD88:MAL(TIRAP) cascade initiated on plasma membrane | R-HSA-166058 | 7.127399e-01 | 0.147 | 0 | 0 |
| Toll Like Receptor TLR6:TLR2 Cascade | R-HSA-168188 | 7.127399e-01 | 0.147 | 0 | 0 |
| Co-stimulation by CD28 | R-HSA-389356 | 7.129156e-01 | 0.147 | 0 | 0 |
| Infectious disease | R-HSA-5663205 | 7.142289e-01 | 0.146 | 1 | 0 |
| Termination of O-glycan biosynthesis | R-HSA-977068 | 7.147532e-01 | 0.146 | 0 | 0 |
| Interleukin receptor SHC signaling | R-HSA-912526 | 7.147532e-01 | 0.146 | 0 | 0 |
| The role of Nef in HIV-1 replication and disease pathogenesis | R-HSA-164952 | 7.147532e-01 | 0.146 | 0 | 0 |
| Growth hormone receptor signaling | R-HSA-982772 | 7.147532e-01 | 0.146 | 0 | 0 |
| Glycosphingolipid transport | R-HSA-9845576 | 7.182782e-01 | 0.144 | 0 | 0 |
| Triglyceride catabolism | R-HSA-163560 | 7.182782e-01 | 0.144 | 0 | 0 |
| FGFR2 mutant receptor activation | R-HSA-1839126 | 7.182782e-01 | 0.144 | 0 | 0 |
| Signaling by FGFR | R-HSA-190236 | 7.247879e-01 | 0.140 | 0 | 0 |
| Synthesis of diphthamide-EEF2 | R-HSA-5358493 | 7.269742e-01 | 0.138 | 0 | 0 |
| Regulation of TBK1, IKKε (IKBKE)-mediated activation of IRF3, IRF7 | R-HSA-9824878 | 7.269742e-01 | 0.138 | 0 | 0 |
| Regulation of gene expression by Hypoxia-inducible Factor | R-HSA-1234158 | 7.269742e-01 | 0.138 | 0 | 0 |
| Plasmalogen biosynthesis | R-HSA-75896 | 7.269742e-01 | 0.138 | 0 | 0 |
| ERKs are inactivated | R-HSA-202670 | 7.269742e-01 | 0.138 | 0 | 0 |
| Viral RNP Complexes in the Host Cell Nucleus | R-HSA-168330 | 7.269742e-01 | 0.138 | 0 | 0 |
| APOBEC3G mediated resistance to HIV-1 infection | R-HSA-180689 | 7.269742e-01 | 0.138 | 0 | 0 |
| Condensation of Prometaphase Chromosomes | R-HSA-2514853 | 7.269742e-01 | 0.138 | 0 | 0 |
| Sensing of DNA Double Strand Breaks | R-HSA-5693548 | 7.269742e-01 | 0.138 | 0 | 0 |
| Recognition of DNA damage by PCNA-containing replication complex | R-HSA-110314 | 7.319688e-01 | 0.136 | 0 | 0 |
| Norepinephrine Neurotransmitter Release Cycle | R-HSA-181430 | 7.319688e-01 | 0.136 | 0 | 0 |
| TRAF6 mediated IRF7 activation | R-HSA-933541 | 7.325088e-01 | 0.135 | 0 | 0 |
| UCH proteinases | R-HSA-5689603 | 7.327223e-01 | 0.135 | 0 | 0 |
| Toll Like Receptor TLR1:TLR2 Cascade | R-HSA-168179 | 7.375375e-01 | 0.132 | 0 | 0 |
| Toll Like Receptor 2 (TLR2) Cascade | R-HSA-181438 | 7.375375e-01 | 0.132 | 0 | 0 |
| IGF1R signaling cascade | R-HSA-2428924 | 7.449714e-01 | 0.128 | 0 | 0 |
| Homologous DNA Pairing and Strand Exchange | R-HSA-5693579 | 7.461664e-01 | 0.127 | 0 | 0 |
| SLC-mediated transport of inorganic anions | R-HSA-9958790 | 7.461664e-01 | 0.127 | 0 | 0 |
| RIPK1-mediated regulated necrosis | R-HSA-5213460 | 7.461664e-01 | 0.127 | 0 | 0 |
| Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA) | R-HSA-5693554 | 7.482924e-01 | 0.126 | 0 | 0 |
| Acyl chain remodelling of PS | R-HSA-1482801 | 7.482924e-01 | 0.126 | 0 | 0 |
| Laminin interactions | R-HSA-3000157 | 7.482924e-01 | 0.126 | 0 | 0 |
| Erythropoietin activates Phosphoinositide-3-kinase (PI3K) | R-HSA-9027276 | 7.496206e-01 | 0.125 | 0 | 0 |
| Maple Syrup Urine Disease | R-HSA-9865114 | 7.496206e-01 | 0.125 | 0 | 0 |
| Defective EXT2 causes exostoses 2 | R-HSA-3656237 | 7.496206e-01 | 0.125 | 0 | 0 |
| Defective EXT1 causes exostoses 1, TRPS2 and CHDS | R-HSA-3656253 | 7.496206e-01 | 0.125 | 0 | 0 |
| RUNX3 regulates p14-ARF | R-HSA-8951936 | 7.496206e-01 | 0.125 | 0 | 0 |
| SHC-related events triggered by IGF1R | R-HSA-2428933 | 7.496206e-01 | 0.125 | 0 | 0 |
| Regulation of IFNG signaling | R-HSA-877312 | 7.496206e-01 | 0.125 | 0 | 0 |
| Serotonin clearance from the synaptic cleft | R-HSA-380615 | 7.496206e-01 | 0.125 | 0 | 0 |
| Advanced glycosylation endproduct receptor signaling | R-HSA-879415 | 7.496206e-01 | 0.125 | 0 | 0 |
| Reversal of alkylation damage by DNA dioxygenases | R-HSA-73943 | 7.496206e-01 | 0.125 | 0 | 0 |
| Regulation of FOXO transcriptional activity by acetylation | R-HSA-9617629 | 7.496206e-01 | 0.125 | 0 | 0 |
| Signaling by LTK | R-HSA-9842663 | 7.496206e-01 | 0.125 | 0 | 0 |
| Signaling by NOTCH1 HD Domain Mutants in Cancer | R-HSA-2691230 | 7.496206e-01 | 0.125 | 0 | 0 |
| Constitutive Signaling by NOTCH1 HD Domain Mutants | R-HSA-2691232 | 7.496206e-01 | 0.125 | 0 | 0 |
| OAS antiviral response | R-HSA-8983711 | 7.496206e-01 | 0.125 | 0 | 0 |
| Estrogen biosynthesis | R-HSA-193144 | 7.496206e-01 | 0.125 | 0 | 0 |
| Interleukin-15 signaling | R-HSA-8983432 | 7.496206e-01 | 0.125 | 0 | 0 |
| Activation of NF-kappaB in B cells | R-HSA-1169091 | 7.497673e-01 | 0.125 | 0 | 0 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 7.555188e-01 | 0.122 | 0 | 0 |
| Pentose phosphate pathway | R-HSA-71336 | 7.592608e-01 | 0.120 | 0 | 0 |
| Cdc20:Phospho-APC/C mediated degradation of Cyclin A | R-HSA-174184 | 7.612133e-01 | 0.118 | 0 | 0 |
| Transcriptional Regulation by NPAS4 | R-HSA-9634815 | 7.612133e-01 | 0.118 | 0 | 0 |
| Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock genes | R-HSA-9931510 | 7.637537e-01 | 0.117 | 0 | 0 |
| Synthesis of PIPs at the Golgi membrane | R-HSA-1660514 | 7.637537e-01 | 0.117 | 0 | 0 |
| Activated NOTCH1 Transmits Signal to the Nucleus | R-HSA-2122948 | 7.637537e-01 | 0.117 | 0 | 0 |
| TRP channels | R-HSA-3295583 | 7.637537e-01 | 0.117 | 0 | 0 |
| Adenylate cyclase activating pathway | R-HSA-170660 | 7.703898e-01 | 0.113 | 0 | 0 |
| Processing of SMDT1 | R-HSA-8949664 | 7.703898e-01 | 0.113 | 0 | 0 |
| HDR through MMEJ (alt-NHEJ) | R-HSA-5685939 | 7.703898e-01 | 0.113 | 0 | 0 |
| Membrane binding and targetting of GAG proteins | R-HSA-174490 | 7.703898e-01 | 0.113 | 0 | 0 |
| Golgi Cisternae Pericentriolar Stack Reorganization | R-HSA-162658 | 7.703898e-01 | 0.113 | 0 | 0 |
| CD28 dependent Vav1 pathway | R-HSA-389359 | 7.703898e-01 | 0.113 | 0 | 0 |
| rRNA modification in the mitochondrion | R-HSA-6793080 | 7.703898e-01 | 0.113 | 0 | 0 |
| RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs) | R-HSA-8877330 | 7.703898e-01 | 0.113 | 0 | 0 |
| Acyl chain remodeling of DAG and TAG | R-HSA-1482883 | 7.703898e-01 | 0.113 | 0 | 0 |
| Interleukin-6 signaling | R-HSA-1059683 | 7.703898e-01 | 0.113 | 0 | 0 |
| Replication of the SARS-CoV-1 genome | R-HSA-9682706 | 7.703898e-01 | 0.113 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation by EBF2 | R-HSA-9844594 | 7.718031e-01 | 0.112 | 0 | 0 |
| Transcriptional regulation of brown and beige adipocyte differentiation | R-HSA-9843743 | 7.718031e-01 | 0.112 | 0 | 0 |
| Generation of second messenger molecules | R-HSA-202433 | 7.718031e-01 | 0.112 | 0 | 0 |
| APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint | R-HSA-179419 | 7.722482e-01 | 0.112 | 0 | 0 |
| Amino acids regulate mTORC1 | R-HSA-9639288 | 7.722482e-01 | 0.112 | 0 | 0 |
| Nucleotide biosynthesis | R-HSA-8956320 | 7.722482e-01 | 0.112 | 0 | 0 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 7.771473e-01 | 0.109 | 0 | 0 |
| EPHA-mediated growth cone collapse | R-HSA-3928663 | 7.783832e-01 | 0.109 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in Cytochrome C Release | R-HSA-6803204 | 7.783832e-01 | 0.109 | 0 | 0 |
| Insulin processing | R-HSA-264876 | 7.783832e-01 | 0.109 | 0 | 0 |
| CD28 dependent PI3K/Akt signaling | R-HSA-389357 | 7.783832e-01 | 0.109 | 0 | 0 |
| Transcriptional activation of mitochondrial biogenesis | R-HSA-2151201 | 7.803749e-01 | 0.108 | 0 | 0 |
| Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template | R-HSA-110313 | 7.838053e-01 | 0.106 | 0 | 0 |
| Purine ribonucleoside monophosphate biosynthesis | R-HSA-73817 | 7.838053e-01 | 0.106 | 0 | 0 |
| FLT3 Signaling | R-HSA-9607240 | 7.838053e-01 | 0.106 | 0 | 0 |
| Regulated Necrosis | R-HSA-5218859 | 7.851934e-01 | 0.105 | 0 | 0 |
| BCKDH synthesizes BCAA-CoA from KIC, KMVA, KIV | R-HSA-9859138 | 7.894374e-01 | 0.103 | 0 | 0 |
| ERBB2 Activates PTK6 Signaling | R-HSA-8847993 | 7.894374e-01 | 0.103 | 0 | 0 |
| Regulation of CDH1 mRNA translation by microRNAs | R-HSA-9764562 | 7.894374e-01 | 0.103 | 0 | 0 |
| Hydrolysis of LPC | R-HSA-1483115 | 7.894374e-01 | 0.103 | 0 | 0 |
| TP53 Regulates Transcription of Death Receptors and Ligands | R-HSA-6803211 | 7.894374e-01 | 0.103 | 0 | 0 |
| cGMP effects | R-HSA-418457 | 7.894374e-01 | 0.103 | 0 | 0 |
| Synthesis And Processing Of GAG, GAGPOL Polyproteins | R-HSA-174495 | 7.894374e-01 | 0.103 | 0 | 0 |
| Physiological factors | R-HSA-5578768 | 7.894374e-01 | 0.103 | 0 | 0 |
| Respiratory syncytial virus genome transcription | R-HSA-9828642 | 7.894374e-01 | 0.103 | 0 | 0 |
| HDL assembly | R-HSA-8963896 | 7.894374e-01 | 0.103 | 0 | 0 |
| Signal regulatory protein family interactions | R-HSA-391160 | 7.894374e-01 | 0.103 | 0 | 0 |
| Acyl chain remodeling of CL | R-HSA-1482798 | 7.894374e-01 | 0.103 | 0 | 0 |
| SARS-CoV-1 Genome Replication and Transcription | R-HSA-9679514 | 7.894374e-01 | 0.103 | 0 | 0 |
| Unfolded Protein Response (UPR) | R-HSA-381119 | 7.896776e-01 | 0.103 | 0 | 0 |
| PINK1-PRKN Mediated Mitophagy | R-HSA-5205685 | 7.922126e-01 | 0.101 | 0 | 0 |
| Telomere Extension By Telomerase | R-HSA-171319 | 7.922126e-01 | 0.101 | 0 | 0 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 7.922126e-01 | 0.101 | 0 | 0 |
| Phase 0 - rapid depolarisation | R-HSA-5576892 | 7.922126e-01 | 0.101 | 0 | 0 |
| Pyroptosis | R-HSA-5620971 | 7.922126e-01 | 0.101 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176409 | 7.931095e-01 | 0.101 | 0 | 0 |
| Mitochondrial protein degradation | R-HSA-9837999 | 7.937928e-01 | 0.100 | 0 | 0 |
| Degradation of GLI1 by the proteasome | R-HSA-5610780 | 7.952805e-01 | 0.099 | 0 | 0 |
| SLC-mediated transport of neurotransmitters | R-HSA-442660 | 7.952805e-01 | 0.099 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9683701 | 7.952805e-01 | 0.099 | 0 | 0 |
| Interleukin-1 family signaling | R-HSA-446652 | 7.963932e-01 | 0.099 | 0 | 0 |
| Regulation of actin dynamics for phagocytic cup formation | R-HSA-2029482 | 8.025634e-01 | 0.096 | 0 | 0 |
| Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins | R-HSA-176814 | 8.029499e-01 | 0.095 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in TC-NER | R-HSA-6782210 | 8.029499e-01 | 0.095 | 0 | 0 |
| Toll-like Receptor Cascades | R-HSA-168898 | 8.043272e-01 | 0.095 | 0 | 0 |
| Signaling by Erythropoietin | R-HSA-9006335 | 8.052739e-01 | 0.094 | 0 | 0 |
| Impaired BRCA2 binding to RAD51 | R-HSA-9709570 | 8.052739e-01 | 0.094 | 0 | 0 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.052739e-01 | 0.094 | 0 | 0 |
| Regulation of pyruvate dehydrogenase (PDH) complex | R-HSA-204174 | 8.052739e-01 | 0.094 | 0 | 0 |
| Competing endogenous RNAs (ceRNAs) regulate PTEN translation | R-HSA-8948700 | 8.069058e-01 | 0.093 | 0 | 0 |
| Adenylate cyclase inhibitory pathway | R-HSA-170670 | 8.069058e-01 | 0.093 | 0 | 0 |
| TICAM1, RIP1-mediated IKK complex recruitment | R-HSA-168927 | 8.069058e-01 | 0.093 | 0 | 0 |
| Translesion synthesis by REV1 | R-HSA-110312 | 8.069058e-01 | 0.093 | 0 | 0 |
| Activation of BAD and translocation to mitochondria | R-HSA-111447 | 8.069058e-01 | 0.093 | 0 | 0 |
| DNA Damage Reversal | R-HSA-73942 | 8.069058e-01 | 0.093 | 0 | 0 |
| Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA | R-HSA-450513 | 8.069058e-01 | 0.093 | 0 | 0 |
| Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA | R-HSA-450385 | 8.069058e-01 | 0.093 | 0 | 0 |
| Transcriptional regulation by RUNX2 | R-HSA-8878166 | 8.109275e-01 | 0.091 | 0 | 0 |
| Hedgehog 'on' state | R-HSA-5632684 | 8.119952e-01 | 0.090 | 0 | 0 |
| Cardiac conduction | R-HSA-5576891 | 8.158474e-01 | 0.088 | 0 | 0 |
| TGF-beta receptor signaling activates SMADs | R-HSA-2173789 | 8.167055e-01 | 0.088 | 0 | 0 |
| Aberrant regulation of mitotic cell cycle due to RB1 defects | R-HSA-9687139 | 8.175992e-01 | 0.087 | 0 | 0 |
| Interleukin-37 signaling | R-HSA-9008059 | 8.175992e-01 | 0.087 | 0 | 0 |
| Translesion synthesis by POLI | R-HSA-5656121 | 8.229260e-01 | 0.085 | 0 | 0 |
| Class I peroxisomal membrane protein import | R-HSA-9603798 | 8.229260e-01 | 0.085 | 0 | 0 |
| Phase 4 - resting membrane potential | R-HSA-5576886 | 8.229260e-01 | 0.085 | 0 | 0 |
| Serotonin and melatonin biosynthesis | R-HSA-209931 | 8.229260e-01 | 0.085 | 0 | 0 |
| SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion | R-HSA-399955 | 8.229260e-01 | 0.085 | 0 | 0 |
| TP53 Regulates Transcription of Caspase Activators and Caspases | R-HSA-6803207 | 8.229260e-01 | 0.085 | 0 | 0 |
| Caspase activation via Death Receptors in the presence of ligand | R-HSA-140534 | 8.229260e-01 | 0.085 | 0 | 0 |
| Class I MHC mediated antigen processing & presentation | R-HSA-983169 | 8.239895e-01 | 0.084 | 0 | 0 |
| TCR signaling | R-HSA-202403 | 8.265993e-01 | 0.083 | 0 | 0 |
| Amine ligand-binding receptors | R-HSA-375280 | 8.266844e-01 | 0.083 | 0 | 0 |
| Regulation of activated PAK-2p34 by proteasome mediated degradation | R-HSA-211733 | 8.292209e-01 | 0.081 | 0 | 0 |
| Negative regulators of DDX58/IFIH1 signaling | R-HSA-936440 | 8.292209e-01 | 0.081 | 0 | 0 |
| Aspartate and asparagine metabolism | R-HSA-8963693 | 8.292209e-01 | 0.081 | 0 | 0 |
| Triglyceride metabolism | R-HSA-8979227 | 8.302053e-01 | 0.081 | 0 | 0 |
| Pyruvate metabolism | R-HSA-70268 | 8.359004e-01 | 0.078 | 0 | 0 |
| p53-Independent G1/S DNA Damage Checkpoint | R-HSA-69613 | 8.361944e-01 | 0.078 | 0 | 0 |
| Ubiquitin-Mediated Degradation of Phosphorylated Cdc25A | R-HSA-69601 | 8.361944e-01 | 0.078 | 0 | 0 |
| G beta:gamma signalling through CDC42 | R-HSA-8964616 | 8.376180e-01 | 0.077 | 0 | 0 |
| Translesion synthesis by POLK | R-HSA-5655862 | 8.376180e-01 | 0.077 | 0 | 0 |
| Antigen processing: Ub, ATP-independent proteasomal degradation | R-HSA-9912633 | 8.376180e-01 | 0.077 | 0 | 0 |
| Defective B4GALT7 causes EDS, progeroid type | R-HSA-3560783 | 8.376180e-01 | 0.077 | 0 | 0 |
| Defective B3GALT6 causes EDSP2 and SEMDJL1 | R-HSA-4420332 | 8.376180e-01 | 0.077 | 0 | 0 |
| STAT5 activation downstream of FLT3 ITD mutants | R-HSA-9702518 | 8.376180e-01 | 0.077 | 0 | 0 |
| Regulation of innate immune responses to cytosolic DNA | R-HSA-3134975 | 8.376180e-01 | 0.077 | 0 | 0 |
| Acetylcholine regulates insulin secretion | R-HSA-399997 | 8.376180e-01 | 0.077 | 0 | 0 |
| TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest | R-HSA-6804114 | 8.376180e-01 | 0.077 | 0 | 0 |
| TFAP2 (AP-2) family regulates transcription of growth factors and their receptors | R-HSA-8866910 | 8.376180e-01 | 0.077 | 0 | 0 |
| Developmental Lineage of Multipotent Pancreatic Progenitor Cells | R-HSA-9937080 | 8.401708e-01 | 0.076 | 0 | 0 |
| Downregulation of SMAD2/3:SMAD4 transcriptional activity | R-HSA-2173795 | 8.401708e-01 | 0.076 | 0 | 0 |
| Hemostasis | R-HSA-109582 | 8.415742e-01 | 0.075 | 0 | 0 |
| Autodegradation of Cdh1 by Cdh1:APC/C | R-HSA-174084 | 8.452508e-01 | 0.073 | 0 | 0 |
| Formation of TC-NER Pre-Incision Complex | R-HSA-6781823 | 8.452508e-01 | 0.073 | 0 | 0 |
| Regulation of pyruvate metabolism | R-HSA-9861718 | 8.452508e-01 | 0.073 | 0 | 0 |
| Purinergic signaling in leishmaniasis infection | R-HSA-9660826 | 8.452508e-01 | 0.073 | 0 | 0 |
| Cell recruitment (pro-inflammatory response) | R-HSA-9664424 | 8.452508e-01 | 0.073 | 0 | 0 |
| Diseases of DNA repair | R-HSA-9675135 | 8.452508e-01 | 0.073 | 0 | 0 |
| Inactivation, recovery and regulation of the phototransduction cascade | R-HSA-2514859 | 8.452508e-01 | 0.073 | 0 | 0 |
| Extra-nuclear estrogen signaling | R-HSA-9009391 | 8.498867e-01 | 0.071 | 0 | 0 |
| Beta-catenin independent WNT signaling | R-HSA-3858494 | 8.504164e-01 | 0.070 | 0 | 0 |
| HDR through Single Strand Annealing (SSA) | R-HSA-5685938 | 8.504802e-01 | 0.070 | 0 | 0 |
| G-protein beta:gamma signalling | R-HSA-397795 | 8.504802e-01 | 0.070 | 0 | 0 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 8.504802e-01 | 0.070 | 0 | 0 |
| CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling | R-HSA-442742 | 8.504802e-01 | 0.070 | 0 | 0 |
| Defective B3GAT3 causes JDSSDHD | R-HSA-3560801 | 8.510917e-01 | 0.070 | 0 | 0 |
| Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha) | R-HSA-5358565 | 8.510917e-01 | 0.070 | 0 | 0 |
| Synthesis of PIPs at the late endosome membrane | R-HSA-1660517 | 8.510917e-01 | 0.070 | 0 | 0 |
| Glycogen storage diseases | R-HSA-3229121 | 8.510917e-01 | 0.070 | 0 | 0 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 8.510917e-01 | 0.070 | 0 | 0 |
| Regulation of FZD by ubiquitination | R-HSA-4641263 | 8.510917e-01 | 0.070 | 0 | 0 |
| Catecholamine biosynthesis | R-HSA-209905 | 8.510917e-01 | 0.070 | 0 | 0 |
| Choline catabolism | R-HSA-6798163 | 8.510917e-01 | 0.070 | 0 | 0 |
| Uptake and function of anthrax toxins | R-HSA-5210891 | 8.510917e-01 | 0.070 | 0 | 0 |
| Replication of the SARS-CoV-2 genome | R-HSA-9694686 | 8.510917e-01 | 0.070 | 0 | 0 |
| Gastrulation | R-HSA-9758941 | 8.533988e-01 | 0.069 | 0 | 0 |
| APC/C:Cdc20 mediated degradation of Securin | R-HSA-174154 | 8.538693e-01 | 0.069 | 0 | 0 |
| Regulation of APC/C activators between G1/S and early anaphase | R-HSA-176408 | 8.542482e-01 | 0.068 | 0 | 0 |
| Neurotransmitter release cycle | R-HSA-112310 | 8.559629e-01 | 0.068 | 0 | 0 |
| Potential therapeutics for SARS | R-HSA-9679191 | 8.583520e-01 | 0.066 | 0 | 0 |
| Resolution of D-Loop Structures | R-HSA-5693537 | 8.601801e-01 | 0.065 | 0 | 0 |
| Regulation of CDH1 posttranslational processing and trafficking to plasma membrane | R-HSA-9768727 | 8.601801e-01 | 0.065 | 0 | 0 |
| G1/S DNA Damage Checkpoints | R-HSA-69615 | 8.615924e-01 | 0.065 | 0 | 0 |
| Gluconeogenesis | R-HSA-70263 | 8.620655e-01 | 0.064 | 0 | 0 |
| TP53 Regulates Metabolic Genes | R-HSA-5628897 | 8.624631e-01 | 0.064 | 0 | 0 |
| Mismatch Repair | R-HSA-5358508 | 8.634482e-01 | 0.064 | 0 | 0 |
| Polo-like kinase mediated events | R-HSA-156711 | 8.634482e-01 | 0.064 | 0 | 0 |
| Synaptic adhesion-like molecules | R-HSA-8849932 | 8.634482e-01 | 0.064 | 0 | 0 |
| Cytosolic iron-sulfur cluster assembly | R-HSA-2564830 | 8.634482e-01 | 0.064 | 0 | 0 |
| FOXO-mediated transcription of cell death genes | R-HSA-9614657 | 8.634482e-01 | 0.064 | 0 | 0 |
| Regulation of TP53 Activity through Methylation | R-HSA-6804760 | 8.634482e-01 | 0.064 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9679504 | 8.634482e-01 | 0.064 | 0 | 0 |
| Dual Incision in GG-NER | R-HSA-5696400 | 8.693007e-01 | 0.061 | 0 | 0 |
| Diseases of DNA Double-Strand Break Repair | R-HSA-9675136 | 8.693007e-01 | 0.061 | 0 | 0 |
| Antigen Presentation: Folding, assembly and peptide loading of class I MHC | R-HSA-983170 | 8.693007e-01 | 0.061 | 0 | 0 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 8.693007e-01 | 0.061 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA2 loss of function | R-HSA-9701190 | 8.693007e-01 | 0.061 | 0 | 0 |
| Ubiquitin-dependent degradation of Cyclin D | R-HSA-75815 | 8.693007e-01 | 0.061 | 0 | 0 |
| NPAS4 regulates expression of target genes | R-HSA-9768919 | 8.693007e-01 | 0.061 | 0 | 0 |
| Degradation of CDH1 | R-HSA-9766229 | 8.698548e-01 | 0.061 | 0 | 0 |
| Protein localization | R-HSA-9609507 | 8.724219e-01 | 0.059 | 0 | 0 |
| Signaling by Insulin receptor | R-HSA-74752 | 8.739640e-01 | 0.059 | 0 | 0 |
| IKK complex recruitment mediated by RIP1 | R-HSA-937041 | 8.747801e-01 | 0.058 | 0 | 0 |
| Impaired BRCA2 binding to PALB2 | R-HSA-9709603 | 8.747801e-01 | 0.058 | 0 | 0 |
| Pyrimidine biosynthesis | R-HSA-500753 | 8.747801e-01 | 0.058 | 0 | 0 |
| Translesion Synthesis by POLH | R-HSA-110320 | 8.747801e-01 | 0.058 | 0 | 0 |
| Specification of the neural plate border | R-HSA-9834899 | 8.747801e-01 | 0.058 | 0 | 0 |
| Mechanical load activates signaling by PIEZO1 and integrins in osteocytes | R-HSA-9856532 | 8.747801e-01 | 0.058 | 0 | 0 |
| SARS-CoV-2 Genome Replication and Transcription | R-HSA-9694682 | 8.747801e-01 | 0.058 | 0 | 0 |
| Cellular response to hypoxia | R-HSA-1234174 | 8.753342e-01 | 0.058 | 0 | 0 |
| Azathioprine ADME | R-HSA-9748787 | 8.772530e-01 | 0.057 | 0 | 0 |
| PI3K Cascade | R-HSA-109704 | 8.772530e-01 | 0.057 | 0 | 0 |
| Signaling by FGFR2 in disease | R-HSA-5655253 | 8.772530e-01 | 0.057 | 0 | 0 |
| Regulation of Apoptosis | R-HSA-169911 | 8.778711e-01 | 0.057 | 0 | 0 |
| Transferrin endocytosis and recycling | R-HSA-917977 | 8.778711e-01 | 0.057 | 0 | 0 |
| Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha | R-HSA-1234176 | 8.842752e-01 | 0.053 | 0 | 0 |
| The phototransduction cascade | R-HSA-2514856 | 8.842752e-01 | 0.053 | 0 | 0 |
| Regulation of PD-L1(CD274) translation | R-HSA-9909620 | 8.851721e-01 | 0.053 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to PALB2 loss of function | R-HSA-9701193 | 8.851721e-01 | 0.053 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function | R-HSA-9704331 | 8.851721e-01 | 0.053 | 0 | 0 |
| Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function | R-HSA-9704646 | 8.851721e-01 | 0.053 | 0 | 0 |
| Defective homologous recombination repair (HRR) due to BRCA1 loss of function | R-HSA-9701192 | 8.851721e-01 | 0.053 | 0 | 0 |
| Co-inhibition by CTLA4 | R-HSA-389513 | 8.851721e-01 | 0.053 | 0 | 0 |
| Glycogen synthesis | R-HSA-3322077 | 8.851721e-01 | 0.053 | 0 | 0 |
| Wax and plasmalogen biosynthesis | R-HSA-8848584 | 8.851721e-01 | 0.053 | 0 | 0 |
| Signaling by NODAL | R-HSA-1181150 | 8.851721e-01 | 0.053 | 0 | 0 |
| Acyl chain remodelling of PI | R-HSA-1482922 | 8.851721e-01 | 0.053 | 0 | 0 |
| Signal transduction by L1 | R-HSA-445144 | 8.851721e-01 | 0.053 | 0 | 0 |
| Lysosome Vesicle Biogenesis | R-HSA-432720 | 8.859200e-01 | 0.053 | 0 | 0 |
| Formation of Fibrin Clot (Clotting Cascade) | R-HSA-140877 | 8.859200e-01 | 0.053 | 0 | 0 |
| Adipogenesis | R-HSA-9843745 | 8.876431e-01 | 0.052 | 0 | 0 |
| HDR through Homologous Recombination (HRR) | R-HSA-5685942 | 8.878797e-01 | 0.052 | 0 | 0 |
| tRNA processing | R-HSA-72306 | 8.908139e-01 | 0.050 | 0 | 0 |
| AMPK-induced ERAD and lysosome mediated degradation of PD-L1(CD274) | R-HSA-9931269 | 8.909368e-01 | 0.050 | 0 | 0 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 8.933584e-01 | 0.049 | 0 | 0 |
| Degradation of DVL | R-HSA-4641258 | 8.934747e-01 | 0.049 | 0 | 0 |
| GSK3B and BTRC:CUL1-mediated-degradation of NFE2L2 | R-HSA-9762114 | 8.934747e-01 | 0.049 | 0 | 0 |
| MyD88 deficiency (TLR2/4) | R-HSA-5602498 | 8.947023e-01 | 0.048 | 0 | 0 |
| Regulation of MITF-M-dependent genes involved in apoptosis | R-HSA-9824594 | 8.947023e-01 | 0.048 | 0 | 0 |
| Acyl chain remodelling of PG | R-HSA-1482925 | 8.947023e-01 | 0.048 | 0 | 0 |
| Interferon gamma signaling | R-HSA-877300 | 8.971877e-01 | 0.047 | 0 | 0 |
| APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 | R-HSA-174178 | 8.972525e-01 | 0.047 | 0 | 0 |
| Regulation of PTEN stability and activity | R-HSA-8948751 | 8.972525e-01 | 0.047 | 0 | 0 |
| Transcriptional regulation of white adipocyte differentiation | R-HSA-381340 | 8.997656e-01 | 0.046 | 0 | 0 |
| CDK-mediated phosphorylation and removal of Cdc6 | R-HSA-69017 | 9.032371e-01 | 0.044 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 2 Promoter | R-HSA-76066 | 9.034421e-01 | 0.044 | 0 | 0 |
| IRAK4 deficiency (TLR2/4) | R-HSA-5603041 | 9.034421e-01 | 0.044 | 0 | 0 |
| Gap-filling DNA repair synthesis and ligation in GG-NER | R-HSA-5696397 | 9.034421e-01 | 0.044 | 0 | 0 |
| Attachment and Entry | R-HSA-9694614 | 9.034421e-01 | 0.044 | 0 | 0 |
| Molybdenum cofactor biosynthesis | R-HSA-947581 | 9.034421e-01 | 0.044 | 0 | 0 |
| Signaling by NTRK3 (TRKC) | R-HSA-9034015 | 9.034421e-01 | 0.044 | 0 | 0 |
| Metabolism of Angiotensinogen to Angiotensins | R-HSA-2022377 | 9.034421e-01 | 0.044 | 0 | 0 |
| Ribavirin ADME | R-HSA-9755088 | 9.034421e-01 | 0.044 | 0 | 0 |
| Assembly Of The HIV Virion | R-HSA-175474 | 9.034421e-01 | 0.044 | 0 | 0 |
| Stabilization of p53 | R-HSA-69541 | 9.072071e-01 | 0.042 | 0 | 0 |
| GSK3B-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929356 | 9.072071e-01 | 0.042 | 0 | 0 |
| Plasma lipoprotein clearance | R-HSA-8964043 | 9.072071e-01 | 0.042 | 0 | 0 |
| G alpha (z) signalling events | R-HSA-418597 | 9.089049e-01 | 0.041 | 0 | 0 |
| APC/C-mediated degradation of cell cycle proteins | R-HSA-174143 | 9.096958e-01 | 0.041 | 0 | 0 |
| Regulation of mitotic cell cycle | R-HSA-453276 | 9.096958e-01 | 0.041 | 0 | 0 |
| Developmental Lineage of Mammary Stem Cells | R-HSA-9938206 | 9.114569e-01 | 0.040 | 0 | 0 |
| RNA Polymerase III Transcription Initiation From Type 1 Promoter | R-HSA-76061 | 9.114569e-01 | 0.040 | 0 | 0 |
| Neurotoxicity of clostridium toxins | R-HSA-168799 | 9.114569e-01 | 0.040 | 0 | 0 |
| WNT ligand biogenesis and trafficking | R-HSA-3238698 | 9.114569e-01 | 0.040 | 0 | 0 |
| Ethanol oxidation | R-HSA-71384 | 9.114569e-01 | 0.040 | 0 | 0 |
| Cholesterol biosynthesis via lathosterol | R-HSA-6807062 | 9.114569e-01 | 0.040 | 0 | 0 |
| LDL clearance | R-HSA-8964038 | 9.114569e-01 | 0.040 | 0 | 0 |
| Translation of Replicase and Assembly of the Replication Transcription Complex | R-HSA-9694676 | 9.114569e-01 | 0.040 | 0 | 0 |
| Gamma carboxylation, hypusinylation, hydroxylation, and arylsulfatase activation | R-HSA-163841 | 9.128270e-01 | 0.040 | 0 | 0 |
| Negative regulation of NOTCH4 signaling | R-HSA-9604323 | 9.134348e-01 | 0.039 | 0 | 0 |
| Glycogen metabolism | R-HSA-8982491 | 9.134348e-01 | 0.039 | 0 | 0 |
| Interleukin-2 family signaling | R-HSA-451927 | 9.134348e-01 | 0.039 | 0 | 0 |
| Metabolism of amine-derived hormones | R-HSA-209776 | 9.142698e-01 | 0.039 | 0 | 0 |
| Signaling by FGFR1 | R-HSA-5654736 | 9.142698e-01 | 0.039 | 0 | 0 |
| Cyclin A:Cdk2-associated events at S phase entry | R-HSA-69656 | 9.145238e-01 | 0.039 | 0 | 0 |
| Regulation of PTEN mRNA translation | R-HSA-8943723 | 9.188069e-01 | 0.037 | 0 | 0 |
| G beta:gamma signalling through PI3Kgamma | R-HSA-392451 | 9.188069e-01 | 0.037 | 0 | 0 |
| Synthesis of pyrophosphates in the cytosol | R-HSA-1855167 | 9.188069e-01 | 0.037 | 0 | 0 |
| Mitochondrial mRNA modification | R-HSA-9937008 | 9.188069e-01 | 0.037 | 0 | 0 |
| Carnitine shuttle | R-HSA-200425 | 9.188069e-01 | 0.037 | 0 | 0 |
| Syndecan interactions | R-HSA-3000170 | 9.188069e-01 | 0.037 | 0 | 0 |
| Maturation of spike protein | R-HSA-9694548 | 9.192685e-01 | 0.037 | 0 | 0 |
| Resolution of Abasic Sites (AP sites) | R-HSA-73933 | 9.192685e-01 | 0.037 | 0 | 0 |
| IRS-mediated signalling | R-HSA-112399 | 9.193456e-01 | 0.037 | 0 | 0 |
| Developmental Cell Lineages of the Exocrine Pancreas | R-HSA-9820448 | 9.211379e-01 | 0.036 | 0 | 0 |
| Dual incision in TC-NER | R-HSA-6782135 | 9.241454e-01 | 0.034 | 0 | 0 |
| Early SARS-CoV-2 Infection Events | R-HSA-9772572 | 9.241454e-01 | 0.034 | 0 | 0 |
| Signaling by FLT3 ITD and TKD mutants | R-HSA-9703648 | 9.255471e-01 | 0.034 | 0 | 0 |
| ADP signalling through P2Y purinoceptor 1 | R-HSA-418592 | 9.255471e-01 | 0.034 | 0 | 0 |
| Complex III assembly | R-HSA-9865881 | 9.255471e-01 | 0.034 | 0 | 0 |
| Plasma lipoprotein assembly | R-HSA-8963898 | 9.255471e-01 | 0.034 | 0 | 0 |
| Interleukin-6 family signaling | R-HSA-6783589 | 9.255471e-01 | 0.034 | 0 | 0 |
| Transcription-Coupled Nucleotide Excision Repair (TC-NER) | R-HSA-6781827 | 9.276534e-01 | 0.033 | 0 | 0 |
| TP53 Regulates Transcription of Cell Death Genes | R-HSA-5633008 | 9.276534e-01 | 0.033 | 0 | 0 |
| Regulation of beta-cell development | R-HSA-186712 | 9.286822e-01 | 0.032 | 0 | 0 |
| Assembly of collagen fibrils and other multimeric structures | R-HSA-2022090 | 9.286822e-01 | 0.032 | 0 | 0 |
| Downstream TCR signaling | R-HSA-202424 | 9.290236e-01 | 0.032 | 0 | 0 |
| Cytosolic tRNA aminoacylation | R-HSA-379716 | 9.298429e-01 | 0.032 | 0 | 0 |
| MicroRNA (miRNA) biogenesis | R-HSA-203927 | 9.317282e-01 | 0.031 | 0 | 0 |
| Hyaluronan degradation | R-HSA-2160916 | 9.317282e-01 | 0.031 | 0 | 0 |
| Synthesis of PIPs at the early endosome membrane | R-HSA-1660516 | 9.317282e-01 | 0.031 | 0 | 0 |
| PIWI-interacting RNA (piRNA) biogenesis | R-HSA-5601884 | 9.317282e-01 | 0.031 | 0 | 0 |
| Glycogen breakdown (glycogenolysis) | R-HSA-70221 | 9.317282e-01 | 0.031 | 0 | 0 |
| Signaling by Retinoic Acid | R-HSA-5362517 | 9.329684e-01 | 0.030 | 0 | 0 |
| Sphingolipid de novo biosynthesis | R-HSA-1660661 | 9.329684e-01 | 0.030 | 0 | 0 |
| Signaling by FGFR4 | R-HSA-5654743 | 9.346254e-01 | 0.029 | 0 | 0 |
| Translation of Structural Proteins | R-HSA-9694635 | 9.353663e-01 | 0.029 | 0 | 0 |
| Regulation of RUNX2 expression and activity | R-HSA-8939902 | 9.370159e-01 | 0.028 | 0 | 0 |
| MET activates PTK2 signaling | R-HSA-8874081 | 9.373965e-01 | 0.028 | 0 | 0 |
| Diseases of branched-chain amino acid catabolism | R-HSA-9865118 | 9.373965e-01 | 0.028 | 0 | 0 |
| Metalloprotease DUBs | R-HSA-5689901 | 9.373965e-01 | 0.028 | 0 | 0 |
| Regulation of RUNX1 Expression and Activity | R-HSA-8934593 | 9.373965e-01 | 0.028 | 0 | 0 |
| Linoleic acid (LA) metabolism | R-HSA-2046105 | 9.373965e-01 | 0.028 | 0 | 0 |
| Adrenaline,noradrenaline inhibits insulin secretion | R-HSA-400042 | 9.373965e-01 | 0.028 | 0 | 0 |
| Urea cycle | R-HSA-70635 | 9.373965e-01 | 0.028 | 0 | 0 |
| PCP/CE pathway | R-HSA-4086400 | 9.389360e-01 | 0.027 | 0 | 0 |
| Surfactant metabolism | R-HSA-5683826 | 9.390978e-01 | 0.027 | 0 | 0 |
| Synthesis of PIPs at the plasma membrane | R-HSA-1660499 | 9.408366e-01 | 0.026 | 0 | 0 |
| Signaling by PDGF | R-HSA-186797 | 9.408366e-01 | 0.026 | 0 | 0 |
| Platelet homeostasis | R-HSA-418346 | 9.410240e-01 | 0.026 | 0 | 0 |
| Regulation of cholesterol biosynthesis by SREBP (SREBF) | R-HSA-1655829 | 9.423255e-01 | 0.026 | 0 | 0 |
| Antigen activates B Cell Receptor (BCR) leading to generation of second messengers | R-HSA-983695 | 9.424827e-01 | 0.026 | 0 | 0 |
| RNA Polymerase I Transcription Termination | R-HSA-73863 | 9.425945e-01 | 0.026 | 0 | 0 |
| Triglyceride biosynthesis | R-HSA-75109 | 9.425945e-01 | 0.026 | 0 | 0 |
| Maturation of hRSV A proteins | R-HSA-9828806 | 9.425945e-01 | 0.026 | 0 | 0 |
| Dectin-1 mediated noncanonical NF-kB signaling | R-HSA-5607761 | 9.432786e-01 | 0.025 | 0 | 0 |
| Signaling by FGFR3 | R-HSA-5654741 | 9.432786e-01 | 0.025 | 0 | 0 |
| Signaling by Interleukins | R-HSA-449147 | 9.438308e-01 | 0.025 | 0 | 0 |
| Activation of gene expression by SREBF (SREBP) | R-HSA-2426168 | 9.444415e-01 | 0.025 | 0 | 0 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 9.457232e-01 | 0.024 | 0 | 0 |
| ATF4 activates genes in response to endoplasmic reticulum stress | R-HSA-380994 | 9.473611e-01 | 0.023 | 0 | 0 |
| Pyrimidine salvage | R-HSA-73614 | 9.473611e-01 | 0.023 | 0 | 0 |
| Insulin receptor signalling cascade | R-HSA-74751 | 9.478414e-01 | 0.023 | 0 | 0 |
| Thyroxine biosynthesis | R-HSA-209968 | 9.517323e-01 | 0.021 | 0 | 0 |
| Termination of translesion DNA synthesis | R-HSA-5656169 | 9.517323e-01 | 0.021 | 0 | 0 |
| Nitric oxide stimulates guanylate cyclase | R-HSA-392154 | 9.517323e-01 | 0.021 | 0 | 0 |
| Glucagon-type ligand receptors | R-HSA-420092 | 9.517323e-01 | 0.021 | 0 | 0 |
| Signaling by CSF3 (G-CSF) | R-HSA-9674555 | 9.517323e-01 | 0.021 | 0 | 0 |
| Formation of the cornified envelope | R-HSA-6809371 | 9.532357e-01 | 0.021 | 0 | 0 |
| Neddylation | R-HSA-8951664 | 9.548646e-01 | 0.020 | 0 | 0 |
| RNA Polymerase III Transcription Initiation | R-HSA-76046 | 9.557406e-01 | 0.020 | 0 | 0 |
| Thrombin signalling through proteinase activated receptors (PARs) | R-HSA-456926 | 9.557406e-01 | 0.020 | 0 | 0 |
| Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation | R-HSA-1474151 | 9.557406e-01 | 0.020 | 0 | 0 |
| Neurotransmitter clearance | R-HSA-112311 | 9.557406e-01 | 0.020 | 0 | 0 |
| RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression | R-HSA-9933387 | 9.557406e-01 | 0.020 | 0 | 0 |
| p53-Dependent G1/S DNA damage checkpoint | R-HSA-69580 | 9.574236e-01 | 0.019 | 0 | 0 |
| p53-Dependent G1 DNA Damage Response | R-HSA-69563 | 9.574236e-01 | 0.019 | 0 | 0 |
| SLC transporter disorders | R-HSA-5619102 | 9.576324e-01 | 0.019 | 0 | 0 |
| Budding and maturation of HIV virion | R-HSA-162588 | 9.594164e-01 | 0.018 | 0 | 0 |
| Cargo concentration in the ER | R-HSA-5694530 | 9.594164e-01 | 0.018 | 0 | 0 |
| Synthesis of glycosylphosphatidylinositol (GPI) | R-HSA-162710 | 9.594164e-01 | 0.018 | 0 | 0 |
| FCGR3A-mediated IL10 synthesis | R-HSA-9664323 | 9.595891e-01 | 0.018 | 1 | 1 |
| Parasitic Infection Pathways | R-HSA-9824443 | 9.608689e-01 | 0.017 | 1 | 0 |
| Leishmania infection | R-HSA-9658195 | 9.608689e-01 | 0.017 | 1 | 0 |
| Parasite infection | R-HSA-9664407 | 9.609759e-01 | 0.017 | 0 | 0 |
| FCGR3A-mediated phagocytosis | R-HSA-9664422 | 9.609759e-01 | 0.017 | 0 | 0 |
| Leishmania phagocytosis | R-HSA-9664417 | 9.609759e-01 | 0.017 | 0 | 0 |
| Regulation of PD-L1(CD274) Post-translational modification | R-HSA-9909615 | 9.616284e-01 | 0.017 | 0 | 0 |
| Cellular response to chemical stress | R-HSA-9711123 | 9.621650e-01 | 0.017 | 0 | 0 |
| Regulation of ornithine decarboxylase (ODC) | R-HSA-350562 | 9.627870e-01 | 0.016 | 0 | 0 |
| HS-GAG degradation | R-HSA-2024096 | 9.627870e-01 | 0.016 | 0 | 0 |
| Cyclin E associated events during G1/S transition | R-HSA-69202 | 9.644902e-01 | 0.016 | 0 | 0 |
| Fatty acyl-CoA biosynthesis | R-HSA-75105 | 9.644902e-01 | 0.016 | 0 | 0 |
| Resolution of D-loop Structures through Holliday Junction Intermediates | R-HSA-5693568 | 9.658779e-01 | 0.015 | 0 | 0 |
| PI Metabolism | R-HSA-1483255 | 9.666326e-01 | 0.015 | 0 | 0 |
| Negative regulation of the PI3K/AKT network | R-HSA-199418 | 9.668461e-01 | 0.015 | 0 | 0 |
| NFE2L2 regulating anti-oxidant/detoxification enzymes | R-HSA-9818027 | 9.687123e-01 | 0.014 | 0 | 0 |
| Acyl chain remodelling of PC | R-HSA-1482788 | 9.687123e-01 | 0.014 | 0 | 0 |
| Vpu mediated degradation of CD4 | R-HSA-180534 | 9.687123e-01 | 0.014 | 0 | 0 |
| Heme degradation | R-HSA-189483 | 9.687123e-01 | 0.014 | 0 | 0 |
| Interconversion of nucleotide di- and triphosphates | R-HSA-499943 | 9.688239e-01 | 0.014 | 0 | 0 |
| ER-Phagosome pathway | R-HSA-1236974 | 9.697717e-01 | 0.013 | 0 | 0 |
| Glycosaminoglycan-protein linkage region biosynthesis | R-HSA-1971475 | 9.713113e-01 | 0.013 | 0 | 0 |
| Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding | R-HSA-6814122 | 9.713113e-01 | 0.013 | 0 | 0 |
| Regulation of TLR by endogenous ligand | R-HSA-5686938 | 9.713113e-01 | 0.013 | 0 | 0 |
| Autodegradation of the E3 ubiquitin ligase COP1 | R-HSA-349425 | 9.713113e-01 | 0.013 | 0 | 0 |
| Hyaluronan metabolism | R-HSA-2142845 | 9.713113e-01 | 0.013 | 0 | 0 |
| Calnexin/calreticulin cycle | R-HSA-901042 | 9.713113e-01 | 0.013 | 0 | 0 |
| BMAL1:CLOCK,NPAS2 activates circadian expression | R-HSA-1368108 | 9.713113e-01 | 0.013 | 0 | 0 |
| Signal amplification | R-HSA-392518 | 9.713113e-01 | 0.013 | 0 | 0 |
| Circadian clock | R-HSA-9909396 | 9.714872e-01 | 0.013 | 0 | 0 |
| FBXL7 down-regulates AURKA during mitotic entry and in early mitosis | R-HSA-8854050 | 9.736946e-01 | 0.012 | 0 | 0 |
| SCF-beta-TrCP mediated degradation of Emi1 | R-HSA-174113 | 9.736946e-01 | 0.012 | 0 | 0 |
| Acyl chain remodelling of PE | R-HSA-1482839 | 9.736946e-01 | 0.012 | 0 | 0 |
| PERK regulates gene expression | R-HSA-381042 | 9.736946e-01 | 0.012 | 0 | 0 |
| Disease | R-HSA-1643685 | 9.740035e-01 | 0.011 | 1 | 0 |
| Detoxification of Reactive Oxygen Species | R-HSA-3299685 | 9.744377e-01 | 0.011 | 0 | 0 |
| HS-GAG biosynthesis | R-HSA-2022928 | 9.758801e-01 | 0.011 | 0 | 0 |
| RNA Polymerase III Transcription | R-HSA-74158 | 9.758801e-01 | 0.011 | 0 | 0 |
| RNA Polymerase III Abortive And Retractive Initiation | R-HSA-749476 | 9.758801e-01 | 0.011 | 0 | 0 |
| Vif-mediated degradation of APOBEC3G | R-HSA-180585 | 9.758801e-01 | 0.011 | 0 | 0 |
| GPVI-mediated activation cascade | R-HSA-114604 | 9.758801e-01 | 0.011 | 0 | 0 |
| Dectin-2 family | R-HSA-5621480 | 9.762526e-01 | 0.010 | 0 | 0 |
| Late SARS-CoV-2 Infection Events | R-HSA-9772573 | 9.762772e-01 | 0.010 | 0 | 0 |
| Voltage gated Potassium channels | R-HSA-1296072 | 9.778841e-01 | 0.010 | 0 | 0 |
| Degradation of AXIN | R-HSA-4641257 | 9.778841e-01 | 0.010 | 0 | 0 |
| SLC-mediated transport of organic cations | R-HSA-549127 | 9.778841e-01 | 0.010 | 0 | 0 |
| Lysine catabolism | R-HSA-71064 | 9.778841e-01 | 0.010 | 0 | 0 |
| NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux | R-HSA-9029569 | 9.779425e-01 | 0.010 | 0 | 0 |
| Immune System | R-HSA-168256 | 9.779656e-01 | 0.010 | 0 | 0 |
| PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | R-HSA-6811558 | 9.780835e-01 | 0.010 | 0 | 0 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 9.790127e-01 | 0.009 | 0 | 0 |
| Collagen formation | R-HSA-1474290 | 9.790127e-01 | 0.009 | 0 | 0 |
| Peroxisomal protein import | R-HSA-9033241 | 9.795157e-01 | 0.009 | 0 | 0 |
| Extension of Telomeres | R-HSA-180786 | 9.795157e-01 | 0.009 | 0 | 0 |
| Amino acid transport across the plasma membrane | R-HSA-352230 | 9.795157e-01 | 0.009 | 0 | 0 |
| alpha-linolenic acid (ALA) metabolism | R-HSA-2046106 | 9.797217e-01 | 0.009 | 0 | 0 |
| Purine salvage | R-HSA-74217 | 9.797217e-01 | 0.009 | 0 | 0 |
| Transcriptional regulation of pluripotent stem cells | R-HSA-452723 | 9.797217e-01 | 0.009 | 0 | 0 |
| tRNA Aminoacylation | R-HSA-379724 | 9.809798e-01 | 0.008 | 0 | 0 |
| Cross-presentation of soluble exogenous antigens (endosomes) | R-HSA-1236978 | 9.814067e-01 | 0.008 | 0 | 0 |
| Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1) | R-HSA-381771 | 9.814067e-01 | 0.008 | 0 | 0 |
| Signaling by ALK | R-HSA-201556 | 9.814067e-01 | 0.008 | 0 | 0 |
| Formation of paraxial mesoderm | R-HSA-9793380 | 9.823422e-01 | 0.008 | 0 | 0 |
| rRNA processing in the mitochondrion | R-HSA-8868766 | 9.829518e-01 | 0.007 | 0 | 0 |
| Regulation of RUNX3 expression and activity | R-HSA-8941858 | 9.829518e-01 | 0.007 | 0 | 0 |
| Maturation of TCA enzymes and regulation of TCA cycle | R-HSA-9854311 | 9.829518e-01 | 0.007 | 0 | 0 |
| G alpha (s) signalling events | R-HSA-418555 | 9.831813e-01 | 0.007 | 0 | 0 |
| NCAM signaling for neurite out-growth | R-HSA-375165 | 9.836096e-01 | 0.007 | 0 | 0 |
| Hh mutants are degraded by ERAD | R-HSA-5362768 | 9.843686e-01 | 0.007 | 0 | 0 |
| SPOP-mediated proteasomal degradation of PD-L1(CD274) | R-HSA-9929491 | 9.843686e-01 | 0.007 | 0 | 0 |
| NIK-->noncanonical NF-kB signaling | R-HSA-5676590 | 9.843686e-01 | 0.007 | 0 | 0 |
| FOXO-mediated transcription | R-HSA-9614085 | 9.855413e-01 | 0.006 | 0 | 0 |
| Intra-Golgi traffic | R-HSA-6811438 | 9.856677e-01 | 0.006 | 0 | 0 |
| Degradation of CRY and PER proteins | R-HSA-9932298 | 9.856677e-01 | 0.006 | 0 | 0 |
| Activation of GABAB receptors | R-HSA-991365 | 9.868589e-01 | 0.006 | 0 | 0 |
| GABA B receptor activation | R-HSA-977444 | 9.868589e-01 | 0.006 | 0 | 0 |
| Incretin synthesis, secretion, and inactivation | R-HSA-400508 | 9.868589e-01 | 0.006 | 0 | 0 |
| Post-translational protein modification | R-HSA-597592 | 9.869090e-01 | 0.006 | 0 | 0 |
| Interleukin-4 and Interleukin-13 signaling | R-HSA-6785807 | 9.870361e-01 | 0.006 | 0 | 0 |
| Hh mutants abrogate ligand secretion | R-HSA-5387390 | 9.879512e-01 | 0.005 | 0 | 0 |
| Synthesis of very long-chain fatty acyl-CoAs | R-HSA-75876 | 9.879512e-01 | 0.005 | 0 | 0 |
| Response of Mtb to phagocytosis | R-HSA-9637690 | 9.879512e-01 | 0.005 | 0 | 0 |
| Metabolism of proteins | R-HSA-392499 | 9.881119e-01 | 0.005 | 0 | 0 |
| SLC-mediated transport of amino acids | R-HSA-9958863 | 9.887315e-01 | 0.005 | 0 | 0 |
| Proteasome assembly | R-HSA-9907900 | 9.889527e-01 | 0.005 | 0 | 0 |
| SCF(Skp2)-mediated degradation of p27/p21 | R-HSA-187577 | 9.889527e-01 | 0.005 | 0 | 0 |
| Synthesis of Leukotrienes (LT) and Eoxins (EX) | R-HSA-2142691 | 9.889527e-01 | 0.005 | 0 | 0 |
| Cobalamin (Cbl, vitamin B12) transport and metabolism | R-HSA-196741 | 9.889527e-01 | 0.005 | 0 | 0 |
| O-linked glycosylation of mucins | R-HSA-913709 | 9.895495e-01 | 0.005 | 0 | 0 |
| Diseases associated with glycosaminoglycan metabolism | R-HSA-3560782 | 9.898711e-01 | 0.004 | 0 | 0 |
| Asymmetric localization of PCP proteins | R-HSA-4608870 | 9.898711e-01 | 0.004 | 0 | 0 |
| Defective CFTR causes cystic fibrosis | R-HSA-5678895 | 9.898711e-01 | 0.004 | 0 | 0 |
| Somitogenesis | R-HSA-9824272 | 9.898711e-01 | 0.004 | 0 | 0 |
| COPII-mediated vesicle transport | R-HSA-204005 | 9.910154e-01 | 0.004 | 0 | 0 |
| alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | R-HSA-2046104 | 9.914852e-01 | 0.004 | 0 | 0 |
| Diseases associated with O-glycosylation of proteins | R-HSA-3906995 | 9.916709e-01 | 0.004 | 0 | 0 |
| Metal ion SLC transporters | R-HSA-425410 | 9.921932e-01 | 0.003 | 0 | 0 |
| Antigen processing-Cross presentation | R-HSA-1236975 | 9.923492e-01 | 0.003 | 0 | 0 |
| PPARA activates gene expression | R-HSA-1989781 | 9.924355e-01 | 0.003 | 0 | 0 |
| N-glycan trimming in the ER and Calnexin/Calreticulin cycle | R-HSA-532668 | 9.928423e-01 | 0.003 | 0 | 0 |
| Chemokine receptors bind chemokines | R-HSA-380108 | 9.928423e-01 | 0.003 | 0 | 0 |
| Plasma lipoprotein assembly, remodeling, and clearance | R-HSA-174824 | 9.929461e-01 | 0.003 | 0 | 0 |
| Regulation of lipid metabolism by PPARalpha | R-HSA-400206 | 9.932306e-01 | 0.003 | 0 | 0 |
| ROS and RNS production in phagocytes | R-HSA-1222556 | 9.933693e-01 | 0.003 | 0 | 0 |
| Iron uptake and transport | R-HSA-917937 | 9.938562e-01 | 0.003 | 0 | 0 |
| Branched-chain amino acid catabolism | R-HSA-70895 | 9.939832e-01 | 0.003 | 0 | 0 |
| Hedgehog ligand biogenesis | R-HSA-5358346 | 9.939832e-01 | 0.003 | 0 | 0 |
| Cytosolic sulfonation of small molecules | R-HSA-156584 | 9.939832e-01 | 0.003 | 0 | 0 |
| FCERI mediated NF-kB activation | R-HSA-2871837 | 9.946858e-01 | 0.002 | 0 | 0 |
| NR1H2 and NR1H3-mediated signaling | R-HSA-9024446 | 9.947271e-01 | 0.002 | 0 | 0 |
| Metabolism of amino acids and derivatives | R-HSA-71291 | 9.948197e-01 | 0.002 | 0 | 0 |
| Cholesterol biosynthesis | R-HSA-191273 | 9.951159e-01 | 0.002 | 0 | 0 |
| Integrin cell surface interactions | R-HSA-216083 | 9.951159e-01 | 0.002 | 0 | 0 |
| FCERI mediated Ca+2 mobilization | R-HSA-2871809 | 9.957482e-01 | 0.002 | 0 | 0 |
| Role of phospholipids in phagocytosis | R-HSA-2029485 | 9.957482e-01 | 0.002 | 0 | 0 |
| Paracetamol ADME | R-HSA-9753281 | 9.957488e-01 | 0.002 | 0 | 0 |
| Peptide hormone metabolism | R-HSA-2980736 | 9.962750e-01 | 0.002 | 0 | 0 |
| Synthesis of PA | R-HSA-1483166 | 9.964266e-01 | 0.002 | 0 | 0 |
| Cytoprotection by HMOX1 | R-HSA-9707564 | 9.966754e-01 | 0.001 | 0 | 0 |
| Heparan sulfate/heparin (HS-GAG) metabolism | R-HSA-1638091 | 9.969965e-01 | 0.001 | 0 | 0 |
| Extracellular matrix organization | R-HSA-1474244 | 9.970192e-01 | 0.001 | 0 | 0 |
| GABA receptor activation | R-HSA-977443 | 9.972464e-01 | 0.001 | 0 | 0 |
| Metabolism of polyamines | R-HSA-351202 | 9.972464e-01 | 0.001 | 0 | 0 |
| Anti-inflammatory response favouring Leishmania parasite infection | R-HSA-9662851 | 9.974321e-01 | 0.001 | 1 | 0 |
| Leishmania parasite growth and survival | R-HSA-9664433 | 9.974321e-01 | 0.001 | 1 | 0 |
| Nucleotide salvage | R-HSA-8956321 | 9.974755e-01 | 0.001 | 0 | 0 |
| Collagen degradation | R-HSA-1442490 | 9.974755e-01 | 0.001 | 0 | 0 |
| Complex I biogenesis | R-HSA-6799198 | 9.978782e-01 | 0.001 | 0 | 0 |
| Disorders of transmembrane transporters | R-HSA-5619115 | 9.982511e-01 | 0.001 | 0 | 0 |
| tRNA modification in the nucleus and cytosol | R-HSA-6782315 | 9.983651e-01 | 0.001 | 0 | 0 |
| Metabolism of steroid hormones | R-HSA-196071 | 9.985012e-01 | 0.001 | 0 | 0 |
| Collagen biosynthesis and modifying enzymes | R-HSA-1650814 | 9.986259e-01 | 0.001 | 0 | 0 |
| Innate Immune System | R-HSA-168249 | 9.988302e-01 | 0.001 | 0 | 0 |
| Retinoid metabolism and transport | R-HSA-975634 | 9.989414e-01 | 0.000 | 0 | 0 |
| Metabolism of cofactors | R-HSA-8978934 | 9.989414e-01 | 0.000 | 0 | 0 |
| ECM proteoglycans | R-HSA-3000178 | 9.989414e-01 | 0.000 | 0 | 0 |
| Metabolism of porphyrins | R-HSA-189445 | 9.989414e-01 | 0.000 | 0 | 0 |
| Potassium Channels | R-HSA-1296071 | 9.990443e-01 | 0.000 | 0 | 0 |
| Diseases of carbohydrate metabolism | R-HSA-5663084 | 9.991103e-01 | 0.000 | 0 | 0 |
| Post-translational protein phosphorylation | R-HSA-8957275 | 9.991835e-01 | 0.000 | 0 | 0 |
| Synthesis of bile acids and bile salts | R-HSA-192105 | 9.992453e-01 | 0.000 | 0 | 0 |
| Citric acid cycle (TCA cycle) | R-HSA-71403 | 9.992523e-01 | 0.000 | 0 | 0 |
| ABC-family proteins mediated transport | R-HSA-382556 | 9.993025e-01 | 0.000 | 0 | 0 |
| Nuclear Receptor transcription pathway | R-HSA-383280 | 9.994240e-01 | 0.000 | 0 | 0 |
| ABC transporter disorders | R-HSA-5619084 | 9.994240e-01 | 0.000 | 0 | 0 |
| Developmental Lineage of Pancreatic Acinar Cells | R-HSA-9925561 | 9.994720e-01 | 0.000 | 0 | 0 |
| Metabolism of fat-soluble vitamins | R-HSA-6806667 | 9.995563e-01 | 0.000 | 0 | 0 |
| Asparagine N-linked glycosylation | R-HSA-446203 | 9.996248e-01 | 0.000 | 0 | 0 |
| TNFR2 non-canonical NF-kB pathway | R-HSA-5668541 | 9.996272e-01 | 0.000 | 0 | 0 |
| Visual phototransduction | R-HSA-2187338 | 9.996367e-01 | 0.000 | 0 | 0 |
| G alpha (i) signalling events | R-HSA-418594 | 9.996385e-01 | 0.000 | 1 | 0 |
| Metabolism of carbohydrates and carbohydrate derivatives | R-HSA-71387 | 9.996534e-01 | 0.000 | 0 | 0 |
| Keratinization | R-HSA-6805567 | 9.996714e-01 | 0.000 | 0 | 0 |
| Bile acid and bile salt metabolism | R-HSA-194068 | 9.997083e-01 | 0.000 | 0 | 0 |
| Degradation of the extracellular matrix | R-HSA-1474228 | 9.997474e-01 | 0.000 | 0 | 0 |
| FCERI mediated MAPK activation | R-HSA-2871796 | 9.997513e-01 | 0.000 | 0 | 0 |
| Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs) | R-HSA-381426 | 9.998043e-01 | 0.000 | 0 | 0 |
| Class B/2 (Secretin family receptors) | R-HSA-373080 | 9.998141e-01 | 0.000 | 0 | 0 |
| Interferon alpha/beta signaling | R-HSA-909733 | 9.998332e-01 | 0.000 | 0 | 0 |
| Metabolism of nucleotides | R-HSA-15869 | 9.998365e-01 | 0.000 | 0 | 0 |
| Mitochondrial Fatty Acid Beta-Oxidation | R-HSA-77289 | 9.998898e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation elongation | R-HSA-5389840 | 9.999074e-01 | 0.000 | 0 | 0 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 9.999074e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation initiation | R-HSA-5368286 | 9.999222e-01 | 0.000 | 0 | 0 |
| Mitochondrial ribosome-associated quality control | R-HSA-9937383 | 9.999497e-01 | 0.000 | 0 | 0 |
| Phospholipid metabolism | R-HSA-1483257 | 9.999569e-01 | 0.000 | 0 | 0 |
| Post-translational modification: synthesis of GPI-anchored proteins | R-HSA-163125 | 9.999577e-01 | 0.000 | 0 | 0 |
| Glycerophospholipid biosynthesis | R-HSA-1483206 | 9.999704e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation termination | R-HSA-5419276 | 9.999726e-01 | 0.000 | 0 | 0 |
| Antimicrobial peptides | R-HSA-6803157 | 9.999770e-01 | 0.000 | 0 | 0 |
| O-linked glycosylation | R-HSA-5173105 | 9.999778e-01 | 0.000 | 0 | 0 |
| Metabolism of water-soluble vitamins and cofactors | R-HSA-196849 | 9.999815e-01 | 0.000 | 0 | 0 |
| GPCR downstream signalling | R-HSA-388396 | 9.999865e-01 | 0.000 | 1 | 0 |
| Infection with Mycobacterium tuberculosis | R-HSA-9635486 | 9.999919e-01 | 0.000 | 0 | 0 |
| G alpha (q) signalling events | R-HSA-416476 | 9.999925e-01 | 0.000 | 0 | 0 |
| Binding and Uptake of Ligands by Scavenger Receptors | R-HSA-2173782 | 9.999929e-01 | 0.000 | 0 | 0 |
| Sensory perception of sweet, bitter, and umami (glutamate) taste | R-HSA-9717207 | 9.999932e-01 | 0.000 | 0 | 0 |
| Arachidonate metabolism | R-HSA-2142753 | 9.999940e-01 | 0.000 | 0 | 0 |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | R-HSA-198933 | 9.999957e-01 | 0.000 | 0 | 0 |
| Diseases of glycosylation | R-HSA-3781865 | 9.999963e-01 | 0.000 | 0 | 0 |
| Sensory perception of taste | R-HSA-9717189 | 9.999972e-01 | 0.000 | 0 | 0 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 9.999976e-01 | 0.000 | 0 | 0 |
| Drug ADME | R-HSA-9748784 | 9.999983e-01 | 0.000 | 0 | 0 |
| Mitochondrial translation | R-HSA-5368287 | 9.999986e-01 | 0.000 | 0 | 0 |
| Sphingolipid metabolism | R-HSA-428157 | 9.999990e-01 | 0.000 | 0 | 0 |
| Metabolism of steroids | R-HSA-8957322 | 9.999995e-01 | 0.000 | 0 | 0 |
| Signaling by GPCR | R-HSA-372790 | 9.999997e-01 | 0.000 | 1 | 0 |
| Glycosaminoglycan metabolism | R-HSA-1630316 | 9.999998e-01 | 0.000 | 0 | 0 |
| Aerobic respiration and respiratory electron transport | R-HSA-1428517 | 9.999998e-01 | 0.000 | 0 | 0 |
| SLC-mediated transmembrane transport | R-HSA-425407 | 9.999999e-01 | 0.000 | 0 | 0 |
| Respiratory electron transport | R-HSA-611105 | 1.000000e+00 | 0.000 | 0 | 0 |
| Transport of small molecules | R-HSA-382551 | 1.000000e+00 | 0.000 | 0 | 0 |
| Metabolism of vitamins and cofactors | R-HSA-196854 | 1.000000e+00 | 0.000 | 0 | 0 |
| Bacterial Infection Pathways | R-HSA-9824439 | 1.000000e+00 | 0.000 | 0 | 0 |
| Peptide ligand-binding receptors | R-HSA-375276 | 1.000000e+00 | 0.000 | 0 | 0 |
| Fatty acid metabolism | R-HSA-8978868 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase II - Conjugation of compounds | R-HSA-156580 | 1.000000e+00 | 0.000 | 0 | 0 |
| Phase I - Functionalization of compounds | R-HSA-211945 | 1.000000e+00 | 0.000 | 0 | 0 |
| Class A/1 (Rhodopsin-like receptors) | R-HSA-373076 | 1.000000e+00 | 0.000 | 0 | 0 |
| Diseases of metabolism | R-HSA-5668914 | 1.000000e+00 | 0.000 | 0 | 0 |
| Expression and translocation of olfactory receptors | R-HSA-9752946 | 1.000000e+00 | -0.000 | 0 | 0 |
| Olfactory Signaling Pathway | R-HSA-381753 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism | R-HSA-1430728 | 1.000000e+00 | -0.000 | 0 | 0 |
| Metabolism of lipids | R-HSA-556833 | 1.000000e+00 | -0.000 | 0 | 0 |
| Sensory Perception | R-HSA-9709957 | 1.000000e+00 | -0.000 | 0 | 0 |
| GPCR ligand binding | R-HSA-500792 | 1.000000e+00 | -0.000 | 0 | 0 |
| Biological oxidations | R-HSA-211859 | 1.000000e+00 | -0.000 | 0 | 0 |